{"SLR NAME":"Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis","References":[{"title1":"Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes","References":[{"title2":"Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships","References":[{"title3":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission"},{"title3":"Rising rural body-mass index is the main driver of the global obesity epidemic in adults"},{"title3":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 128.9 million participants"},{"title3":"Dynamics of the double burden of malnutrition and the changing nutrition reality"},{"title3":"Diet, nutrition, physical activity and cancer: a global perspective (A summary of the third expert report)"},{"title3":"Diet, nutrition, physical activity and cancer: a global perspective"},{"title3":"Health effects of overweight and obesity in 195 countries over 25 years"},{"title3":"Covid-19: wave 2, 27-30 March among connected South African consumers"},{"title3":"Body mass index is associated with the development of acute respiratory distress syndrome"},{"title3":"A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1)"},{"title3":"Recent underweight and overweight trends by rural-urban residence among women in low- and middle-income countries"},{"title3":"Recent dynamics suggest selected countries catching up to US obesity"},{"title3":"The obesity epidemic is a worldwide phenomenon"},{"title3":"New dynamics in global obesity facing low- and middle-income countries"},{"title3":"Cross-national comparisons of time trends in overweight inequality by socioeconomic status among women using repeated cross-sectional surveys from 37 developing countries, 1989-2007"},{"title3":"Is the burden of overweight shifting to the poor across the globe? Time trends among women in 39 low- and middle-income countries (1991-2008)"},{"title3":"Socioeconomic status and obesity in adult populations of developing countries: a review"},{"title3":"Exploring secular changes in the association between BMI and waist circumference in Mexican-origin and white women: a comparison of Mexico and the United States"},{"title3":"Is waist circumference per body mass index rising differentially across the United States, England, China and Mexico"},{"title3":"Changes in waist circumference relative to body mass index in Chinese adults, 1993-2009"},{"title3":"Weight of nations: a socioeconomic analysis of women in low- to middle-income countries"},{"title3":"Predictors of COVID-19 incidence, mortality, and epidemic growth rate at the country level"},{"title3":"Smoking and the risk of COVID-19 infection in the UK Biobank Prospective Study"},{"title3":"Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico"},{"title3":"Risk of infection and hospitalization by Covid-19 in Mexico: a case-control study"},{"title3":"Vitamin D status, body mass index, ethnicity and COVID-19: initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723)"},{"title3":"Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study"},{"title3":"ICNARC report on COVID-19 in critical care 10 July 2020"},{"title3":"Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank"},{"title3":"Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study"},{"title3":"Obesity is a risk factor for greater COVID-19 severity"},{"title3":"Low plasma 25(OH) vitamin D3 level is associated with increased risk of COVID-19 infection: an Israeli population-based study"},{"title3":"Comorbidities might be a risk factor for the incidence of COVID-19: evidence from a web-based survey of 780,961 participants"},{"title3":"Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes"},{"title3":"The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths among 5,627,520 people"},{"title3":"The association between obesity, type 2 diabetes, and hypertension with severe COVID-19 on admission among Mexicans"},{"title3":"Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases"},{"title3":"COVID-19 outcomes, risk factors and associations by race: a comprehensive analysis using electronic health records data in Michigan Medicine"},{"title3":"Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study"},{"title3":"Death by SARS-CoV2:a Romanian COVID-19 multi-centre comorbidity study"},{"title3":"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Individuals with obesity"},{"title3":"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City"},{"title3":"Pre-existing characteristics associated with Covid-19 illness severity"},{"title3":"Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico"},{"title3":"Lifestyle risk factors for cardiovascular disease in relation to COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK"},{"title3":"What factors increase the risk of complications in SARS-CoV-2 positive patients? A cohort study in a nationwide Israeli health organization"},{"title3":"Special report: prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020"},{"title3":"A primary care approach to the COVID-19 pandemic: clinical features and natural history of 2,073 suspected cases in the Corona Sao Caetano programme, Sao Paulo, Brazil"},{"title3":"Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a tertiary care center in Mexico City: a prospective cohort study"},{"title3":"Outcomes of COVID-19 in patients with obesity in United States: a large research network study"},{"title3":"Prognostic factors in Spanish Covid-19 patients: a case series from Barcelona"},{"title3":"In young adults with COVID-19, obesity is associated with adverse outcomes"},{"title3":"Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit"},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 states, March 1-30, 2020"},{"title3":"Personalized predictive models for symptomatic COVID-19 patients using basic preconditions: hospitalizations, mortality, and the need for an ICU or ventilator"},{"title3":"Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)"},{"title3":"Covid-19 in critically ill patients in the Seattle Region:case series"},{"title3":"Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia"},{"title3":"Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Critical care for severe COVID-19: a population-based study from a province with low case-fatality rate in China"},{"title3":"Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series"},{"title3":"Ethnicity, comorbidity, socioeconomic status, and their associations with COVID-19 infection in England: a cohort analysis of UK Biobank data"},{"title3":"Non-white ethnicity, male sex, and higher body mass index, but not medications acting on the renin-angiotensin system are associated with coronavirus disease 2019 (COVID-19) hospitalisation: review of the first 669 cases from the UK biobank"},{"title3":"Global status report on noncommunicable diseases 2014"},{"title3":"Obesity and COVID-19 severity in a designated hospital in Shenzhen, China (3/13/2020)"},{"title3":"Association of obesity with disease severity among patients with COVID-19"},{"title3":"C-Reactive protein and SOFA score as early predictors of critical care requirement in patients with COVID-19 pneumonia in Spain"},{"title3":"Interim analysis of risk factors for severe outcomes among a cohort of hospitalized adults identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)"},{"title3":"Is sleep apnoea a risk factor for Covid-19? Findings from a retrospective cohort study"},{"title3":"Prevalence of obesity among adult inpatients with COVID-19 in France"},{"title3":"COVID-19: impact of obesity and diabetes in disease severity"},{"title3":"Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: a retrospective, descriptive, multiple-center study"},{"title3":"Derivation and validation of a predictive score for disease worsening in patients with COVID-19: the COMPASS-COVID-19 prospective observational cohort study"},{"title3":"Obesity is associated with worse outcomes in COVID-19: analysis of early data from New York City"},{"title3":"Risk Factors Associated with Severe COVID-19 in Eastern France: Analysis of 1045 Cases"},{"title3":"Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 atients"},{"title3":"Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19"},{"title3":"Clinical course and potential predicting factors of pneumonia of adult patients with coronavirus disease 2019 (COVID-19): a retrospective observational analysis of 193 confirmed cases in Thailand"},{"title3":"Obesity is associated with severe forms of COVID-19"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study"},{"title3":"Demographics, comorbidities and outcomes in hospitalized Covid-19 patients in rural Southwest Georgia"},{"title3":"Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility"},{"title3":"Lung disease severity, coronary artery calcium, coronary inflammation and mortality in coronavirus disease 2019"},{"title3":"Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy"},{"title3":"Fatality rate and predictors of mortality in a large Italian cohort of hospitalized COVID-19 patients"},{"title3":"Ethnicity and risk of death in patients hospitalised for COVID-19 infection: an observational cohort study in an urban catchment area"},{"title3":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward"},{"title3":"Correlation of coagulation parameters with clinical outcomes in coronavirus-19 affected minorities in United States: observational cohort"},{"title3":"Ethnic and regional variation in hospital mortality from COVID-19 in Brazil"},{"title3":"A cohort of patients with COVID-19 in a major teaching hospital in Europe"},{"title3":"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol"},{"title3":"30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study"},{"title3":"Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China"},{"title3":"Survival in adult inpatients with COVID-19"},{"title3":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York"},{"title3":"Obesity as a risk factor for unfavourable outcomes in critically ill patients affected by Covid-19 related respiratory failure: clinical relevance and potential pathophysiological mechanism"},{"title3":"Predicting the disease outcome in COVID-19 positive patients through machine learning: a retrospective cohort study with Brazilian data"},{"title3":"Sociodemographic predictors of outcomes in COVID-19: examining the impact of ethnic disparities in Northern Nevada"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Immunology of COVID-19: current state of the science"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Individuals with obesity and the outcome of infection"},{"title3":"Obesity and the risk and outcome of infection"},{"title3":"Obesity paradox, obesity orthodox, and the metabolic syndrome: an approach to unity"},{"title3":"Adipocytokines and the metabolic complications of obesity"},{"title3":"Metabolic effects of obesity: a review"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Molecular understanding of hyperglycemia's adverse effects for diabetic complications"},{"title3":"Insulin receptor-mediated stimulation boosts T cell immunity during inflammation and infection"},{"title3":"Leptin metabolically licenses T cells for activation to link nutrition and immunity"},{"title3":"Metabolic regulation of immune responses"},{"title3":"n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases"},{"title3":"Polyunsaturated fatty acids and inflammation"},{"title3":"Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling"},{"title3":"Polyunsaturated fatty acids in the food chain in the United States"},{"title3":"Hormonal dysregulation and unbalanced specialized pro-resolving mediator biosynthesis contribute toward impaired B cell outcomes in obesity"},{"title3":"Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2"},{"title3":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease"},{"title3":"Obesity and impaired metabolic health in patients with COVID-19"},{"title3":"Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms"},{"title3":"Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype"},{"title3":"Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity"},{"title3":"Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection"},{"title3":"Immunophenotyping of COVID-19 and influenza s the role of type I interferons in development of severe COVID-19"},{"title3":"Role of innate and adaptive immunity in obesity-associated metabolic disease"},{"title3":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes"},{"title3":"T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans"},{"title3":"Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFalpha production"},{"title3":"Fatty acid metabolites combine with reduced beta oxidation to activate Th17 inflammation in human type 2 diabetes"},{"title3":"Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019?"},{"title3":"Obesity expands a distinct population of T cells in adipose tissue and increases vulnerability to infection"},{"title3":"The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Mechanisms and clinical consequences of acute lung injury"},{"title3":"&quot;Obesity Paradox&quot; in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Middle East respiratory syndrome: emergence of a pathogenic human coronavirus"},{"title3":"Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection"},{"title3":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study"},{"title3":"Clinical and immunological features of severe and moderate coronavirus disease 2019"},{"title3":"Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus"},{"title3":"Obesity in men: the hypogonadal-estrogen receptor relationship and its effect on glucose homeostasis"},{"title3":"Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation"},{"title3":"17beta-Estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs"},{"title3":"Increased estrogen production in obese men"},{"title3":"Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)"},{"title3":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"},{"title3":"Pharmacotherapy in COVID-19; a narrative review for emergency providers"},{"title3":"Cytokine release syndrome in severe COVID-19"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"Effect of dexamethasone in hospitalized patients with Covid-19: preliminary report"},{"title3":"Dexamethasone in the management of covid-19"},{"title3":"Obesity is associated with impaired immune response to influenza vaccination in humans"},{"title3":"Increased risk of influenza among vaccinated adults who are obese"},{"title3":"Obesity outweighs protection conferred by adjuvanted influenza vaccination"},{"title3":"Reduced tetanus antibody titers in overweight children"},{"title3":"The weight of obesity on the human immune response to vaccination"},{"title3":"Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection"},{"title3":"Duration of antibody responses after severe acute respiratory syndrome"},{"title3":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals"},{"title3":"Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors"},{"title3":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls"},{"title3":"SARS-CoV-2 T cell immunity: specificity, function, durability, and role in protection"},{"title3":"2020 Global nutrition report: action on equity to end malnutrition"},{"title3":"COVID-19-related school closings and risk of weight gain among children"},{"title3":"Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey"},{"title3":"The impact of coronavirus on packaged and fresh food"},{"title3":"Association between consumption of ultra-processed foods and all cause mortality: SUN prospective cohort study"},{"title3":"Ultraprocessed food consumption and risk of overweight and obesity: the University of Navarra Follow-Up (SUN) cohort study"},{"title3":"Ultra-processed food consumption and adiposity trajectories in a Brazilian cohort of adolescents: ELANA study"},{"title3":"Ultra-processed food consumption and the incidence of hypertension in a Mediterranean cohort: the Seguimiento Universidad de Navarra Project"},{"title3":"Relationships between consumption of ultra-processed foods, gestational weight gain and neonatal outcomes in a sample of US pregnant women"},{"title3":"Global trends in ultraprocessed food and drink product sales and their association with adult body mass index trajectories"},{"title3":"Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake"},{"title3":"Ultra-processed food and adverse health outcomes"},{"title3":"Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Sante)"},{"title3":"Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort"},{"title3":"Consumption of ultra-processed food products and its effects on children's lipid profiles: a longitudinal study"},{"title3":"Prospective association between ultra-processed food consumption and incident depressive symptoms in the French NutriNet-Sante cohort"},{"title3":"Ultra-processed food consumption and its effects on anthropometric and glucose profile: a longitudinal study during childhood"},{"title3":"Ultra-processed food consumption and the incidence of depression in a Mediterranean cohort: the SUN Project"},{"title3":"Ultra-processed food intake and mortality in the USA: results from the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994)"},{"title3":"Ultra-processed food consumption and chronic non-communicable diseases-related dietary nutrient profile in the UK (2008-2014)"},{"title3":"Ultra-processed food consumption and incident frailty: a prospective cohort study of older adults"},{"title3":"Association between ultraprocessed food consumption and risk of mortality among middle-aged adults in France"},{"title3":"Exploratory analysis of nutritional quality and metrics of snack consumption among Nepali children during the complementary feeding period"},{"title3":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period"},{"title3":"Structural responses to the obesity and non-communicable diseases epidemic: update on the Chilean law of food labelling and advertising"},{"title3":"An evaluation of Chile's Law of Food Labeling and Advertising on sugar-sweetened beverage purchases from 2015 to 2017: a before-and-after study"},{"title3":"Strengthening local food systems in times of concomitant global crises: reflections from Chile"},{"title3":"Policy and practice:regulatory measures to improve the built nutrition environment for prevention of individuals with obesity and related morbidity in Israel"}]},{"title2":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","References":[{"title3":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia:a systematic review, meta-analysis, and meta-regression"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Report of characteristics of patients who died positive for COVID-19 in Italy"},{"title3":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study"},{"title3":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients"},{"title3":"National diabetes audit:report 1: care processes and treatment targets 2018-19, short report"},{"title3":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"},{"title3":"Bridges to Health Segmentation Model: person-level clinical segmentation data model"},{"title3":"English indices of deprivation 2019"},{"title3":"NOMIS official labour market statistics. Ethnic group by sex by age"},{"title3":"Deaths involving COVID-19 in the care sector, England and Wales: deaths occurring up to 1 May 2020 and registered up to 9 May 2020 (provisional)"},{"title3":"National diabetes audit:report 2: complications and mortality, 2017-18"},{"title3":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis"}]},{"title2":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","References":[]},{"title2":"A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes","References":[]},{"title2":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study","References":[]},{"title2":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","References":[]},{"title2":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis","References":[]},{"title2":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease","References":[{"title3":"Chronic obstructive pulmonary disease: current burden and future projections"},{"title3":"Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary"},{"title3":"Systemic effects of chronic obstructive pulmonary disease"},{"title3":"Global initiative for chronic obstructive lung D. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary"},{"title3":"Evaluation of CLtIPSEI. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort"},{"title3":"The natural history of chronic obstructive pulmonary disease"},{"title3":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030"},{"title3":"Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD"},{"title3":"Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature"},{"title3":"Diabetes mellitus in patients with chronic obstructive pulmonary disease-the impact on mortality"},{"title3":"Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease"},{"title3":"Predictors of rehospitalization and death after a severe exacerbation of COPD"},{"title3":"Standards of medical care in diabetes--2013"},{"title3":"Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects"},{"title3":"Diabetes prevention program research G. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance"},{"title3":"Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose"},{"title3":"Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease"},{"title3":"Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study"},{"title3":"The impact of insulin sensitisers on lung function in patients with chronic obstructive pulmonary disease and diabetes"},{"title3":"Respiratory effects of insulin sensitisation with metformin: a prospective observational study"},{"title3":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary"},{"title3":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review"},{"title3":"Recent improvement in long-term survival after a COPD hospitalisation"},{"title3":"7. Approaches to glycemic treatment"},{"title3":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report"},{"title3":"Toward a clearer definition of confounding"},{"title3":"COPD in Taiwan: a National Epidemiology Survey"},{"title3":"Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus"},{"title3":"Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: a matched-subject design"},{"title3":"Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus"},{"title3":"Anti-inflammatory effects of metformin irrespective of Diabetes status"},{"title3":"Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase"},{"title3":"Metformin attenuates lung fibrosis development via NOX4 suppression"},{"title3":"Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation"},{"title3":"Skeletal muscle mitochondrial dysfunction &amp; diabetes"},{"title3":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes"},{"title3":"Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats"},{"title3":"Prevalence of comorbidities in patients with chronic obstructive pulmonary disease"},{"title3":"Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: two nationwide population-based retrospective cohort studies"},{"title3":"Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: a nation-wide cohort twin study"}]},{"title2":"Association of metformin and mortality for patients with diabetes who are hospitalized with pneumonia","References":[]},{"title2":"Association of metformin initiation and risk of asthma exacerbation. a claims-based cohort study","References":[]},{"title2":"Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies","References":[{"title3":"Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Patients with sepsis in infectious diseases department in years 1997-2010 - epidemiology and clinical features"},{"title3":"Early management of sepsis"},{"title3":"Cytokine storm and sepsis disease pathogenesis"},{"title3":"Conventional drug therapy for inflammatory bowel disease"},{"title3":"Inflammasomes on the crossroads of innate immune recognition and metabolic control"},{"title3":"Metformin; a review of its history and future: from lilac to longevity"},{"title3":"Gray SG, McGuire TM, Cohen N, Little PJ. The emerging role of metformin in gestational diabetes mellitus. Diabetes Obes Metab. 2017;19(6):765-72."},{"title3":"Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase"},{"title3":"Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury"},{"title3":"Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells"},{"title3":"Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice"},{"title3":"Metformin attenuated endotoxin-induced acute myocarditis via activating AMPK"},{"title3":"Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer"},{"title3":"Current understanding of metformin effect on the control of hyperglycemia in diabetes"},{"title3":"AMP-activated protein kinase and glycogen synthase kinase 3beta modulate the severity of Sepsis-induced lung injury"},{"title3":"Stimulation of brain AMP-activated protein kinase attenuates inflammation and acute lung injury in Sepsis"},{"title3":"Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation"},{"title3":"Lactic acidosis and severe septic shock in metformin users: a cohort study"},{"title3":"Jochmans S, Alphonsine JE, Chelly J, Vong LVP, Sy O, Rolin N, Ellrodt O, Monchi M, Vinsonneau C. Does metformin exposure before ICU stay have any impact on patients' outcome? A retrospective cohort study of diabetic patients. Ann Intensive Care. 2017;7(1):116."},{"title3":"Impact of metformin use on the prognostic value of lactate in sepsis"},{"title3":"Impact of metformin use on lactate kinetics in patients with severe sepsis and septic shock"},{"title3":"Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients"},{"title3":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group"},{"title3":"Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction"},{"title3":"Operating characteristics of a rank correlation test for publication bias"},{"title3":"Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity"},{"title3":"Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community"},{"title3":"Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes"},{"title3":"Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C"},{"title3":"Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study"},{"title3":"Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin"},{"title3":"Metformin inhibits Porphyromonas gingivalis lipopolysaccharide-influenced inflammatory response in human gingival fibroblasts via regulating activating transcription factor-3 expression"},{"title3":"Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction"},{"title3":"Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart"},{"title3":"Metformin protects against LPS-induced intestinal barrier dysfunction by activating AMPK pathway"},{"title3":"The alleviative effects of metformin for lipopolysaccharide-induced acute lung injury rat model and its underlying mechanism"},{"title3":"Metformin alleviated endotoxemia-induced acute lung injury via restoring AMPK-dependent suppression of mTOR"},{"title3":"Effect of metformin on survival rate in experimental sepsis"},{"title3":"Cheng SC, Scicluna BP, Arts RJ, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol. 2016;17(4):406-13."},{"title3":"Glucose feeds the TCA cycle via circulating lactate"},{"title3":"Outcome of severe lactic acidosis associated with metformin accumulation"},{"title3":"Metformin-induced lactic acidosis: no one left behind"},{"title3":"Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process"},{"title3":"Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin"},{"title3":"Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with type 2 diabetes mellitus"},{"title3":"Metformin attenuates production of nitric oxide in response to lipopolysaccharide by inhibiting MyD88-independent pathway"},{"title3":"AMPK: a nutrient and energy sensor that maintains energy homeostasis"},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase"},{"title3":"Metformin can inhibit helicobacter pylori growth"},{"title3":"Malik F, Mehdi SF. Is metformin poised for a second career as an antimicrobial? Diabetes Metab Res Rev. 2018;34(4):e2975."}]},{"title2":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","References":[]},{"title2":"Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis","References":[]},{"title2":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection","References":[{"title3":"Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes"},{"title3":"Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection"},{"title3":"Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection"},{"title3":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression"},{"title3":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis"},{"title3":"Metformin in COVID-19: a possible role beyond diabetes"},{"title3":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations"},{"title3":"COVID-19 and diabetes: is metformin a friend or foe?"},{"title3":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward"}]},{"title2":"Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19","References":[{"title3":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures"},{"title3":"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19"},{"title3":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy"},{"title3":"Sex difference and smoking predisposition in patients with COVID-19"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China"},{"title3":"Identification of sex-specific thresholds for accumulation of visceral adipose tissue in adults"},{"title3":"Medical consequences of obesity"},{"title3":"Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes"},{"title3":"Difficulties in diagnosing pulmonary embolism in the obese patient: a literature review"},{"title3":"Immunomodulation in COVID-19"},{"title3":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs"},{"title3":"Does Therapy With Anti-TNF-alpha Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?"},{"title3":"Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1beta (IL-1beta) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages"},{"title3":"Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock"},{"title3":"Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus"},{"title3":"Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients"},{"title3":"The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment"},{"title3":"Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review"},{"title3":"Regression Shrinkage and Selection Via the Lasso"},{"title3":"How to handle mortality when investigating length of hospital stay and time to clinical stability"},{"title3":"Remdesivir for the Treatment of Covid-19 - Preliminary Report"},{"title3":"Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching"},{"title3":"Variable selection for propensity score models"},{"title3":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease"},{"title3":"Tumor necrosis factor-alpha signaling in macrophages"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"The mechanisms of action of metformin"},{"title3":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States"},{"title3":"AMPK: a balancer of the renin-angiotensin system"},{"title3":"Metformin in COVID-19: A possible role beyond diabetes"},{"title3":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues"},{"title3":"Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study"},{"title3":"Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China"},{"title3":"Can we predict the severity of COVID-19 with a routine blood test?"},{"title3":"Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis"},{"title3":"Severe Covid-19"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Sex differences in immune responses"},{"title3":"Metformin inhibits IgE- and aryl hydrocarbon receptor-mediated mast cell activation in vitro and in vivo"},{"title3":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy"},{"title3":"Sexual dimorphism in the mast cell transcriptome and the pathophysiological responses to immunological and psychological stress"},{"title3":"Antihypertensive drugs and risk of COVID-19?"},{"title3":"Stereoselectivity at the beta2-adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists"},{"title3":"Metformin in 2019"},{"title3":"Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes"},{"title3":"National Survey of Primary Care Physicians' Knowledge, Practices, and Perceptions of Prediabetes"},{"title3":"Dropping Highly Collinear Variables from a Model: Why it Typically is Not a Good Idea*"},{"title3":"Collinearity and Causal Diagrams: A Lesson on the Importance of Model Specification"}]},{"title2":"Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes","References":[]},{"title2":"AMPK: a balancer of the renin-angiotensin system","References":[{"title3":"The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases"},{"title3":"Renin-angiotensin system: biochemistry and mechanisms of action"},{"title3":"Angiotensin II induces insulin resistance independent of changes in interstitial insulin"},{"title3":"Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism"},{"title3":"Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2"},{"title3":"Dysregulation of the renin-angiotensin system and the vasopressinergic system interactions in cardiovascular disorders"},{"title3":"AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease"},{"title3":"AMPK activation enhances PPARalpha activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway"},{"title3":"AMP-activated protein kinase sparks the fire of cardioprotection against myocardial ischemia and cardiac ageing"},{"title3":"Apelin ameliorates high glucose-induced downregulation of Connexin 43 via AMPK-dependent pathway in neonatal rat cardiomyocytes"},{"title3":"Angiotensin II receptors and functional correlates"},{"title3":"Role of renin-angiotensin system blockades in reciprocal relationship between insulin resistance and endothelial dysfunction"},{"title3":"Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease"},{"title3":"Modulation of the renin-angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training"},{"title3":"The ACE2/Angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)"},{"title3":"Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened"},{"title3":"Angiotensin-(1-7): beyond the cardio-renal actions"},{"title3":"The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle"},{"title3":"AT1 receptor signaling pathways in the cardiovascular system"},{"title3":"The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity"},{"title3":"Renin-angiotensin system and cardiovascular risk"},{"title3":"Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons"},{"title3":"Angiotensin II stimulation of the stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin AT1 receptor subtype"},{"title3":"Water deprivation upregulates ANG II AT1 binding and mRNA in rat subfornical organ and anterior pituitary"},{"title3":"Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas"},{"title3":"Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7)"},{"title3":"Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis"},{"title3":"Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro"},{"title3":"Gene therapy with angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction"},{"title3":"Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor"},{"title3":"Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system"},{"title3":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology"},{"title3":"Angiotensin III: a physiological relevant peptide of the renin angiotensin system"},{"title3":"Alamandine: a new member of the angiotensin family"},{"title3":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system"},{"title3":"Sugar or fat: the metabolic choice of the trained heart"},{"title3":"Can exercise teach us how to treat heart disease?"},{"title3":"AMP-activated protein kinase: an ubiquitous signaling pathway with key roles in the cardiovascular system"},{"title3":"Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status"},{"title3":"Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation"},{"title3":"Structure of mammalian AMPK and its regulation by ADP"},{"title3":"AMPK orchestrates an elaborate cascade protecting tissue from fibrosis and aging"},{"title3":"Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?"},{"title3":"Interplay between adenylate metabolizing enzymes and AMP-activated protein kinase"},{"title3":"AMP-activated protein kinase, stress responses and cardiovascular diseases"},{"title3":"AMP-activated protein kinase as a reprogramming strategy for hypertension and kidney disease of developmental origin"},{"title3":"Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade"},{"title3":"Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding"},{"title3":"Regulation and function of AMPK in physiology and diseases"},{"title3":"AMPK activators: mechanisms of action and physiological activities"},{"title3":"Mechanism of action of compound-13: an alpha1-selective small molecule activator of AMPK"},{"title3":"PPAR control: it's SIRTainly as easy as PGC"},{"title3":"Prostaglandin E2 negatively regulates AMP-activated protein kinase via protein kinase A signaling pathway"},{"title3":"AMPK: a nutrient and energy sensor that maintains energy homeostasis"},{"title3":"AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease"},{"title3":"A potential strategy for treating atherosclerosis: improving endothelial function via AMP-activated protein kinase"},{"title3":"Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway"},{"title3":"Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function"},{"title3":"AMPK: a therapeutic target of heart failure-not only metabolism regulation"},{"title3":"AMPK blunts chronic heart failure by inhibiting autophagy"},{"title3":"The effects of ginsenoside Rb1 on fatty acid beta-oxidation, mediated by AMPK, in the failing heart"},{"title3":"AMPK and cardiac remodelling"},{"title3":"Dichloroacetate ameliorates cardiac dysfunction caused by ischemic insults through AMPK signal pathway-not only shifts metabolism"},{"title3":"Quercetin-induced AMP-activated protein kinase activation attenuates vasoconstriction through LKB1-AMPK signaling pathway"},{"title3":"Emerging role of AMPK in brown and beige adipose tissue (BAT): implications for obesity, insulin resistance, and Type 2 diabetes"},{"title3":"AMPK at the nexus of energetics and aging"},{"title3":"Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review)"},{"title3":"AMPK-sensing energy while talking to other signaling pathways"},{"title3":"Signaling by the angiotensin-converting enzyme"},{"title3":"Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function"},{"title3":"Role of AMP-activated protein kinase in kidney tubular transport, metabolism, and disease"},{"title3":"Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype"},{"title3":"AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145"},{"title3":"Cross-talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice"},{"title3":"Insulin alone or with captopril: effects on signaling pathways (AKT and AMPK) and oxidative balance after ischemia-reperfusion in isolated hearts"},{"title3":"Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway"},{"title3":"Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice"},{"title3":"The renin-angiotensin-aldosterone system and glucose homeostasis"},{"title3":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis"},{"title3":"Nutritional strategies in the prevention and treatment of metabolic syndrome"},{"title3":"Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis"},{"title3":"Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase"},{"title3":"The sirtuin 6 prevents angiotensin II-mediated myocardial fibrosis and injury by targeting AMPK-ACE2 signaling"},{"title3":"A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II"},{"title3":"Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart"},{"title3":"STAT3 balances myocyte hypertrophy vis-a-vis autophagy in response to Angiotensin II by modulating the AMPKalpha/mTOR axis"},{"title3":"Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes"},{"title3":"Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes"},{"title3":"AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation"},{"title3":"Thymoquinone inhibits angiotensin II-induced proliferation and migration of vascular smooth muscle cells through the AMPK/PPARgamma/PGC-1alpha pathway"},{"title3":"Activation of AMP-activated protein kinase by metformin ablates angiotensin II-induced endoplasmic reticulum stress and hypertension in mice in vivo"},{"title3":"Tumor suppressor serine/threonine kinase LKB1 expression, not kinase activity, increased in the vascular smooth muscle cells and neointima in the rat carotid artery injury model"},{"title3":"Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance"},{"title3":"Improvement of insulin sensitivity by antagonism of the renin-angiotensin system"},{"title3":"Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats"},{"title3":"The novel angiotensin II receptor blocker azilsartan medoxomil ameliorates insulin resistance induced by chronic angiotensin II treatment in rat skeletal muscle"},{"title3":"Angiotensin II inhibits glucose uptake of skeletal muscle via the adenosine monophosphate-activated protein kinase pathway"},{"title3":"Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension"},{"title3":"Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling"},{"title3":"Angiotensin II modulates p130Cas of podocytes by the suppression of AMP-activated protein kinase"},{"title3":"Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy"},{"title3":"Losartan inhibits vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase"},{"title3":"Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways"},{"title3":"Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice"},{"title3":"Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice"},{"title3":"Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK/TGF-beta/Smads signaling pathway"},{"title3":"Apelin/APJ axis improves angiotensin II-induced endothelial cell senescence through AMPK/SIRT1 signaling pathway"},{"title3":"Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance"},{"title3":"Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats"},{"title3":"Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria"},{"title3":"Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats"},{"title3":"Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain"},{"title3":"Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats"},{"title3":"Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome"},{"title3":"Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats"},{"title3":"The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats"},{"title3":"Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis"},{"title3":"Angiotensin II activates AMPK for execution of apoptosis through energy-dependent and -independent mechanisms"},{"title3":"Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: involvement of interaction between AMPKbeta1/2 and Cdk4"},{"title3":"Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats"},{"title3":"Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction"},{"title3":"ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity"},{"title3":"Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress"},{"title3":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension"},{"title3":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis"},{"title3":"Role of the ACE2/Angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation"},{"title3":"Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications"},{"title3":"Heat shock prevents insulin resistance-induced vascular complications by augmenting angiotensin-(1-7) signaling"},{"title3":"ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts"},{"title3":"MAS and its related G protein-coupled receptors, Mrgprs"},{"title3":"Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?"},{"title3":"Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation"},{"title3":"New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D"},{"title3":"International union of pharmacology. XXIII. The angiotensin II receptors"},{"title3":"New frontiers in the intrarenal renin-angiotensin system: a critical review of classical and new paradigms"},{"title3":"Pharmacology and signaling of MAS-related G protein-coupled receptors"},{"title3":"Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance"},{"title3":"Cross-talk between AMP-activated protein kinase and renin-angiotensin system in uninephrectomised rats"},{"title3":"Age-associated changes in the vascular renin-angiotensin system in mice"},{"title3":"The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system"},{"title3":"Vinegar decreases blood pressure by down-regulating AT1R expression via the AMPK/PGC-1alpha/PPARgamma pathway in spontaneously hypertensive rats"},{"title3":"Nuclear sirtuins and inflammatory signaling pathways"},{"title3":"Conserved metabolic regulatory functions of sirtuins"},{"title3":"NAD(+), sirtuins, and cardiovascular disease"},{"title3":"Sirtuins: the 'magnificent seven', function, metabolism and longevity"},{"title3":"Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure"},{"title3":"Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism"},{"title3":"SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy"},{"title3":"Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis"},{"title3":"Fish oil alleviates liver injury induced by intestinal ischemia/reperfusion via AMPK/SIRT-1/autophagy pathway"},{"title3":"Atractylenolide III enhances energy metabolism by increasing the SIRT-1 and PGC1alpha expression with AMPK phosphorylation in C2C12 mouse skeletal muscle cells"},{"title3":"Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease"},{"title3":"AdipoRs-a potential therapeutic target for fibrotic disorders"},{"title3":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity"},{"title3":"Adiponectin attenuates angiotensin II-induced vascular smooth muscle cell remodeling through nitric oxide and the RhoA/ROCK pathway"},{"title3":"Adiponectin and its receptors are involved in hypertensive vascular injury"},{"title3":"Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet"},{"title3":"ACE2/Ang 1-7 axis: a critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity"},{"title3":"Adiponectin relieves human adult cardiac myocytes injury induced by intermittent hypoxia"},{"title3":"Adiponectin protects against lung ischemia-reperfusion injury in rats with type 2 diabetes mellitus"},{"title3":"Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway"},{"title3":"Cardioprotection of ischemic preconditioning in rats involves upregulating adiponectin"},{"title3":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase"},{"title3":"Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation"},{"title3":"The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin"},{"title3":"Angiotensin-(1-7) improves non-alcoholic steatohepatitis through an adiponectin-independent mechanism"},{"title3":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders"},{"title3":"Pro-inflammatory cytokines negatively regulate PPARgamma mediated gene expression in both human and murine macrophages via multiple mechanisms"},{"title3":"Peroxisome proliferator-activated receptors and inflammation"},{"title3":"Effects of telmisartan on TNFalpha induced PPARgamma phosphorylation and insulin resistance in adipocytes"},{"title3":"Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor gamma activation"},{"title3":"Irbesartan, an angiotensin II receptor antagonist, with selective PPAR-gamma-modulating activity improves function and structure of chemotherapy-damaged ovaries in rats"},{"title3":"Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-gamma, AMPK/Akt/mTOR signaling and autophagy"},{"title3":"Candesartan, an angiotensin II AT(1)-receptor blocker and PPAR-gamma agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice"},{"title3":"Gentiopicroside ameliorates diabetic peripheral neuropathy by modulating PPAR-gamma/AMPK/ACC signaling pathway"},{"title3":"Peroxisome proliferator-activated receptor (PPARgamma) plays a protective role in cigarette smoking-induced inflammation via AMP-Activated protein kinase (AMPK) signaling"},{"title3":"Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-gamma-mediated NF-small ka, CyrillicB and AMPK/mTOR signaling"},{"title3":"Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARgamma"},{"title3":"Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKKbeta-dependent AMPK activation"}]},{"title2":"Metformin in COVID-19: A possible role beyond diabetes","References":[{"title3":"The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth"},{"title3":"Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System [published online ahead of print, 2020 Apr 8]"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Angiotensin-converting enzyme 2 regulates autophagy in acute lung injury through AMPK/mTOR signaling"},{"title3":"AMPK: a balancer of the renin-angiotensin system"},{"title3":"Angiotensin Converting Enzyme 2: A Double-Edged Sword [published online ahead of print, 2020 Mar 26]"},{"title3":"Metformin in prostate cancer: Two for the price of one"},{"title3":"Effect of Silubin-retard (1-butyl-biguanide hydrochloride) on the course of influenza-virus infection in mice"},{"title3":"Inhaled biguanides and mTOR inhibition for influenza and coronavirus"},{"title3":"Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis"},{"title3":"A SARS-CoV-2-Human ProteinProtein Interaction Map Reveals Drug Targets and Potential Drug- Repurposing"},{"title3":"AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting Glycolysis"},{"title3":"COVID-19 and Diabetes: Knowledge in Progress"},{"title3":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"COVID-19 and diabetes management: what should be considered?"},{"title3":"Metformin Might Inhibit Virus through Increasing Insulin Sensitivity"}]},{"title2":"COVID-19 and diabetes: is metformin a friend or foe?","References":[]},{"title2":"The role of Metformin in Metformin-Associated Lactic Acidosis (MALA): case series and formulation of a model of pathogenesis","References":[]},{"title2":"Sodium-glucose-co-transporter-2 inhibitors and susceptibility to COVID-19: a population-based retrospective cohort study","References":[{"title3":"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv preprint"},{"title3":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study"},{"title3":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study"},{"title3":"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication"},{"title3":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review"},{"title3":"Issues of cardiovascular risk Management in People with Diabetes in the COVID-19 era"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Sodium-glucose Cotransporter-2 (SGLT-2) inhibitors and the treatment of type 2 diabetes"},{"title3":"The importance of defining periods of complete mortality reporting for research using automated data from primary care"},{"title3":"Is DPP4 inhibition a comrade or adversary in COVID-19 infection"},{"title3":"Type 2 diabetes in adults: management NICE guideline [NG28] "},{"title3":"Negative control exposure studies in the presence of measurement error: implications for attempted effect estimate calibration"},{"title3":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"},{"title3":"Drugs and the renin-angiotensin system in covid-19"},{"title3":"Lack of efficacy of SGLT2-i in severe pneumonia related to novel coronavirus (nCoV) infection: no little help from our friends"}]},{"title2":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","References":[]},{"title2":"Updating the Read Codes: user-interactive maintenance of a dynamic clinical vocabulary","References":[]},{"title2":"Clinical terminologies in the NHS: SNOMED CT and dm+ d","References":[]},{"title2":"The importance of defining periods of complete mortality reporting for research using automated data from primary care","References":[]},{"title2":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","References":[]},{"title2":"Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores","References":[]},{"title2":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","References":[{"title3":"The central role of the propensity score in observational studies for causal effects"},{"title3":"Reducing bias in observational studies using subclassification on the propensity score"},{"title3":"A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use"},{"title3":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score"},{"title3":"A critical appraisal of propensity score matching in the medical literature from 1996 to 2003"},{"title3":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement"},{"title3":"A report card on propensity-score matching in the cardiology literature from 2004 to 2006: results of a systematic review"},{"title3":"Nonparametric estimation of average treatment effects under exogeneity: a review"},{"title3":"Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses"},{"title3":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods"},{"title3":"Odds ratio, relative risk, absolute risk reduction, and the number needed to treat-which of these should we use?"},{"title3":"The number needed to treat: a clinically useful measure of treatment effect"},{"title3":"Basis statistics for clinicians 3: assessing the effects of treatment: measures of association"},{"title3":"Clinically useful measures of effect in binary analyses of randomized trials"},{"title3":"Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study"},{"title3":"The performance of different propensity score methods for estimating marginal odds ratios"},{"title3":"Interpretation and choice of effect measures in epidemiologic analyses"},{"title3":"A data-generation process for data with specified risk differences or numbers needed to treat"},{"title3":"The performance of different propensity score methods for estimating difference in proportions (risk differences or absolute risk reductions) in observational studies"},{"title3":"The performance of two data-generation processes for data with specified marginal treatment odds ratios"},{"title3":"Controlling bias in observational studies: a review"},{"title3":"Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data"},{"title3":"Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model"},{"title3":"Standard distance in univariate and multivariate analysis"},{"title3":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"The relative ability of different propensity-score methods to balance measured covariates between treated and untreated subjects in observational studies"}]},{"title2":"Negative control exposure studies in the presence of measurement error: implications for attempted effect estimate calibration","References":[{"title3":"Negative controls: a tool for detecting confounding and bias in observational studies"},{"title3":"Negative control exposures in epidemiological studies"},{"title3":"Negative control exposures in epidemiologic studies"},{"title3":"Control outcomes and exposures for improving internal validity of nonrandomized studies"},{"title3":"Validating studies of adherence through the use of control outcomes and exposures"},{"title3":"Triangulation in aetiological epidemiology"},{"title3":"Assessing intrauterine influences on offspring health outcomes: can epidemiological studies yield robust findings?"},{"title3":"Brief report: negative controls to detect selection bias and measurement bias in epidemiologic studies"},{"title3":"Negative control outcomes: a tool to detect bias in randomized trials"},{"title3":"Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies"},{"title3":"The Society for Social Medicine John Pemberton Lecture 2011. Developmental overnutrition:an old hypothesis with new importance?"},{"title3":"Approaches for drawing causal inferences from epidemiological birth cohorts: A review"},{"title3":"Causal inference in Developmental Origins of Health and Disease (DOHaD) research"},{"title3":"Commentary: Smoking in pregnancy and offspring health: early insights into family-based and 'negative control' studies?"},{"title3":"Associations of prenatal maternal smoking with offspring hyperactivity: causal or confounded?"},{"title3":"Smoking during pregnancy and offspring fat and lean mass in childhood"},{"title3":"Similar associations of parental prenatal smoking suggest child blood pressure is not influenced by intrauterine effects"},{"title3":"Maternal smoking habits and cognitive development of children at age 4 years in a population-based birth cohort"},{"title3":"Maternal and paternal smoking during pregnancy and risk of ADHD symptoms in offspring: testing for intrauterine effects"},{"title3":"Maternal smoking and offspring inattention and hyperactivity: results from a cross-national European survey"},{"title3":"Parental smoking during pregnancy and the risk of gestational diabetes in the daughter"},{"title3":"Parental smoking during pregnancy, early growth, and risk of obesity in preschool children: the Generation R Study"},{"title3":"GME Study Group. Parental smoking and childhood obesity:is maternal smoking in pregnancy the critical exposure?"},{"title3":"Maternal smoking during pregnancy and offspring trajectories of height and adiposity: comparing maternal and paternal associations"},{"title3":"Maternal smoking during pregnancy and offspring growth in childhood: 1993 and 2004 Pelotas cohort studies"},{"title3":"Epidemiologic evidence for the fetal overnutrition hypothesis: findings from the mater-university study of pregnancy and its outcomes"},{"title3":"Exploring the developmental overnutrition hypothesis using parental-offspring associations and FTO as an instrumental variable"},{"title3":"Maternal pre-pregnancy BMI and gestational weight gain, offspring DNA methylation and later offspring adiposity: findings from the Avon Longitudinal Study of Parents and Children"},{"title3":"Is there an intrauterine influence on obesity? Evidence from parent child associations in the Avon Longitudinal Study of Parents and Children (ALSPAC)"},{"title3":"Substantial intergenerational increases in body mass index are not explained by the fetal overnutrition hypothesis: the Cardiovascular Risk in Young Finns Study"},{"title3":"Parent-offspring body mass index associations in the Norwegian Mother and Child Cohort Study: a family-based approach to studying the role of the intrauterine environment in childhood adiposity"},{"title3":"Familial associations of adiposity: findings from a cross-sectional study of 12, 181 parental-offspring trios from Belarus"},{"title3":"Comparison of father-offspring and mother-offspring associations of cardiovascular risk factors: family linkage within the population-based HUNT Study, Norway"},{"title3":"Effect of a diabetic environment in utero on predisposition to type 2 diabetes"},{"title3":"Maternal macronutrient and energy intakes in pregnancy and offspring intake at 10 y: exploring parental comparisons and prenatal effects"},{"title3":"Maternal body mass index during early pregnancy, gestational weight gain, and risk of autism spectrum disorders: Results from a Swedish total population and discordant sibling study"},{"title3":"Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children"},{"title3":"Folic acid supplements in pregnancy and severe language delay in children"},{"title3":"Effects of pre- and postnatal exposure to parental smoking on early childhood respiratory health"},{"title3":"Maternal alcohol use during pregnancy and offspring attention-deficit hyperactivity disorder (ADHD): a prospective sibling control study"},{"title3":"Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: a nested case-control analysis within the Nurses' Health Study II Cohort"},{"title3":"Interpreting observational studies: why empirical calibration is needed to correct p-values"},{"title3":"A comparison of the empirical performance of methods for a risk identification system"},{"title3":"A new method for partial correction of residual confounding in time-series and other observational studies"},{"title3":"Invited commentary: bias attenuation and identification of causal effects with multiple negative controls"},{"title3":"Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring"},{"title3":"The effect of misclassification in the presence of covariates"},{"title3":"Invited commentary: causal diagrams and measurement bias"},{"title3":"Commentary: On the use of imperfect negative control exposures in epidemiologic studies"},{"title3":"The control outcome calibration approach for causal inference with unobserved confounding"},{"title3":"Assessment and indirect adjustment for confounding by smoking in cohort studies using relative hazards models"},{"title3":"The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study"},{"title3":"The association of maternal prenatal psychosocial stress with vascular function in the child at age 10-11 years: findings from the Avon Longitudinal Study of Parents And Children"},{"title3":"Maternal pre-pregnancy overweight and obesity, and child neuropsychological development: two Southern European birth cohort studies"},{"title3":"Pre-conception inter-pregnancy interval and risk of schizophrenia"},{"title3":"Trimethoprim use before pregnancy and risk of congenital malformation: reanalyzed using a case-crossover design and a case-time-control design"},{"title3":"Selective association of multiple sclerosis with infectious mononucleosis"},{"title3":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction"},{"title3":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors"},{"title3":"Using rapid indicators for Enterococcus to assess the risk of illness after exposure to urban runoff contaminated marine water"}]},{"title2":"Factors associated with COVID-19-related death using OpenSAFELY","References":[{"title3":"Clinical determinants for fatality of 44,672 patients with COVID-19"},{"title3":"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Is ethnicity linked to incidence or outcomes of covid-19?"},{"title3":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?"},{"title3":"COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive study"},{"title3":"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years"},{"title3":"Impact Of Electronic Health Record Interface Design On Unsafe Prescribing Of Ciclosporin, Tacrolimus and Diltiazem: A Cohort Study In English NHS Primary Care"},{"title3":"Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record"},{"title3":"Ghost branded generics: Why does the cost of generic atorvastatin vary?"},{"title3":"Completeness and usability of ethnicity data in UK-based primary care and hospital databases"},{"title3":"Closing the gap in a generation: health equity through action on the social determinants of health"},{"title3":"Development and validation of an electronic frailty index using routine primary care electronic health record data"},{"title3":"Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data"},{"title3":"The relationship between time since registration and measured incidence rates in the General Practice Research Database"},{"title3":"A New Equation to Estimate Glomerular Filtration Rate"},{"title3":"What is the dm+d? The NHS Dictionary of Medicines and Devices"},{"title3":"Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)"},{"title3":"OpenSAFELY Codelists: Asthma Oral Prednisolone Medication"},{"title3":"Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis"},{"title3":"OpenSAFELY Codelists: Permanent Immunosuppresion"},{"title3":"OpenSAFELY Codelists: Temporary Immunosuppresion"},{"title3":"Clinical Code List-Psoriasis-Read Codes"},{"title3":"Clinical code list - SLE codes"},{"title3":"Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England"},{"title3":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases"},{"title3":"Population-calibrated multiple imputation for a binary/categorical covariate in categorical regression models"}]},{"title2":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","References":[{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)"},{"title3":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China"},{"title3":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study"},{"title3":"Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension"},{"title3":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies"},{"title3":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"Influence of diabetes mellitus on immunity to human tuberculosis"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind"},{"title3":"Web site and R package for computing E-values"},{"title3":"Factors determining the appearance of glucose in upper and lower respiratory tract secretions"},{"title3":"Benefits and harms of intensive glycemic control in patients with type 2 diabetes"},{"title3":"Multivariate and propensity score matching software with automated balance optimization: the matching package for R"},{"title3":"Penalized survival models and frailty"},{"title3":"Intensive insulin therapy in the medical ICU"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"Comparison of imputation methods for missing laboratory data in medicine"},{"title3":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Innate immune signaling and its role in metabolic and cardiovascular diseases"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"}]},{"title2":"COVID-19 and diabetes management: What should be considered?","References":[{"title3":"Management of diabetes today: An exciting confusion"},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"Prevalence and impact of diabetes among people infected with SARS-CoV-2"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy"},{"title3":"COVID-19, diabetes mellitus and ACE2: The conundrum"},{"title3":"COVID-19 in patients with diabetes: risk factors that increase morbidity"},{"title3":"https://www.ema.europa.eu/en/news/ema-advises-continued-use-medicines-hypertension-heart-kidney-disease-during-covid-19-pandemic."},{"title3":"Diabetes and the COVID-19 pandemic: how insights from recent experience might guide future management"},{"title3":"Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19: immunopathology and its implications for therapy"},{"title3":"COVID-19 and Diabetes: can DPP4 inhibition play a role?"},{"title3":"Incretin-based therapies, glucometabolic health and endovascular inflammation"},{"title3":"GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms"},{"title3":"Mast cell and M1 macrophage infiltration and local pro-inflammatory factors were attenuated with incretin-based therapies in obesity-related glomerulopathy"},{"title3":"Empagliflozin attenuates transient cerebral ischemia/reperfusion injury in hyperglycemic rats via repressing oxidative-inflammatory-apoptotic pathway"},{"title3":"Thiazolidinediones as anti-inflammatory and anti-atherogenic agents"},{"title3":"Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus"},{"title3":"Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?"},{"title3":"COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used)"},{"title3":"COVID-19 and diabetes: knowledge in progress"}]},{"title2":"Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes","References":[{"title3":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area"},{"title3":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York"},{"title3":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China"},{"title3":"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports"},{"title3":"Hospitalization and Mortality among Black Patients and White Patients with Covid-19"},{"title3":"The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States"},{"title3":"Black-White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges"},{"title3":"Racial/ethnic differences in the burden of type 2 diabetes over the life course: a focus on the USA and India"},{"title3":"Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19"},{"title3":"Metformin: From Research to Clinical Practice"},{"title3":"Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis"},{"title3":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice"},{"title3":"The effects of metformin on the fibrinolytic system in diabetic and non-diabetic subjects"},{"title3":"Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release"},{"title3":"The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications"},{"title3":"COVID-19 and its implications for thrombosis and anticoagulation"},{"title3":"The need to manage the risk of thromboembolism in COVID-19 patients"},{"title3":"Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study"},{"title3":"Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes"},{"title3":"The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings"},{"title3":"Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study"},{"title3":"A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids"},{"title3":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"COVID-19 infection may cause ketosis and ketoacidosis"},{"title3":"Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19"},{"title3":"Sex differences in immune responses"},{"title3":"Metformin Use Is Associated with Reduced Mortality in a Diverse Population with Covid-19 and Diabetes"}]},{"title2":"Risk of metformin in type 2 diabetes patients with COVID-19: a preliminary retrospective report","References":[]},{"title2":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis","References":[{"title3":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 infection: the perspectives on immune responses"},{"title3":"Host-directed therapy as a novel treatment strategy to overcome tuberculosis: targeting immune modulation"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Commentary: COVID-19 in patients with diabetes"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"COVID-19: melatonin as a potential adjuvant treatment"},{"title3":"Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues"},{"title3":"Metformin, a new era for an old drug in the treatment of immune mediated disease?"},{"title3":"Metformin inhibits pro-inflammatory responses via targeting nuclear factor-kappaB in HaCaT cells"},{"title3":"Metformin effect on gut microbiota: insights for HIV-related inflammation"},{"title3":"Metformin as a host-directed therapeutic in tuberculosis: is there a promise?"},{"title3":"Metformin improves healthspan and lifespan in mice"},{"title3":"The role of metformin in controlling oxidative stress in muscle of diabetic rats"}]},{"title2":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward","References":[{"title3":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020."},{"title3":"Robilotti EV, Babady NE, Mead PA, et al. Determinants of severity in cancer patients with COVID-19 illness. medRxiv. 2020; 2020.05.04.20086322."},{"title3":"Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020."},{"title3":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China"},{"title3":"Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020."},{"title3":"Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020."},{"title3":"Multiple myeloma"},{"title3":"Role of the immune response in disease progression and therapy in multiple myeloma"},{"title3":"Immune therapies in multiple myeloma"},{"title3":"Ingraham NE, Lotfi-Emran S, Thielen BK, et al. Immunomodulation in COVID-19. Lancet Respir Med."},{"title3":"Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020."},{"title3":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020."},{"title3":"Cytokine release syndrome: grading, modeling, and new therapy"},{"title3":"ASTCT Consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells"},{"title3":"Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020;105954."},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Gong J, Dong H, Xia SQ, et al. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia. medRxiv. 2020; 2020.02.25.20025643."},{"title3":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma"},{"title3":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma"},{"title3":"Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study"},{"title3":"In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals"},{"title3":"KPT-330, a potent and selective CRM1 inhibitor, exhibits anti-inflammation effects and protection against sepsis"},{"title3":"Al Saleh AS, Sher T, Gertz MA. Multiple myeloma in the time of COVID-19. Acta Haematol. 2020:1-7."},{"title3":"Malard F, Mohty M. Management of patients with multiple myeloma during the COVID-19 pandemic. Lancet Haematol. 2020."},{"title3":"COVID-19: Data. 2020. at https://www1.nyc.gov/site/doh/covid/covid-19-data.page.)."},{"title3":"Cook G, Ashcroft AJ, Pratt G, et al. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy. Br J Haematol."},{"title3":"Gross CP, Essien UR, Pasha S, Gross JR, Wang S-Y, Nunez-Smith M. Racial and ethnic disparities in population level COVID-19 mortality. medRxiv. 2020; 2020.05.07.20094250."},{"title3":"Henning-Smith C, Tuttle M, Kozhimannil KB. Unequal distribution of COVID-19 risk among rural residents by race and ethnicity. J Rural Health. 2020."},{"title3":"Racial differences in the incidence of cardiovascular risk factors in older Black and White adults"},{"title3":"Diane Marie Del Valle M, Seunghee Kim-Schulze PD, Hsin-Hui Huang PD, et al. An inflammatory cytokine signature helps predict COVID-19 severity and death. MEDRXIV. 2020;115758."},{"title3":"Jatiani SS, Aleman A, Madduri D, et al. Myeloma CAR-T CRS management with IL-1R antagonist anakinra. Clin Lymphoma MyelomaLeukemia. 2020."},{"title3":"Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia"},{"title3":"Costa LJ WS, Bermudez A. First clinical study of the B-cell maturation antigen (BCMA) 2 + 1 T cell engager (TCE) CC-93269 in patients (pts) with relapsed/refractory multiple myeloma (RRMM): interim results of a phase 1 multicenter trial. Abstract #143. American Society of Hematology. Orlando: ASH Annual Meeting Proceedings; 2019."},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"Cao Y, Wei J, Zou L, et al. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020."},{"title3":"Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection"},{"title3":"Bryce C, Grimes Z, Pujadas E, et al. Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. medRxiv. 2020; 2020.05.18.20099960."}]},{"title2":"Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases","References":[{"title3":"Tolerance to plant disease"},{"title3":"Tolerance of parasites and disease in plants and its significance in host-parasite interactions"},{"title3":"The evolutionary ecology of tolerance to consumer damage"},{"title3":"Genetic variation for disease resistance and tolerance among Arabidopsis thaliana accessions"},{"title3":"SNF1-related kinases allow plants to tolerate herbivory by allocating carbon to roots"},{"title3":"Defining Tolerance as a norm of reaction"},{"title3":"Costs and benefits of plant responses to disease: resistance and tolerance"},{"title3":"Measuring tolerance to herbivory: accuracy and precision of estimates made using natural versus imposed damage"},{"title3":"Natural selection on the Drosophila antimicrobial immune system"},{"title3":"Toll-like receptors - taking an evolutionary approach"},{"title3":"Regulation of Nox and Dox enzymatic activity and expression"},{"title3":"Nox enzymes, ROS and chronic disease: an example of antagonistic pleiotropy"},{"title3":"How TNF was recognized as a key mechanism of disease"},{"title3":"Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria"},{"title3":"Akt and FOXO dysregulation contribute to infection-induced wasting in Drosophila"},{"title3":"Endotoxin and tumor necrosis factor challenges in dogs stimulate the cardiovascular profile of human septic shock"},{"title3":"Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages"},{"title3":"Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection"},{"title3":"Protective effects of the sickle cell gene against malaria morbidity and mortality"},{"title3":"Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases"},{"title3":"Both heterozygous and homozygous alpha(+) thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya"},{"title3":"The effect of a+-thalasemia on the incidence of malaria and other diseases in children living in the coast of Kenya"},{"title3":"X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria"},{"title3":"Host genotype by parasite genotype interactions underlying the resistance of anopheline mosquitos to Plasmodium falciparum"},{"title3":"Genetic basis of natural variation in D. melanogaster antibacterial immunity"},{"title3":"Cost of resistance: genetic correlations and potential trade-offs in an insect immune system"},{"title3":"The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potential antifungal response in Drosophila adults"},{"title3":"Dif, a dorsal-related gene that mediates an immune response in Drosophila"},{"title3":"Regulated nuclear import of Rel proteins in the Drosophila immune response"},{"title3":"Toll receptor-mediated Drosophila immune response requires Dif, an NF-kappaB factor"},{"title3":"Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections"},{"title3":"Constitutive activation of Toll-mediated antifungal defense in serpin-deficient Drosophila"},{"title3":"Binding of the Drosophila cytokine Spatzle to Toll is direct and establishes signaling"},{"title3":"A recessive mutation, immune deficiency (imd), defines two distinct pathways in the Drosophila host defense"},{"title3":"The Drosophila caspase Dredd is required to resist gram-negative bacterial infections"},{"title3":"Role of Drosophila IKKgamma in a Toll-independent antibacterial immune response"},{"title3":"Relish, a central factor in the control of humoral, but not cellular immunity in Drosophila"},{"title3":"The Drosophila immune defense against gram-negative infection requires the death protein Dfadd"},{"title3":"The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein"},{"title3":"The Drosophila melanogaster Toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa"},{"title3":"Alternative measures of response to Pseudomonas aeruginosa infection in Drosophila melanogaster"},{"title3":"Disentangling genetic variation for resistance and tolerance to infectious diseases in animals"},{"title3":"Distince characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice"},{"title3":"Gene knockout of the KCNJ8-encoded Kir6.1 KATP channel imparts fatal susceptibility to endotoxemia"},{"title3":"ATP-sensitive potassium channels mediate survival during infection in mammals and insects"},{"title3":"Tolerance to bacterial pyrogens I: Factors influencing its development"},{"title3":"Tolerance to bacterial pyrogens II: Role of the reticulo-endothelial system"},{"title3":"Endotoxin tolerance: A review"},{"title3":"Bench to bedside: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis"},{"title3":"Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine and toll-like receptor 2 and 4 gene expression"},{"title3":"Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor associated kinase 1 activation in endotoxin-tolerant cells"},{"title3":"Induction of in vitro reprogramming by Toll-like receptor TLR2 and TLR4 agonists in murine macrophages: Effects of TLR &quot;homotolerance&quot; versus &quot;heterotolerance&quot; on NF-kB signaling pathway components"},{"title3":"Gene-specific control of inflammation by TLR-induced chromatin modifications"},{"title3":"Immunity or tolerance in malarial infections"},{"title3":"Evaluation of the pyrogenic threshold for the Plasmodium falciparum malaria in naive individuals"},{"title3":"Malaria tolerance - for whom the cell tolls?"},{"title3":"Identification of Drosophila mutants altering defense and endurance of to Listeria monocytogenes infection"},{"title3":"MyD88 - dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms but is not required for the immunological control of parasites during rodent malaria"},{"title3":"A defect in interleukin-10 leads to enhanced malaria disease in Plasmodium chabaudi chabaudi infection in mice"},{"title3":"Functional analysis of the Drosophila immune response during aging"},{"title3":"Drosophila eiger mutants are sensitive to extracellular pathogens"},{"title3":"Secreted bacterial effectors and host-produced Eiger/TNF drive death in a Salmonella-infected fruit fly"},{"title3":"Corticosteroids for managing tuberculous meningitis"},{"title3":"Co-evolution and plant resistance to natural enemies"},{"title3":"Biological and biomedical implications of the co-evolution of pathogens and their hosts"},{"title3":"Fight or learn to live with the consequences"},{"title3":"The evolution of parasites in response to tolerance in their hosts: The good, the bad and the apparent commensalism"},{"title3":"Evolutionary dynamics of pathogen resistance and tolerance"},{"title3":"Terrestrial plant tolerance to herbivory"},{"title3":"The ecology and evolution of tolerance to herbivory"},{"title3":"Are tolerance, avoidance and antibiosis evolutionarily and ecologically equivalent responses of plants to herbivores?"}]},{"title2":"Metformin inhibits the production of reactive oxygen species from NADH: ubiquinone oxidoreductase to limit induction of interleukin-1beta (IL-1beta) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages","References":[]},{"title2":"An inflammatory cytokine signature predicts COVID-19 severity and survival","References":[{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward"},{"title3":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages"},{"title3":"Advancing scientific knowledge in times of pandemics"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19"},{"title3":"Viral and host factors related to the clinical outcome of COVID-19"},{"title3":"Middle East respiratory syndrome: emergence of a pathogenic human coronavirus"},{"title3":"Cytokine release syndrome in severe COVID-19"},{"title3":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"},{"title3":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases"},{"title3":"Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils"},{"title3":"Myeloma CAR-T CRS management with IL-1R antagonist anakinra"},{"title3":"SOHO State of the Art updates and next questions: T-cell-directed immune therapies for multiple myeloma: chimeric antigen receptor-modified T cells and bispecific T-cell-engaging agents"},{"title3":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease"},{"title3":"Dexamethasone in hospitalized patients with COVID-19 : preliminary report"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Coronavirus breakthrough: dexamethasone is first drug shown to save lives"},{"title3":"Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents"},{"title3":"A practical guide to understanding Kaplan-Meier curves"},{"title3":"A note on competing risks in survival data analysis"},{"title3":"Subdistribution hazard models for competing risks in discrete time"},{"title3":"External validation of a Cox prognostic model: principles and methods"}]},{"title2":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","References":[{"title3":"Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? Nature reviews"},{"title3":"N-linked protein glycosylation in the endoplasmic reticulum"},{"title3":"CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic"},{"title3":"Metformin in breast cancer - an evolving mystery"},{"title3":"Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper"},{"title3":"Expression of Fas ligand is not a main mechanism used by tumors to counteract antitumor immunity"},{"title3":"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity"},{"title3":"Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future"},{"title3":"Death by a thousand cuts: granzyme pathways of programmed cell death"},{"title3":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors"},{"title3":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin"},{"title3":"Metformin and reduced risk of cancer in diabetic patients"},{"title3":"Glycoprotein folding and quality-control mechanisms in protein-folding diseases"},{"title3":"Comparison of Cytotoxic Activity of Anticancer Drugs against Various Human Tumor Cell Lines Using In Vitro Cell-Based Approach"},{"title3":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin"},{"title3":"Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial"},{"title3":"Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial"},{"title3":"Metformin: an old drug with new potential"},{"title3":"AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs"},{"title3":"Ipilimumab plus nivolumab for advanced melanoma"},{"title3":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation"},{"title3":"AMP-activated protein kinase and human cancer: cancer metabolism revisited"},{"title3":"Regulation of Endoplasmic Reticulum-Associated Protein Degradation (ERAD) by Ubiquitin"},{"title3":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity"},{"title3":"Compartmentalized AMPK signaling illuminated by genetically encoded molecular sensors and actuators"},{"title3":"Inhibition of endoplasmic reticulum (ER)-toGolgi transport induces relocalization of binding protein (BiP) within the ER to form the BiP bodies"},{"title3":"The blockade of immune checkpoints in cancer immunotherapy. Nature reviews"},{"title3":"Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth"},{"title3":"Metformin--mode of action and clinical implications for diabetes and cancer. Nature reviews"},{"title3":"Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database"},{"title3":"Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue"},{"title3":"Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients"},{"title3":"Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia"},{"title3":"Effect of glycosylation on protein folding: a close look at thermodynamic stabilization"},{"title3":"IRE1alpha is an endogenous substrate of endoplasmic-reticulum-associated degradation"},{"title3":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy"},{"title3":"Role of N-glycosylation in trafficking of apical membrane proteins in epithelia"},{"title3":"Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I"},{"title3":"One step at a time: endoplasmic reticulum-associated degradation"},{"title3":"Cellular and molecular mechanisms of metformin: an overview"},{"title3":"Coinhibitory molecules in autoimmune diseases"},{"title3":"PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer"},{"title3":"Nivolumab plus ipilimumab in advanced melanoma"},{"title3":"Adaptive immune activation: glycosylation does matter"},{"title3":"Glycosylation-directed quality control of protein folding"},{"title3":"Direct Mapping of Additional Modifications on Phosphorylated O-glycans of alpha-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy"},{"title3":"COPII and the regulation of protein sorting in mammals"},{"title3":"Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"}]},{"title2":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"NKG2A is a NK cell exhaustion checkpoint for HCV persistence"},{"title3":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature579, 270-273 (2020)."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice"},{"title3":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells"},{"title3":"Viral persistence and chronicity in hepatitis C virus infection: role of T-cell apoptosis, senescence and exhaustion"},{"title3":"Restoring function in exhausted CD8 T cells during chronic viral infection"},{"title3":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity"},{"title3":"NKG2A, a new kid on the immune checkpoint block"}]},{"title2":"Metformin-induced suppression of IFN-alpha via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes","References":[{"title3":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045"},{"title3":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus"},{"title3":"The double burden of diabetes and global infection in low and middle-income countries"},{"title3":"Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)"},{"title3":"Benefits of flu vaccination for persons with diabetes mellitus: A review"},{"title3":"Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"NETosis before and after Hyperglycemic Control in Type 2 Diabetes Mellitus Patients"},{"title3":"Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization"},{"title3":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk"},{"title3":"Cellular and molecular mechanisms of metformin: an overview"},{"title3":"Metformin and Autoimmunity: A &quot;New Deal&quot; of an Old Drug"},{"title3":"Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione"},{"title3":"Type I interferons in infectious disease"},{"title3":"Regulation of type I interferon responses"},{"title3":"The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus"},{"title3":"mTOR Regulation of Lymphoid Cells in Immunity to Pathogens"},{"title3":"B cell-specific deficiencies in mTOR limit humoral immune responses"},{"title3":"RAPping production of type I interferon in pDCs through mTOR"},{"title3":"Translational control of the innate immune response through IRF-7"},{"title3":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors"},{"title3":"PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation"},{"title3":"Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway"},{"title3":"TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses"},{"title3":"Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes"},{"title3":"Toll-like receptor 7 controls the anti-retroviral germinal center response"},{"title3":"Cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection"},{"title3":"Programming the magnitude and persistence of antibody responses with innate immunity"},{"title3":"Diabetes Care: Taking It to the Limit One More Time"},{"title3":"Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus: with special reference to age, body mass index, and HbA1c"},{"title3":"The antibody response to influenza vaccination is not impaired in type 2 diabetics"},{"title3":"Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study"},{"title3":"Administration, F. D. A. in Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines (2007)."},{"title3":"Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures"},{"title3":"Global analyses of human immune variation reveal baseline predictors of postvaccination responses"},{"title3":"Whole-Virion Influenza Vaccine Recalls an Early Burst of High-Affinity Memory B Cell Response through TLR Signaling"},{"title3":"Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells"},{"title3":"Toll-like receptor 3 and RIG-I-like receptor activation induces innate antiviral responses in mouse ovarian granulosa cells"},{"title3":"Innate immune sensing and response to influenza"},{"title3":"Interferon-alpha and -beta in kidney inflammation"},{"title3":"Rapamycin and mTOR kinase inhibitors"},{"title3":"Updates of mTOR inhibitors"},{"title3":"Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness"},{"title3":"Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine"},{"title3":"HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains"},{"title3":"Long-Term Immunogenicity and Safety of a Conventional Influenza Vaccine in Patients with Type 2 Diabetes"},{"title3":"The pathology of influenza virus infections"},{"title3":"Peering into the crystal ball: influenza pandemics and vaccine efficacy"},{"title3":"Systems vaccinology"},{"title3":"Reduced IFN-alpha secretion by blood dendritic cells in human diabetes"},{"title3":"Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9"},{"title3":"A systems study reveals concurrent activation of AMPK and mTOR by amino acids"},{"title3":"Suppression of adenosine monophosphate-activated protein kinase selectively triggers apoptosis in activated T cells and ameliorates immune diseases"},{"title3":"Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase"},{"title3":"Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction"},{"title3":"Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice"},{"title3":"Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets"},{"title3":"Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins"},{"title3":"Role of the Akt pathway in mRNA translation of interferon-stimulated genes"},{"title3":"The isolation and purification of human peripheral blood monocytes in cell suspension"}]},{"title2":"Diabetes: glycaemic control in type 2","References":[]}]},{"title1":"Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium","References":[{"title2":"European center for disease prevention and control","References":[]},{"title2":"The major genetic risk factor for severe COVID-19 is inherited from Neanderthals","References":[]},{"title2":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","References":[{"title3":"Emerging pandemic diseases: How we got to COVID-19"},{"title3":"Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories"},{"title3":"The human genetic determinism of life-threatening infectious diseases: Genetic heterogeneity and physiological homogeneity?"},{"title3":"A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection"},{"title3":"Human genetics of life-threatening influenza pneumonitis"},{"title3":"Severe influenza pneumonitis in children with inherited TLR3 deficiency"},{"title3":"Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency"},{"title3":"Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency"},{"title3":"Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency"},{"title3":"Herpes simplex virus encephalitis in human UNC-93B deficiency"},{"title3":"Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis"},{"title3":"Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood"},{"title3":"Functional IRF3 deficiency in a patient with herpes simplex encephalitis"},{"title3":"NEMO is a key component of NF-kappaB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus"},{"title3":"Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines"},{"title3":"Human IFNAR2 deficiency: Lessons for antiviral immunity"},{"title3":"Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency"},{"title3":"STAT2 deficiency and susceptibility to viral illness in humans"},{"title3":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling"},{"title3":"TLR3 deficiency in patients with herpes simplex encephalitis"},{"title3":"A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans"},{"title3":"Identification of an IRF3 variant and defective antiviral interferon responses in a patient with severe influenza"},{"title3":"Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenza"},{"title3":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee"},{"title3":"Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification"},{"title3":"Human inborn errors of immunity: An expanding universe"},{"title3":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients"},{"title3":"Type I IFN immunoprofiling in COVID-19 patients"},{"title3":"Auto-antibodies against type I IFNs in patients with life-threatening COVID-19"},{"title3":"A framework for variation discovery and genotyping using next-generation DNA sequencing data"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency"},{"title3":"Homozygous and hemizygous CNV detection from exome sequencing data in a Mendelian disease cohort"},{"title3":"CANOES: Detecting rare copy number variants from whole exome sequencing data"},{"title3":"The impact of a fine-scale population stratification on rare variant association test results"},{"title3":"Adjusting for population stratification in a fine scale with principal components and sequencing data"},{"title3":"Tuberculosis and impaired IL-23-dependent IFN-gamma immunity in humans homozygous for a common TYK2 missense variant"},{"title3":"TRAF3 Is Required for NF-kappaB Pathway Activation Mediated by HTLV Tax Proteins"},{"title3":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals"},{"title3":"Influenza virus infection induces a narrow antibody response in children but a broad recall response in adults"}]},{"title2":"Auto-antibodies against type I IFNs in patients with life-threatening COVID-19","References":[]},{"title2":"Clinical features and outcomes of adults with COVID-19: a systematic review and pooled analysis of the literature","References":[]},{"title2":"Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis","References":[]},{"title2":"Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"The first 2019 novel coronavirus case in Nepal"},{"title3":"Journey of a Thai taxi driver and novel coronavirus"},{"title3":"Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Republic of Korea"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion"},{"title3":"Pre- and posttreatment chest CT findings: 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity"},{"title3":"A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features"}]},{"title2":"Is diabetes mellitus a risk factor for Corona Virus Disease 19 (COVID-19)?","References":[]},{"title2":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 73 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2"},{"title3":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic"},{"title3":"Bacterial pneumonia: comparison between diabetics and non-dia-betics"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Diabetes and the severity of pandemic influenza A (H1N1) infection"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans"},{"title3":"Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Covid-19 in critically ill patients in the seattle region : case series"},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, february 12-march 28, 2020.CDC COVID-19 response team"},{"title3":"Neutrophil-to-Lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China. JAMA Intern Med. Published online March 13, 2020. doi:10.1001/jamainternmed.2020.0994 (Accessed on March 31, 2020)"},{"title3":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001/jamacardio.2020.1017. Published online March 31, 2020."},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention"},{"title3":"Comorbidities and multi-organ injuries in the treatment of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with covid-19"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Hypertension and diabetes delay the viral clearance in COVID-19 patients"},{"title3":"Characterization of ACE and ACE2 287 expression within different organs of the NOD mouse"},{"title3":"Rao S, Lau A, and So H-C. Exploring diseases/traits and blood proteins causally related to 284 expression of ACE2, the putative receptor of 2019-nCov: a Mendelian Randomization analysis. vol. 285 medRxiv: 2020.2003.2004.20031237, 2020."},{"title3":"Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Metformin mediates protection against Legionella pneumonia through activation of AMPK and mitochondrial reactive oxygen species"},{"title3":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis"},{"title3":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin"},{"title3":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease"},{"title3":"Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study"},{"title3":"Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis"},{"title3":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats"},{"title3":"Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides"},{"title3":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies"},{"title3":"Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation"},{"title3":"Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26"},{"title3":"Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure"},{"title3":"Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans"},{"title3":"Substance P increases sympathetic activity during combined angiotensin converting enzyme and dipeptidyl peptidase-4 inhibition"},{"title3":"DPP-4 inhibitors use associated with increased risk of ACE-inhibitors associated angioedema"},{"title3":"Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme"},{"title3":"COVID-19 and Diabetes: can DPP4 inhibition play a role?"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Prevalence of diabetes in the 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus: a systematic review and meta-analysis"},{"title3":"Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients"},{"title3":"Intravenous insulin infusion protocol compared with subcutaneous insulin for the management of hyperglycemia in critically ill adults"},{"title3":"Comparison of glycemic control between continuous regular insulin infusion and single-dose subcutaneous insulin glargine injection in medical critically ill patients"},{"title3":"Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapy"},{"title3":"Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial"},{"title3":"Continuous glucose monitor interference with commonly prescribed medications: a pilot study"},{"title3":"Continuous glucose monitoring in the surgical intensive care unit: concordance with capillary glucose"},{"title3":"The vasoprotective axes of the renin-angiotensin system:physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV"},{"title3":"ESH statement on COVID-19"},{"title3":"HFSA/ACC/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19"},{"title3":"The use of statins and risk of community-acquired pneumonia"},{"title3":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection"},{"title3":"Statins may decrease the fatality rate of Middle East respiratory syndrome infection"},{"title3":"Preadmission use of calcium channel blockers and outcomes after hospitalization with pneumonia: a retrospective propensity-matched cohort study"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Virtually perfect? Telemedicine for covid-19"},{"title3":"All Feet on Deck-The Role of Podiatry during the COVID-19 Pandemic: preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes"}]},{"title2":"Clinical characteristics of covid-19 in New York city","References":[{"title3":"COVID-19 Map"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Aki in hospitalized patients with and without COVID-19: a comparison study"},{"title3":"Aki in hospitalized patients with COVID-19"},{"title3":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Thrombosis in hospitalized patients with COVID-19 in a new York City health system"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy"},{"title3":"States reporting cases of COVID-19 to CDC"},{"title3":"Defining the Epidemiology of Covid-19 - Studies Needed"},{"title3":"R: a language and environment for statistical computing. R found STAT comput Vienna, Austria; R foundation for statistical computing"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 in critically Ill patients in the seattle region - case series"},{"title3":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","References":[]},{"title2":"Factors associated with COVID-19-related death using OpenSAFELY","References":[{"title3":"Clinical determinants for fatality of 44,672 patients with COVID-19"},{"title3":"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Is ethnicity linked to incidence or outcomes of covid-19?"},{"title3":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?"},{"title3":"COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive study"},{"title3":"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years"},{"title3":"Impact Of Electronic Health Record Interface Design On Unsafe Prescribing Of Ciclosporin, Tacrolimus and Diltiazem: A Cohort Study In English NHS Primary Care"},{"title3":"Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record"},{"title3":"Ghost branded generics: Why does the cost of generic atorvastatin vary?"},{"title3":"Completeness and usability of ethnicity data in UK-based primary care and hospital databases"},{"title3":"Closing the gap in a generation: health equity through action on the social determinants of health"},{"title3":"Development and validation of an electronic frailty index using routine primary care electronic health record data"},{"title3":"Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data"},{"title3":"The relationship between time since registration and measured incidence rates in the General Practice Research Database"},{"title3":"A New Equation to Estimate Glomerular Filtration Rate"},{"title3":"What is the dm+d? The NHS Dictionary of Medicines and Devices"},{"title3":"Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)"},{"title3":"OpenSAFELY Codelists: Asthma Oral Prednisolone Medication"},{"title3":"Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis"},{"title3":"OpenSAFELY Codelists: Permanent Immunosuppresion"},{"title3":"OpenSAFELY Codelists: Temporary Immunosuppresion"},{"title3":"Clinical Code List-Psoriasis-Read Codes"},{"title3":"Clinical code list - SLE codes"},{"title3":"Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England"},{"title3":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases"},{"title3":"Population-calibrated multiple imputation for a binary/categorical covariate in categorical regression models"}]},{"title2":"Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19","References":[{"title3":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis"},{"title3":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study"},{"title3":"Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis"},{"title3":"Prevalence of diabetes mellitus in 2019 novel coronavirus: a meta-analysis"},{"title3":"Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Coronavirus Disease 2019 (COVID-19) in the U.S.: Cases, Data &amp; Surveillance: Cases in the U.S"},{"title3":"Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics"},{"title3":"COVID-19 in people with diabetes: urgently needed lessons from early reports"},{"title3":"Obesity and COVID-19 severity in a designated hospital in Shenzhen, China"},{"title3":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York"},{"title3":"Obesity is a risk factor for greater COVID-19 severity"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Commonwealth of Massachusetts. Accessed 15 June 2020"},{"title3":"Washington, DC, National Committee for Quality Assurance"},{"title3":"Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients"},{"title3":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study"},{"title3":"Disparities in outcomes among COVID-19 patients in a large health care system in California"},{"title3":"Social vulnerability and racial inequality in COVID-19 deaths in Chicago"},{"title3":"City of New York. Accessed 29 May 2020"},{"title3":"COVID-19 and racial/ethnic disparities"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China"},{"title3":"Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico"},{"title3":"The association between obesity, type 2 diabetes, and hypertension with severe COVID-19 on admission among Mexicans"},{"title3":"Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement"},{"title3":"The effect of short-term hyperglycemia on the innate immune system"},{"title3":"Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"}]},{"title2":"Evidence of increased hospitalization rate for COVID-19 in community-dwelling patients with type 1 diabetes","References":[]},{"title2":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","References":[]},{"title2":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","References":[{"title3":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia:a systematic review, meta-analysis, and meta-regression"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Report of characteristics of patients who died positive for COVID-19 in Italy"},{"title3":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study"},{"title3":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients"},{"title3":"National diabetes audit:report 1: care processes and treatment targets 2018-19, short report"},{"title3":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"},{"title3":"Bridges to Health Segmentation Model: person-level clinical segmentation data model"},{"title3":"English indices of deprivation 2019"},{"title3":"NOMIS official labour market statistics. Ethnic group by sex by age"},{"title3":"Deaths involving COVID-19 in the care sector, England and Wales: deaths occurring up to 1 May 2020 and registered up to 9 May 2020 (provisional)"},{"title3":"National diabetes audit:report 2: complications and mortality, 2017-18"},{"title3":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis"}]},{"title2":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","References":[]},{"title2":"Obesity is associated with severe forms of COVID-19","References":[]},{"title2":"Belgian institue for public health","References":[]},{"title2":"Health interview survey","References":[]},{"title2":"International diabetes federation","References":[]},{"title2":"Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: clinical experience in a Belgian tertiary center","References":[{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial"},{"title3":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study"},{"title3":"Chloroquine and hydroxychloroquine in covid-19"},{"title3":"Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus"},{"title3":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France"}]},{"title2":"Institut national d'excellence en sante et services sociaux, Quebec","References":[]},{"title2":"Radiological society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the society of thoracic radiology, the American college of radiology, and RSNA - secondary publication","References":[{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Chest CT findings in Coronavirus Disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT"},{"title3":"Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients"},{"title3":"Imaging of pulmonary viral pneumonia"},{"title3":"Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung Injury (EVALI): evolving knowledge and remaining questions"},{"title3":"Drug-induced lung disease: high-resolution CT findings"},{"title3":"Imaging of cancer immunotherapy: current approaches and future directions"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Acute pulmonary injury: high-resolution CT and histopathological spectrum"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Temporal Changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study"},{"title3":"Emerging 2019 Novel Coronavirus (2019-nCoV) pneumonia"},{"title3":"Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Chest CT findings in cases from the cruise ship &quot;Diamond Princess&quot; with coronavirus disease 2019 (COVID-19)"},{"title3":"Sensitivity of chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Laboratory diagnosis of emerging human coronavirus infections - The State of the Art"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Fleischner society: glossary of terms for thoracic imaging"}]},{"title2":"Laboratory parameters in patients with COVID-19 on first emergency admission is different in non-survivors: albumin and lactate dehydrogenase as risk factors","References":[]},{"title2":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in wuhan, China: a two-center, retrospective study","References":[]},{"title2":"Preadmission diabetes-specific risk factors for mortality in hospitalized patients with diabetes and coronavirus disease 2019","References":[{"title3":"WHO Timeline-COVID-19. WHO Newsroom"},{"title3":"Clinical characteristics of Coronavirus Disease 2019 in China"},{"title3":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Diabetes and the severity of pandemic influenza A (H1N1) infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study"},{"title3":"Introductions and early spread of SARS-CoV-2 in the New York City area"},{"title3":"COVID-19 and racial/ethnic disparities"},{"title3":"QuickFacts: Bronx County (Bronx Borough)"},{"title3":"Standards of Medical Care in Diabetes-2020 abridged for primary care providers"},{"title3":"Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico"},{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study"},{"title3":"The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis"},{"title3":"Effect of A1c and glucose on postoperative mortality in noncardiac and cardiac surgeries"},{"title3":"The presence of diabetes and higher HbA1c are independently associated with adverse outcomes after surgery"},{"title3":"Obesity and COVID-19 severity in a designated hospital in Shenzhen, China"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"The gendered impact of coronavirus disease (COVID-19): do estrogens play a role"},{"title3":"Cardiovascular disease, drug therapy, and mortality in Covid-19"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Kidney disease is associated with in-hospital death of patients with COVID-19"},{"title3":"Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Variability in glycated hemoglobin and risk of poor outcomes among people with type 2 diabetes in a large primary care cohort study"},{"title3":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study"}]},{"title2":"Diabetes is a risk factor for the progression and prognosis of COVID-19","References":[{"title3":"Diabetes is a risk factor for the progression and prognosis of COVID-19"},{"title3":" https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed April 10, 2020."},{"title3":"The immune system's involvement in obesity-driven type 2 diabetes"},{"title3":" https://bit.ly/2xjKnOF. Accessed April 10, 2020."},{"title3":"Severe outcomes among patients with coronavirus disease 2019-United States, February 12-March 16, 2020"}]},{"title2":"Initiative pour la promotion de la qualite et l'epidemiologie du diabete sucre, IPQED, Audit 10, Donnees 2017 - 2018","References":[]},{"title2":"Clinical characteristics and outcomes of type 2 diabetes patients infected with COVID-19: a retrospective study","References":[{"title3":"Coronavirus disease (COVID-2019) situation reports [Internet]. Geneva: World Health Organization; c2020 [cited 7 April 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Coronavirus disease (COVID-19): spectrum of CT findings and temporal progression of the disease"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Morbidity and mortality weekly report: novel coronavirus reports [Internet]. Atlanta: Centers for Disease Control and Prevention of US Department of Health &amp; Human Sevices; [updated 2020 May 14; cited 14 May 2020]. Available from: https://www.cdc.gov/mmwr/Novel_Coronavirus_Reports.html."},{"title3":"Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020;55(5):2000547."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 2020;5(7):831-40."},{"title3":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China"},{"title3":"Clinical features of deaths in the novel coronavirus epidemic in China"},{"title3":"Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis"},{"title3":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak"},{"title3":"Chinese Diabetes Society. Management suggestions for patients with diabetes and novel coronavirus pneumonia. Chin J Diabetes Mellitus 2020;12(2):73-5. Chinese."},{"title3":"The management of blood glucose should be emphasized in the treatment of COVID-19"},{"title3":"Chen Y, Gong X, Wang L, Guo J. Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. 2020. medRxiv:2020.03.25.20043133."},{"title3":"Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 edition). Chin J Pract Intern Med 2018;38:292-44."},{"title3":"Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020;36(7):e3319."},{"title3":"Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy"},{"title3":"Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res 2020;116(10)1688-99."},{"title3":"American Diabetes Association. Standards of medical care in diabetes:2020. Diabetes Care 2020;43(Suppl 1):S3."},{"title3":"Selective IgA deficiency"},{"title3":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180(7):1-11."},{"title3":"Isidori AM, Arnaldi G, Boscaro M, Falorni A, Giordano C, Giordano R, et al. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. J Endocrinol Invest 2020;43:1141-7."},{"title3":"Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine"},{"title3":"Liver-adipose tissue crosstalk: a key player in the pathogenesis of glucolipid metabolic disease"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75(7):1730-41."},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"IDF diabetes atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018"}]},{"title2":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","References":[]},{"title2":"Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes","References":[{"title3":"Naming the coronavirus disease (COVID-19) and the virus that causes it [EB/OL]"},{"title3":"Coronavirus disease 2019 (COVID-19) situation report - 92"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China"},{"title3":"Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"The impact of diet on immunity and respiratory diseases"},{"title3":"Diet, exercise and gut mucosal immunity"},{"title3":"Impact of sepsis on CD4 T cell immunity"},{"title3":"Metabolic reprogramming &amp; inflammation: fuelling the host response to pathogens"},{"title3":"Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Hypertension and COVID-19"}]},{"title2":"The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis","References":[{"title3":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis"},{"title3":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)"},{"title3":"Centers for Disease Control and Prevention (2020) Daily confirmed, and probable COVID-19 infections and deaths in the U.S. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html"},{"title3":"World Health Organisation (2020) WHO Coronavirus disease (COVID-19) Dashboard. Retrieved from https://covid19.who.int"},{"title3":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis"},{"title3":"Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus"},{"title3":"The role of inflammation in diabetes: current concepts and future perspectives"},{"title3":"Diabetes is a risk factor for the progression and prognosis of COVID-19"},{"title3":"Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha"},{"title3":"Diabetes and infection: is there a link?:a mini-review"},{"title3":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms"},{"title3":"Racism and discrimination in COVID-19 responses"},{"title3":"Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al (2020) Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol (in press). https://www.bloomberg.com/press-releases/2020-04-17/covid-19-study-shows-more-than-4-times-in-hospital-mortality-rate-and-increased-length-of-stay-for-patients-with-diabetes-and"},{"title3":"Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"}]},{"title2":"Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes","References":[{"title3":"Coronavirus disease (COVID-19) [internet]"},{"title3":"COVID-19 [internet]"},{"title3":"Koronawirus: Informacje I Zalecenia - Portal Gov.pl [Internet]"},{"title3":"Impact of COVID-19 pandemic on total mortality in Poland"},{"title3":"A reversal of fortune: comparison of health system responses to covid-19 in the visegrad group during the early phases of the pandemic"},{"title3":"Transformation of a large multi-speciality hospital into a dedicated COVID-19 centre during the coronavirus pandemic"},{"title3":"Role of a field hospital in COVID-19 pandemic"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis"},{"title3":"The relationship between diabetes mellitus and COVID-19 prognosis: a retrospective cohort study in wuhan, China"},{"title3":"Coronavirus disease (COVID-19): a systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events"},{"title3":"Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies"},{"title3":"Diabetes is most important cause for mortality in COVID-19 hospitalized patients: systematic review and meta-analysis"},{"title3":"Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection"},{"title3":"Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes"},{"title3":"Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes"},{"title3":"Cultivable oral bacteriota dysbiosis in mechanically ventilated COVID-19 patients"},{"title3":"Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland"},{"title3":"Diagnostic testing for SARS-CoV-2"},{"title3":"ESC Clinical Practice Guidelines"},{"title3":"Simple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score"},{"title3":"Characteristics and clinical outcomes of 116,539 patients hospitalized with COVID-19:Poland, march-december 2020"},{"title3":"Demographic and clinical overview of hospitalized COVID-19 patients during the first 17 Months of the pandemic in Poland"},{"title3":"Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study"},{"title3":"Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis"},{"title3":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis"},{"title3":"Does comorbidity increase the risk of patients with covid-19: evidence from meta-analysis"},{"title3":"Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients"},{"title3":"Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review"},{"title3":"CKD is a key risk factor for COVID-19 mortality"},{"title3":"Effect of heart failure on the outcome of COVID-19 : a meta analysis and systematic review"},{"title3":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews"},{"title3":"Preadmission diabetes-specific risk factors for mortality in hospitalizedpatients withdiabetes and coronavirus disease 2019"},{"title3":"Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital"},{"title3":"Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the pisa COVID-19 study"},{"title3":"Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-Analysis"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"Guidelines on the management of patients with diabetes. A position of Diabetes Poland"},{"title3":"The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis"},{"title3":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19"},{"title3":"ACEI/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis"},{"title3":"Antihypertensive medications and COVID-19 diagnosis and mortality: population-based case-control analysis in the United Kingdom"},{"title3":"The effects of different classes of antihypertensive drugs on patients with COVID-19 and hypertension: a mini-review"},{"title3":"Pathophysiology of diabetic dyslipidaemia: where are we?"},{"title3":"Lack of significant association between dyslipidemia and COVID-19 mortality"},{"title3":"Dyslipidemia increases the risk of severe COVID-19: a systematic review, meta-analysis, and meta-regression"},{"title3":"Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Body Mass index and Mini Nutritional Assessment-Short Form as Predictors of In-Geriatric Hospital Mortality in Older Adults with COVID-19"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area"},{"title3":"Obesity paradox and aging"},{"title3":"Nutritional risk and therapy for severe and critical COVID-19 patients: a multicenter retrospective observational study"},{"title3":"A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic"},{"title3":"1222-P: characteristics, mortality, and clinical outcomes of hospitalized patients with COVID-and diabetes: a reference single-center cohort study from Poland"}]},{"title2":"Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study","References":[{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Aging, male sex, obesity, and metabolic inflammation create the perfect storm for COVID-19"},{"title3":"COVID-19 and Italy: what next"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike"},{"title3":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26"},{"title3":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes"},{"title3":"Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses"},{"title3":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV"},{"title3":"(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes"},{"title3":"A randomized, double-blinded, placebo-controlled trial of sitagliptin for reducing inflammation and immune activation in treated and suppressed human immunodeficiency virus infection"},{"title3":"Sitagliptin exerts an antinflammatory action"},{"title3":"Sitagliptin favorably modulates immune-relevant pathways in human beta cells"},{"title3":"Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection"},{"title3":"DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-kappaB activation"},{"title3":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications"},{"title3":"COVID-19 and diabetes: can DPP4 inhibition play a role"},{"title3":"Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19"},{"title3":"DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19"},{"title3":"Prevalence and impact of diabetes among people infected with SARS-CoV-2"},{"title3":"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes"},{"title3":"Beyond glycemic control: new guidance on cardio-renal protection"},{"title3":"Type 1 diabetes and dysfunctional intestinal homeostasis"},{"title3":"Type 2 diabetes mellitus"},{"title3":"Role of podocyte B7-1 in diabetic nephropathy"},{"title3":"Explaining the increased mortality in type 1 diabetes"},{"title3":"Diabetes: advances in diagnosis and treatment"},{"title3":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes"},{"title3":"1. Improving care and promoting health in populations: Standards of Medical Care in Diabetes:2020"},{"title3":"CS AMD SID 7 aprile 20 (in Italian)"},{"title3":"Issues for the management of people with diabetes and COVID-19 in ICU"},{"title3":"Suppression of a SARS-CoV-2 outbreak in the Italian municipality of vo'"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19"},{"title3":"Adaptations and lessons in the Province of Bergamo"},{"title3":"COVID-19 deaths in Lombardy, Italy: data in context"},{"title3":"Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences"},{"title3":"Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes"},{"title3":"Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis"},{"title3":"Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition"}]},{"title2":"Type 2 diabetes and COVID-19-related mortality in the critical care setting: a national cohort study in England, march-july 2020","References":[{"title3":"WHO Director-General's statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV)"},{"title3":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study"},{"title3":"Quantifying the risk of infectious diseases for people with diabetes"},{"title3":"Excess risk of dying from infectious causes in those with type 1 and type 2 diabetes"},{"title3":"Factors associated with COVID-19-related death using OpenSAFELY"},{"title3":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"},{"title3":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study"},{"title3":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes"},{"title3":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy"},{"title3":"Factors associated with death in critically ill patients with Coronavirus Disease 2019 in the US"},{"title3":"COVID-19 Hospitalisation in England Surveillance System (CHESS)"},{"title3":"COVID-19: investigation and initial clinical management of possible cases"},{"title3":"Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis"},{"title3":"A tutorial on multilevel survival analysis: methods, models and applications"},{"title3":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls"},{"title3":"R: A Language and Environment for Statistical Computing"},{"title3":"Hospital mortality and resource implications of hospitalisation with COVID-19 in London, UK: a prospective cohort study"},{"title3":"A geotemporal survey of hospital bed saturation across England during the first wave of the COVID-19 Pandemic"},{"title3":"Between-centre differences for COVID-19 ICU mortality from early data in England"},{"title3":"Improving COVID-19 critical care mortality over time in England: a national cohort study, March to June 2020"},{"title3":"ICNARC report on COVID-19 in critical care"},{"title3":"Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults"},{"title3":"Determinants of fatal outcome in patients admitted to intensive care units with influenza, European Union 2009-2017"},{"title3":"Is caviar a risk factor for being a millionaire"},{"title3":"Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 Study"},{"title3":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"},{"title3":"Diabetes and COVID-19: moving from news to knowledge and a glucose hypothesis"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study"},{"title3":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports"},{"title3":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Aging, male sex, obesity, and metabolic inflammation create the perfect storm for COVID-19"},{"title3":"COVID-19 in people with diabetes: urgently needed lessons from early reports"}]},{"title2":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","References":[{"title3":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV). MERS monthly summary"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Characteristics of COVID-19 patients dying in Italy. Report based on available data on March 24th, 2020"},{"title3":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study"},{"title3":"Report 17: clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study"},{"title3":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Commentary: COVID-19 and diabetes"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia:a systematic review, meta-analysis, and meta-regression"},{"title3":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study"},{"title3":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study"},{"title3":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms"},{"title3":"National diabetes audit:report 1: care processes and treatment targets 2018-19, short report"},{"title3":"Directions and data provision notices"},{"title3":"[MI] National Data Opt-out, June 2020"},{"title3":"English indices of deprivation 2019"},{"title3":"Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups"},{"title3":"COVID-19 and smoking: a systematic review of the evidence"},{"title3":"Smoking is associated With COVID-19 progression: a meta-analysis"},{"title3":"Analysis of death registrations not involving coronavirus (COVID-19), England and Wales: 28 December 2019 to 1 May 2020"}]},{"title2":"Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes","References":[{"title3":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area"},{"title3":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York"},{"title3":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China"},{"title3":"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports"},{"title3":"Hospitalization and Mortality among Black Patients and White Patients with Covid-19"},{"title3":"The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States"},{"title3":"Black-White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges"},{"title3":"Racial/ethnic differences in the burden of type 2 diabetes over the life course: a focus on the USA and India"},{"title3":"Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19"},{"title3":"Metformin: From Research to Clinical Practice"},{"title3":"Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis"},{"title3":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice"},{"title3":"The effects of metformin on the fibrinolytic system in diabetic and non-diabetic subjects"},{"title3":"Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release"},{"title3":"The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications"},{"title3":"COVID-19 and its implications for thrombosis and anticoagulation"},{"title3":"The need to manage the risk of thromboembolism in COVID-19 patients"},{"title3":"Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study"},{"title3":"Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes"},{"title3":"The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings"},{"title3":"Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study"},{"title3":"A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids"},{"title3":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"COVID-19 infection may cause ketosis and ketoacidosis"},{"title3":"Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19"},{"title3":"Sex differences in immune responses"},{"title3":"Metformin Use Is Associated with Reduced Mortality in a Diverse Population with Covid-19 and Diabetes"}]},{"title2":"Observational study of metformin and risk of mortality in patients hospitalized with covid-19","References":[{"title3":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures"},{"title3":"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19"},{"title3":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy"},{"title3":"Sex difference and smoking predisposition in patients with COVID-19"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China"},{"title3":"Identification of sex-specific thresholds for accumulation of visceral adipose tissue in adults"},{"title3":"Medical consequences of obesity"},{"title3":"Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes"},{"title3":"Difficulties in diagnosing pulmonary embolism in the obese patient: a literature review"},{"title3":"Immunomodulation in COVID-19"},{"title3":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs"},{"title3":"Does Therapy With Anti-TNF-alpha Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?"},{"title3":"Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1beta (IL-1beta) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages"},{"title3":"Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock"},{"title3":"Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus"},{"title3":"Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients"},{"title3":"The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment"},{"title3":"Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review"},{"title3":"Regression Shrinkage and Selection Via the Lasso"},{"title3":"How to handle mortality when investigating length of hospital stay and time to clinical stability"},{"title3":"Remdesivir for the Treatment of Covid-19 - Preliminary Report"},{"title3":"Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching"},{"title3":"Variable selection for propensity score models"},{"title3":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease"},{"title3":"Tumor necrosis factor-alpha signaling in macrophages"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"The mechanisms of action of metformin"},{"title3":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States"},{"title3":"AMPK: a balancer of the renin-angiotensin system"},{"title3":"Metformin in COVID-19: A possible role beyond diabetes"},{"title3":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues"},{"title3":"Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study"},{"title3":"Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China"},{"title3":"Can we predict the severity of COVID-19 with a routine blood test?"},{"title3":"Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis"},{"title3":"Severe Covid-19"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Sex differences in immune responses"},{"title3":"Metformin inhibits IgE- and aryl hydrocarbon receptor-mediated mast cell activation in vitro and in vivo"},{"title3":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy"},{"title3":"Sexual dimorphism in the mast cell transcriptome and the pathophysiological responses to immunological and psychological stress"},{"title3":"Antihypertensive drugs and risk of COVID-19?"},{"title3":"Stereoselectivity at the beta2-adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists"},{"title3":"Metformin in 2019"},{"title3":"Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes"},{"title3":"National Survey of Primary Care Physicians' Knowledge, Practices, and Perceptions of Prediabetes"},{"title3":"Dropping Highly Collinear Variables from a Model: Why it Typically is Not a Good Idea*"},{"title3":"Collinearity and Causal Diagrams: A Lesson on the Importance of Model Specification"}]},{"title2":"Clinical characteristics and outcomes of patients hospitalized for COVID-19 in Africa: early insights from the democratic republic of the Congo","References":[{"title3":"The late arrival of COVID-19 in Africa-mitigating pan-continental spread"},{"title3":"Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries"},{"title3":"Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide"},{"title3":"From easing lockdowns to scaling-up community-based COVID-19 screening, testing, and contact tracing in Africa-shared approaches, innovations, and challenges to minimize morbidity and mortality"},{"title3":"COVID-19 in Africa: the spread and response"},{"title3":"Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-saharan Africa"},{"title3":"What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?"},{"title3":"Venn diagram: a package for the generation of highly customizable Venn and Euler diagrams in R"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series"},{"title3":"Clinical characteristics of COVID-19 in New York city"},{"title3":"A pediatric infectious disease perspective on COVID-19"},{"title3":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review"},{"title3":"The impact of ethnicity on clinical outcomes in COVID-19: a systematic review"},{"title3":"Racial/ethnic disparities in disease severity on admission chest radiographs among patients admitted with confirmed COVID-19: a retrospective cohort study"},{"title3":"High HIV prevalence in an early cohort of hospital admissions with COVID-19 in Cape Town, South Africa"},{"title3":"Can we use interleukin-6 blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Mechanisms linking obesity to insulin resistance and type 2 diabetes"},{"title3":"Is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in COVID-19"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"COVID-19 in diabetic patients: related risks and specifics of management"},{"title3":"Genetic roadmap for kidney involvement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection"},{"title3":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China"},{"title3":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection"},{"title3":"Collapsing glomerulopathy in a COVID-19 patient"},{"title3":"Management of patients on dialysis and with kidney transplant during SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy"},{"title3":"Acute kidney injury in patients hospitalized with COVID-19"},{"title3":"Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial"},{"title3":"Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19"},{"title3":"HIV and risk of COVID-19 death: a population cohort study from the western Cape province, South Africa"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review"},{"title3":"Multisystem inflammatory syndrome in U.S. children and adolescents"},{"title3":"SARS-CoV-2 (COVID-19): what do we know about children? A systematic review"},{"title3":"Multisystem inflammatory syndrome in children in South Africa"}]}]},{"title1":"Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19","References":[{"title2":"Factors associated with COVID-19-related death using OpenSAFELY","References":[{"title3":"Clinical determinants for fatality of 44,672 patients with COVID-19"},{"title3":"Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Is ethnicity linked to incidence or outcomes of covid-19?"},{"title3":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?"},{"title3":"COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive study"},{"title3":"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years"},{"title3":"Impact Of Electronic Health Record Interface Design On Unsafe Prescribing Of Ciclosporin, Tacrolimus and Diltiazem: A Cohort Study In English NHS Primary Care"},{"title3":"Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record"},{"title3":"Ghost branded generics: Why does the cost of generic atorvastatin vary?"},{"title3":"Completeness and usability of ethnicity data in UK-based primary care and hospital databases"},{"title3":"Closing the gap in a generation: health equity through action on the social determinants of health"},{"title3":"Development and validation of an electronic frailty index using routine primary care electronic health record data"},{"title3":"Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data"},{"title3":"The relationship between time since registration and measured incidence rates in the General Practice Research Database"},{"title3":"A New Equation to Estimate Glomerular Filtration Rate"},{"title3":"What is the dm+d? The NHS Dictionary of Medicines and Devices"},{"title3":"Validation of asthma recording in the Clinical Practice Research Datalink (CPRD)"},{"title3":"OpenSAFELY Codelists: Asthma Oral Prednisolone Medication"},{"title3":"Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis"},{"title3":"OpenSAFELY Codelists: Permanent Immunosuppresion"},{"title3":"OpenSAFELY Codelists: Temporary Immunosuppresion"},{"title3":"Clinical Code List-Psoriasis-Read Codes"},{"title3":"Clinical code list - SLE codes"},{"title3":"Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England"},{"title3":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases"},{"title3":"Population-calibrated multiple imputation for a binary/categorical covariate in categorical regression models"}]},{"title2":"2019 Update to: management of hyperglycemia in Type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","References":[]},{"title2":"Diabetes Medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis","References":[{"title3":"Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030"},{"title3":"The evolving diabetes burden in the United States"},{"title3":"Health-related quality of life in type-2 diabetes patients: A cross-sectional study in East China"},{"title3":"Type 2 diabetes quality of life patients treated with insulin and oral hypoglycemic medication"},{"title3":"Improving survival with metformin: The evidence base today"},{"title3":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023"},{"title3":"Trends in diabetes treatment and control in US adults, 1999-2018"},{"title3":"Use of antihyperglycemic medications in US adults: An analysis of the National Health and Nutrition Examination Survey"},{"title3":"The effects of SGLT2 inhibitors on cardiovascular and renal outcomes in diabetic patients: A systematic review and meta-analysis"},{"title3":"The impact of patient-reported outcome data from clinical trials: Perspectives from international stakeholders"},{"title3":"Temporal Trends and Factors Associated With the Inclusion of Patient-Reported Outcomes in Heart Failure Randomized Controlled Trials: A Systematic Review"},{"title3":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO extension"},{"title3":"Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials"},{"title3":"Health related quality of life and healthcare utilization among adults with diabetes and kidney and eye complications in the United States"},{"title3":"Trends of medical expenditures and quality of life in US adults with diabetes: The medical expenditure panel survey, 2002-2011"},{"title3":"Medical Expenditure Panel Survey, Survey Background"},{"title3":"Assessment of Reliability and Validity of SF-12v2 among a Diabetic Population"},{"title3":"How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods"},{"title3":"Estimating the minimal clinically important difference for the Physical Component Summary of the Short Form 36 for patients with stroke"},{"title3":"Minimal important difference to infer changes in health-related quality of life:A systematic review"},{"title3":"Risk of fragility fractures in obesity and diabetes: A retrospective analysis on a nation-wide cohort"},{"title3":"Interpretation and impact of real-world clinical data for the practicing clinician"},{"title3":"Impact of metformin therapy on health-related quality of life outcomes in tuberculosis patients with diabetes mellitus in India: A prospective study"},{"title3":"Assessing health related quality of life in diabetic subjects by SF 36 questionnaire in a tertiary care diabetes unit of Karachi, Pakistan"},{"title3":"Association between glycaemic control and quality of life in diabetes mellitus"},{"title3":"Associations between complications and health-related quality of life in individuals with diabetes"},{"title3":"Pioglitazone improves endothelial and adipose tissue dysfunction in pre-diabetic CAD subjects"},{"title3":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial"},{"title3":"FDA places &quot;black box&quot; warning on antidiabetes drugs"},{"title3":"Cardiovascular safety of sulphonylureas: Over 40 years of continuous controversy without an answer"},{"title3":"Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life"},{"title3":"Insulin-associated weight gain in diabetes-causes, effects and coping strategies"},{"title3":"State of the art paper sulfonylureas and their use in clinical practice"},{"title3":"Safety and efficacy of Pioglitazone/Metformin combination therapy in treatment of type 2 diabetes: A rationale for earlier use"},{"title3":"Racial disparities in health-related quality of life after lung cancer surgery: Findings from the cancer care outcomes research and surveillance consortium"},{"title3":"Hispanic health in the USA: A scoping review of the literature"},{"title3":"Health-Related Quality of Life (HRQoL) of people over 65 years of age"},{"title3":"Development of comorbidities in type 2 diabetes between 2005 and 2017 using German claims data"},{"title3":"Assessing health-related quality of life in patients with diabetes mellitus at a Tertiary Care Center in Central Delhi"},{"title3":"Hospital use among diabetic patients and the general population"},{"title3":"Impact of diabetes on hospital admission and length of stay among a general population aged 45 year or more: A record linkage study"},{"title3":"Research in Tayside SMMUC. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: A retrospective cohort study of resource use"},{"title3":"Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: A case control study"},{"title3":"Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus"},{"title3":"Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: A cohort study"},{"title3":"Thiazolidinediones and cardiovascular outcomes in older patients with diabetes"},{"title3":"Use of diabetes medications in traditional Medicare and Medicare Advantage"}]},{"title2":"Renoprotective effects of metformin","References":[]},{"title2":"Repurposing metformin for the prevention of cancer and cancer recurrence","References":[{"title3":"Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine"},{"title3":"Metformin: historical overview"},{"title3":"Investigating metformin for cancer prevention and treatment: the end of the beginning"},{"title3":"AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell"},{"title3":"Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma"},{"title3":"Metformin: a therapeutic opportunity in breast cancer"},{"title3":"Anti-inflammatory effects of metformin irrespective of diabetes status"},{"title3":"Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans"},{"title3":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines"},{"title3":"OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin"},{"title3":"Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells"},{"title3":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis"},{"title3":"Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides"},{"title3":"Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers"},{"title3":"Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells"},{"title3":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level"},{"title3":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission"},{"title3":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis"},{"title3":"Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review"},{"title3":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis"},{"title3":"Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis"},{"title3":"Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies"},{"title3":"Pharmacologic therapy of diabetes and overall cancer risk and mortality: ameta-analysis of 265 studies"},{"title3":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders"},{"title3":"Association of metformin use with cancer incidence and mortality: a meta-analysis"},{"title3":"The effect of metformin on mortality following cancer among patients with diabetes"},{"title3":"The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis"},{"title3":"Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials"},{"title3":"Repurposing old drugs to chemoprevention: the case of metformin"},{"title3":"Metformin and the risk of cancer: time-related biases in observational studies"},{"title3":"Metformin use and the risk of colorectal adenoma: a systematic review and meta-analysis"},{"title3":"Metformin is associated with slightly reduced risk of colorectal cancer and moderate survival benefits in diabetes mellitus: ameta-analysis"},{"title3":"Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis"},{"title3":"Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis"},{"title3":"Association between metformin therapy and breast cancer incidence and mortality: evidence from a meta-analysis"},{"title3":"Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus"},{"title3":"Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis"},{"title3":"Metformin therapy associated with survival benefit in lung cancer patients with diabetes"},{"title3":"Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis"},{"title3":"Metformin and prostate cancer mortality: a meta-analysis"},{"title3":"Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis"},{"title3":"Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis"},{"title3":"Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis"},{"title3":"Long-term metformin use is associated with decreased risk of breast cancer"},{"title3":"Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus"},{"title3":"Insulin-lowering effects of metformin in women with early breast cancer"},{"title3":"Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study"},{"title3":"Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study"},{"title3":"Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial"},{"title3":"Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial"},{"title3":"Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study"},{"title3":"Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer"},{"title3":"Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial"},{"title3":"Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial"},{"title3":"Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer"},{"title3":"Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial"},{"title3":"Measuring the biological effect of presurgical metformin treatment in endometrial cancer"},{"title3":"Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer"},{"title3":"Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial"},{"title3":"A pilot /'window of opportunity/' neoadjuvant study of metformin in localised prostate cancer"},{"title3":"The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes"}]},{"title2":"The therapeutic potential of metformin in neurodegenerative diseases","References":[{"title3":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015"},{"title3":"Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents"},{"title3":"Cellular and molecular mechanisms of metformin: an overview"},{"title3":"Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials"},{"title3":"Metformin: an old but still the best treatment for type 2 diabetes"},{"title3":"Diabetes drugs and neurological disorders: new views and therapeutic possibilities"},{"title3":"Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects"},{"title3":"Mitochondrial aging defects emerge in directly reprogrammed human neurons due to their metabolic profile"},{"title3":"Insulin and neurodegenerative disease: shared and specific mechanisms"},{"title3":"Diabetes mellitus and dementia"},{"title3":"Insulin resistance and Alzheimer's disease: molecular links &amp; clinical implications"},{"title3":"The role of type 2 diabetes in neurodegeneration"},{"title3":"World population prospects: The 2015 revision, key findings and advance tables"},{"title3":"Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study"},{"title3":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology"},{"title3":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein"},{"title3":"Tau phosphorylation in neuronal cell function and dysfunction"},{"title3":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease"},{"title3":"Regulation of beta-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease"},{"title3":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease"},{"title3":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus"},{"title3":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease"},{"title3":"Pathways to Alzheimer's disease"},{"title3":"Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk"},{"title3":"A common haplotype lowers PU"},{"title3":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease"},{"title3":"A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease"},{"title3":"Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective"},{"title3":"Environmental risk factors for dementia: a systematic review"},{"title3":"Traumatic brain injury and age at onset of cognitive impairment in older adults"},{"title3":"Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein"},{"title3":"Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels"},{"title3":"Increased Abeta production prompts the onset of glucose intolerance and insulin resistance"},{"title3":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes"},{"title3":"Metformin treatment alters memory function in a mouse model of Alzheimer's disease"},{"title3":"Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy"},{"title3":"Interplay between the gut-brain axis, obesity and cognitive function"},{"title3":"Alzheimer-like changes in rat models of spontaneous diabetes"},{"title3":"Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice"},{"title3":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers"},{"title3":"IGF-I and the aging mammalian brain"},{"title3":"Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders"},{"title3":"Impact of intermittent fasting on health and disease processes"},{"title3":"Metformin prevents nigrostriatal dopamine degeneration independent of AMPK activation in dopamine neurons"},{"title3":"Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system"},{"title3":"Activation of the ATF2/CREB-PGC-1alpha pathway by metformin leads to dopaminergic neuroprotection"},{"title3":"Metformin lowers alpha-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease"},{"title3":"Metformin prevents dopaminergic neuron death in MPTP/P-induced mouse model of parkinson's disease via autophagy and mitochondrial ROS clearance"},{"title3":"Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice"},{"title3":"Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation"},{"title3":"Metformin prevented dopaminergic neurotoxicity induced by 3,4-Methylenedioxymethamphetamine administration"},{"title3":"Antidiabetic drugs restore abnormal transport of amyloid-beta across the blood-brain barrier and memory impairment in db/db mice"},{"title3":"Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling"},{"title3":"Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice"},{"title3":"Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-kappaB activation: use of insulin to attenuate metformin's effect"},{"title3":"Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice"},{"title3":"Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice"},{"title3":"A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin"},{"title3":"Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats"},{"title3":"Metformin impairs spatial memory and visual acuity in old male mice"},{"title3":"Metformin therapy in a transgenic mouse model of Huntington's disease"},{"title3":"Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice"},{"title3":"A meta-analysis of cognitive functioning in nondemented adults with type 2 diabetes mellitus"},{"title3":"Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains"},{"title3":"Executive function in adults with type 2 diabetes: a meta-analytic review"},{"title3":"Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis"},{"title3":"Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes"},{"title3":"Brain gray matter changes in type 2 diabetes mellitus: a meta-analysis of whole-brain voxel-based morphometry study"},{"title3":"Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis"},{"title3":"Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders"},{"title3":"Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship"},{"title3":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies"},{"title3":"Increased risk of type 2 diabetes in Alzheimer disease"},{"title3":"Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study"},{"title3":"Individuals with Alzheimer's disease exhibit a high prevalence of undiagnosed impaired glucose tolerance and type 2 diabetes mellitus"},{"title3":"A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease"},{"title3":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine"},{"title3":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Abeta oligomers"},{"title3":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline"},{"title3":"Hyperinsulinemia and risk of Alzheimer disease"},{"title3":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes"},{"title3":"Diabetes is related to cerebral infarction but not to AD pathology in older persons"},{"title3":"Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology"},{"title3":"Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes"},{"title3":"Diabetes is not associated with Alzheimer's disease neuropathology"},{"title3":"Diabetes, hemoglobin A1C, and regional Alzheimer disease and infarct pathology"},{"title3":"Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology"},{"title3":"Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study"},{"title3":"Prevalence of mixed pathologies in the aging brain"},{"title3":"Potential for primary prevention of Alzheimer's disease: an analysis of population-based data"},{"title3":"Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort"},{"title3":"Glitazone use associated with reduced risk of Parkinson's disease"},{"title3":"Simvastatin is associated with decreased risk of Parkinson disease"},{"title3":"Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus"},{"title3":"Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin"},{"title3":"Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis"},{"title3":"Effect of pioglitazone medication on the incidence of dementia"},{"title3":"Impact of insulin sensitizers on the incidence of dementia: a meta-analysis"},{"title3":"Differential effects of metformin on age related comorbidities in older men with type 2 diabetes"},{"title3":"Metformin vs sulfonylurea use and risk of dementia in US veterans aged &gt;/ = 65 years with diabetes"},{"title3":"Long-term metformin usage and cognitive function among older adults with diabetes"},{"title3":"Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study"},{"title3":"Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study"},{"title3":"Effects of the insulin sensitizer metformin in Alzheimer Disease: pilot data from a randomized placebo-controlled crossover study"},{"title3":"Metformin intake associates with better cognitive function in patients with Huntington's disease"},{"title3":"Risk factors associated with abnormal cognition in Japanese outpatients with diabetes, hypertension or dyslipidemia"},{"title3":"Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial"},{"title3":"Epidemiology of Parkinson's disease"},{"title3":"Parkinson's disease: clinical features and diagnosis"},{"title3":"The substantia nigra of the human brain"},{"title3":"Clinical and pathological features of Parkinson's disease"},{"title3":"Alpha-synuclein in Lewy bodies"},{"title3":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)"},{"title3":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction"},{"title3":"Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects"},{"title3":"The genetics of Parkinson disease"},{"title3":"Genetics of Parkinson's disease"},{"title3":"Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease"},{"title3":"The ongoing pursuit of neuroprotective therapies in Parkinson disease"},{"title3":"Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity"},{"title3":"Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet"},{"title3":"Diet-induced obesity accelerates the onset of terminal phenotypes in alpha-synuclein transgenic mice"},{"title3":"Insulin resistance impairs nigrostriatal dopamine function"},{"title3":"Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice"},{"title3":"Type 2 diabetes and the risk of Parkinson's disease"},{"title3":"Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease"},{"title3":"Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease"},{"title3":"Diabetes preceding Parkinson's disease onset"},{"title3":"Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan"},{"title3":"Diabetes and the risk of developing Parkinson's disease in Denmark"},{"title3":"Diabetes and risk of Parkinson's disease"},{"title3":"Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies"},{"title3":"Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis"},{"title3":"Risk of Parkinson disease in diabetes mellitus: an updated meta-analysis of population-based cohort studies"},{"title3":"Glucose levels and risk of dementia"},{"title3":"Lewy body dementias"},{"title3":"Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease"},{"title3":"Dementia is associated with insulin resistance in patients with Parkinson's disease"},{"title3":"Diabetes in a large dementia cohort: clinical characteristics and treatment from the Swedish dementia registry"},{"title3":"Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study"},{"title3":"Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease"},{"title3":"Vascular risk factors and cognition in Parkinson's disease"},{"title3":"Meta-analysis of risk factors for Parkinson's disease dementia"},{"title3":"Statins in neurological disorders: an overview and update"},{"title3":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial"},{"title3":"2017 FDA drug approvals"},{"title3":"Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study"},{"title3":"Association between diabetes and amyotrophic lateral sclerosis in Sweden"},{"title3":"ALS disease onset may occur later in patients with pre-morbid diabetes mellitus"},{"title3":"The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis"},{"title3":"Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis"},{"title3":"Risk of amyotrophic lateral sclerosis in patients with diabetes: a nationwide population-based cohort study"},{"title3":"Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom?"},{"title3":"Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients"},{"title3":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis"},{"title3":"Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial"},{"title3":"A pilot trial of pioglitazone HCl and tretinoin in ALS: cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression"},{"title3":"Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion"},{"title3":"Huntington's disease and diabetes: chronological sequence of its association"},{"title3":"High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington's disease"},{"title3":"Huntington's disease does not appear to increase the risk of diabetes mellitus"},{"title3":"Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patients"},{"title3":"Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study"},{"title3":"Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue"},{"title3":"AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation"},{"title3":"5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells"},{"title3":"AMP-activated protein kinase restricts IFN-gamma signaling"},{"title3":"Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells"},{"title3":"AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism"},{"title3":"AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid beta-peptide exposure"},{"title3":"The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation"},{"title3":"The antidiabetic drug metformin decreases cholesterol metabolism in cultured human fibroblasts"},{"title3":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin"},{"title3":"Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status"},{"title3":"Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction"},{"title3":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes"},{"title3":"The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex"},{"title3":"Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription"},{"title3":"AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"},{"title3":"AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease"},{"title3":"The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro"},{"title3":"Modulating the catalytic activity of AMPK has neuroprotective effects against alpha-synuclein toxicity"},{"title3":"Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of alpha-synuclein oligomers and decrease of neurites"},{"title3":"Glucose metabolism: a sweet relief of Alzheimer's disease"},{"title3":"The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1"},{"title3":"Oligodendroglia metabolically support axons and contribute to neurodegeneration"},{"title3":"Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity"},{"title3":"Lactate is a preferential oxidative energy substrate over glucose for neurons in culture"},{"title3":"Perfusion and metabolism imaging studies in Parkinson's disease"},{"title3":"Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons"},{"title3":"Hypothalamic insulin signaling is required for inhibition of glucose production"},{"title3":"Central nervous system control of food intake and body weight"},{"title3":"Dopamine receptor binding is increased in diabetic rats"},{"title3":"Modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia"},{"title3":"Increased dopamine and serotonin metabolites in CSF during severe insulin-induced hypoglycemia in freely moving rats"},{"title3":"Akt is altered in an animal model of Huntington's disease and in patients"},{"title3":"Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology"},{"title3":"RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation"},{"title3":"Akt signal transduction dysfunction in Parkinson's disease"},{"title3":"Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling"},{"title3":"AKT/PKB signaling: navigating downstream"},{"title3":"Role of translocation in the activation and function of protein kinase B"},{"title3":"PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms"},{"title3":"Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN"},{"title3":"Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice"},{"title3":"A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance"},{"title3":"Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo"},{"title3":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype"},{"title3":"Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance"},{"title3":"Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention"},{"title3":"Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes"},{"title3":"Insulin promotes survival of amyloid-beta oligomers neuroblastoma damaged cells via caspase 9 inhibition and Hsp70 upregulation"},{"title3":"The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts"},{"title3":"Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme"},{"title3":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo"},{"title3":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele"},{"title3":"Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease"},{"title3":"Promoter polymorphisms which modulate insulin degrading enzyme expression may increase susceptibility to Alzheimer's disease"},{"title3":"Association between variants in IDE-KIF11-HHEX and plasma amyloid beta levels"},{"title3":"Association between polymorphisms of the insulin-degrading enzyme gene and late-onset Alzheimer disease"},{"title3":"Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues"},{"title3":"Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3"},{"title3":"Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions"},{"title3":"Neuroprotection of insulin against oxidative stress-induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3-kinase/Akt signal pathway"},{"title3":"The role of PI3/Akt pathway in the protective effect of insulin against corticosterone cell death induction in hippocampal cell culture"},{"title3":"Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus"},{"title3":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism"},{"title3":"A reappraisal on metformin"},{"title3":"Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells"},{"title3":"Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners"},{"title3":"Metformin prevents tobacco carcinogen-induced lung tumorigenesis"},{"title3":"Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells"},{"title3":"Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects"},{"title3":"Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes"},{"title3":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-alpha in mice"},{"title3":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial"},{"title3":"mTOR signaling in growth control and disease"},{"title3":"Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2"},{"title3":"Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex"},{"title3":"PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs"},{"title3":"Systemic elevation of PTEN induces a tumor-suppressive metabolic state"},{"title3":"TSC2 mediates cellular energy response to control cell growth and survival"},{"title3":"AMPK phosphorylation of raptor mediates a metabolic checkpoint"},{"title3":"Control of p70 s6 kinase by kinase activity of FRAP in vivo"},{"title3":"Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin"},{"title3":"Structure of the human mTOR complex I and its implications for rapamycin inhibition"},{"title3":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance"},{"title3":"Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability"},{"title3":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity"},{"title3":"Mitochondrial quality control via the PGC1alpha-TFEB signaling pathway is compromised by parkin Q311X mutation but independently restored by rapamycin"},{"title3":"Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease"},{"title3":"Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia"},{"title3":"mTOR signaling in disease"},{"title3":"Targeting the mTOR signaling network for Alzheimer's disease therapy"},{"title3":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease"},{"title3":"Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature"},{"title3":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies"},{"title3":"Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy"},{"title3":"Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors"},{"title3":"The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer"},{"title3":"Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1"},{"title3":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner"},{"title3":"Innate immune activation in neurodegenerative disease"},{"title3":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity"},{"title3":"Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase"},{"title3":"Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease"},{"title3":"Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease"},{"title3":"Amyloid-beta induces hepatic insulin resistance in vivo via JAK2"},{"title3":"Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease"},{"title3":"Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease"},{"title3":"Regulation of tau pathology by the microglial fractalkine receptor"},{"title3":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains"},{"title3":"Glutathione peroxidase, glial cells and Parkinson's disease"},{"title3":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model"},{"title3":"Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice"},{"title3":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease"},{"title3":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions"},{"title3":"Innate immune function of mitochondrial metabolism"},{"title3":"Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation"},{"title3":"Mitochondrial DNA stress primes the antiviral innate immune response"},{"title3":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells"},{"title3":"Metformin inhibits nuclear factor-kappaB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro"},{"title3":"Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity"},{"title3":"Anti-inflammatory effects of metformin irrespective of diabetes status"},{"title3":"Mitochondrial regulation of beta-cell function: maintaining the momentum for insulin release"},{"title3":"Association between early-onset Parkinson's disease and mutations in the parkin gene"},{"title3":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism"},{"title3":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1"},{"title3":"Mitochondrial dysfunction in Parkinson's disease"},{"title3":"Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin"},{"title3":"Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease"},{"title3":"Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants"},{"title3":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice"},{"title3":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin"},{"title3":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration"},{"title3":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin"},{"title3":"PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1"},{"title3":"PINK1 is selectively stabilized on impaired mitochondria to activate Parkin"},{"title3":"Ubiquitin is phosphorylated by PINK1 to activate parkin"},{"title3":"Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin"},{"title3":"Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand"},{"title3":"PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling"},{"title3":"PINK1 and parkin target miro for phosphorylation and degradation to arrest mitochondrial motility"},{"title3":"The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1"},{"title3":"PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1"},{"title3":"Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease"},{"title3":"PINK1-parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury"},{"title3":"Potential roles of PINK1 for increased PGC-1alpha-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes"},{"title3":"PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways"},{"title3":"PINK1 deficiency in beta-cells increases basal insulin secretion and improves glucose tolerance in mice"},{"title3":"Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1"},{"title3":"Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease"},{"title3":"The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity"},{"title3":"Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease"},{"title3":"Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls"},{"title3":"Reply: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease"},{"title3":"No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease"},{"title3":"Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells"},{"title3":"Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis"},{"title3":"The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase"},{"title3":"Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages"},{"title3":"Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer"},{"title3":"Robust pacemaking in substantia nigra dopaminergic neurons"},{"title3":"The Alzheimer's disease mitochondrial cascade hypothesis"},{"title3":"Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice"},{"title3":"Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice"},{"title3":"Tau reduction prevents Abeta-induced defects in axonal transport"},{"title3":"Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons"},{"title3":"Mitochondria take center stage in aging and neurodegeneration"},{"title3":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications"},{"title3":"Mitochondrial dysfunction in neurodegenerative diseases"},{"title3":"Etiology and pathogenesis of Parkinson's disease"},{"title3":"Mitochondrial free radical generation, oxidative stress, and aging"},{"title3":"A systematic assessment of mitochondrial function identified novel signatures for drug-induced mitochondrial disruption in cells"},{"title3":"The hallmarks of aging"},{"title3":"MITOCHONDRIAL DNA AND HUMAN EVOLUTION"},{"title3":"Mitonuclear protein imbalance as a conserved longevity mechanism"},{"title3":"Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease"},{"title3":"Signal transduction by reactive oxygen species"},{"title3":"Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?"},{"title3":"Oxidative stress in neurodegeneration: cause or consequence?"},{"title3":"Mitochondrial uncoupling proteins in the cns: in support of function and survival"},{"title3":"DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders"},{"title3":"The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis"},{"title3":"DJ-1, a novel regulator of the tumor suppressor PTEN"},{"title3":"Salidroside protects against MPP+-induced neuronal injury through DJ-1-Nrf2 antioxidant pathway"},{"title3":"The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein"},{"title3":"Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity"},{"title3":"RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways"},{"title3":"Human DJ-1 and its homologs are novel glyoxalases"},{"title3":"Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues"},{"title3":"Parkinsonism-associated protein DJ-1 is a bona fide deglycase"},{"title3":"The role of the antioxidant protein DJ-1 in type 2 diabetes mellitus"},{"title3":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial"},{"title3":"Metformin as a tool to target aging"}]},{"title2":"Benefits of metformin in attenuating the hallmarks of aging","References":[{"title3":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes:2019"},{"title3":"Metformin induces PGC-1alpha expression and selectively affects hepatic PGC-1alpha functions"},{"title3":"Health benefits of late-onset metformin treatment every other week in mice"},{"title3":"Metformin reduces endogenous reactive oxygen species and associated DNA damage"},{"title3":"The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth"},{"title3":"Metformin slows down aging and extends life span of female SHR mice"},{"title3":"Telomere length and frailty in older adults-A systematic review and meta-analysis"},{"title3":"Short telomeres are sufficient to cause the degenerative defects associated with aging"},{"title3":"Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study"},{"title3":"Rescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration"},{"title3":"Metformin: historical overview"},{"title3":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders"},{"title3":"Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?"},{"title3":"Metformin as a Tool to Target Aging"},{"title3":"TARGETING AGING WITH METFORMIN (TAME)"},{"title3":"Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway"},{"title3":"Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway"},{"title3":"Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1"},{"title3":"Epigenetic regulation of ageing: linking environmental inputs to genomic stability"},{"title3":"Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses"},{"title3":"Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing"},{"title3":"Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection"},{"title3":"Epigenetic effects of metformin: From molecular mechanisms to clinical implications"},{"title3":"Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis"},{"title3":"From discoveries in ageing research to therapeutics for healthy ageing"},{"title3":"Telomere attrition: metabolic regulation and signalling function?"},{"title3":"Metformin attenuates cisplatin-induced genotoxicity and apoptosis in rat bone marrow cells"},{"title3":"The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes"},{"title3":"Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo"},{"title3":"Metformin extends C. elegans lifespan through lysosomal pathway"},{"title3":"Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms"},{"title3":"Cellular senescence in aging and age-related disease: from mechanisms to therapy"},{"title3":"Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs"},{"title3":"GDF15 mediates the effects of metformin on body weight and energy balance"},{"title3":"The senescence-associated secretory phenotype: the dark side of tumor suppression"},{"title3":"Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review"},{"title3":"Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism"},{"title3":"Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation"},{"title3":"Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2"},{"title3":"Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial"},{"title3":"Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut"},{"title3":"Association Between Long Telomere Length and Insulin Sensitization in Adolescent Girls With Hyperinsulinemic Androgen Excess"},{"title3":"Metformin-associated lactic acidosis: Current perspectives on causes and risk"},{"title3":"Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects"},{"title3":"Nuclear respiratory factor 1 and endurance exercise promote human telomere transcription"},{"title3":"Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes"},{"title3":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells"},{"title3":"Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I"},{"title3":"Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals"},{"title3":"Metformin Has Direct Protective Effect on Human Cardiac Mitochondria"},{"title3":"Cellular and epigenetic drivers of stem cell ageing"},{"title3":"Reversal of epigenetic aging and immunosenescent trends in humans"},{"title3":"Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7"},{"title3":"Metformin Acts on Two Different Molecular Pathways to Enhance Adult Neural Precursor Proliferation/Self-Renewal and Differentiation"},{"title3":"Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences"},{"title3":"Metformin: from mechanisms of action to therapies"},{"title3":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state"},{"title3":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases"},{"title3":"Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle"},{"title3":"Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes"},{"title3":"Cellular senescence causes ageing"},{"title3":"Metformin induces the AP-1 transcription factor network in normal dermal fibroblasts"},{"title3":"Metformin and Aging: A Review"},{"title3":"Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging"},{"title3":"Metformin pathways: pharmacokinetics and pharmacodynamics"},{"title3":"Sirtuins, a promising target in slowing down the ageing process"},{"title3":"Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling"},{"title3":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism"},{"title3":"The serial cultivation of human diploid cell strains"},{"title3":"Repurposing metformin for the prevention of cancer and cancer recurrence"},{"title3":"AMPK: guardian of metabolism and mitochondrial homeostasis"},{"title3":"The proteostasis network and its decline in ageing"},{"title3":"Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex"},{"title3":"Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase"},{"title3":"Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells"},{"title3":"Mechanism of metformin action in non-insulin-dependent diabetes"},{"title3":"The role of mitochondria in aging"},{"title3":"Age-related inflammation triggers skeletal stem/progenitor cell dysfunction"},{"title3":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study"},{"title3":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner"},{"title3":"Metformin Enhances Autophagy and Provides Cardioprotection in delta-Sarcoglycan Deficiency-Induced Dilated Cardiomyopathy"},{"title3":"Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats"},{"title3":"Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction"},{"title3":"Proteostasis and aging"},{"title3":"Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1beta (IL-1beta) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages"},{"title3":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1"},{"title3":"The Clinical Potential of Senolytic Drugs"},{"title3":"Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer"},{"title3":"Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults"},{"title3":"Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type mice"},{"title3":"Metformin prevents against oxidative stress-induced senescence in human periodontal ligament cells"},{"title3":"Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults"},{"title3":"Rapalogs and mTOR inhibitors as anti-aging therapeutics"},{"title3":"Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice"},{"title3":"Combined metformin and resveratrol confers protection against UVC-induced DNA damage in A549 lung cancer cells via modulation of cell cycle checkpoints and DNA repair"},{"title3":"Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes"},{"title3":"Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK"},{"title3":"The Hallmarks of Aging"},{"title3":"Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance"},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase"},{"title3":"Targeting Mitochondria to Counteract Age-Related Cellular Dysfunction"},{"title3":"Metformin improves healthspan and lifespan in mice"},{"title3":"Metformin and the gastrointestinal tract"},{"title3":"The roles of DNA, RNA and histone methylation in ageing and cancer"},{"title3":"The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research"},{"title3":"Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-kappaB activation"},{"title3":"OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects"},{"title3":"Mitochondria as a therapeutic target for common pathologies"},{"title3":"Mechanism of metformin: Inhibition of DNA damage and proliferative activity in Drosophila midgut stem cell"},{"title3":"Metformin inhibits age-related centrosome amplification in Drosophila midgut stem cells through AKT/TOR pathway"},{"title3":"Deficiency of Atg6 impairs beneficial effect of metformin on intestinal stem cell aging in Drosophila"},{"title3":"Metformin: Prevention of genomic instability and cancer: A review"},{"title3":"Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells"},{"title3":"Nuclear Genomic Instability and Aging"},{"title3":"Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence"},{"title3":"Metformin: A Hopeful Promise in Aging Research"},{"title3":"Metformin Induces a Dietary Restriction-Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1"},{"title3":"Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats"},{"title3":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain"},{"title3":"Epigenetics and aging"},{"title3":"Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells"},{"title3":"Metformin Delays Satellite Cell Activation and Maintains Quiescence"},{"title3":"The Metabolic Impact on Histone Acetylation and Transcription in Ageing"},{"title3":"Metformin as a geroprotector: experimental and clinical evidence"},{"title3":"Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity"},{"title3":"Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy"},{"title3":"Repurposing Metformin for Cardiovascular Disease"},{"title3":"Leukocyte telomere length correlates with glucose control in adults with recently diagnosed type 2 diabetes"},{"title3":"The Therapeutic Potential of Metformin in Neurodegenerative Diseases"},{"title3":"Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke"},{"title3":"Metformin Reshapes the Methylation Profile in Breast and Colorectal Cancer Cells"},{"title3":"Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect"},{"title3":"AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network"},{"title3":"Source of Chronic Inflammation in Aging"},{"title3":"Metformin's performance in in vitro and in vivo genetic toxicology studies"},{"title3":"Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners"},{"title3":"Meta-Analysis of Microarray Expression Studies on Metformin in Cancer Cell Lines"},{"title3":"When stem cells grow old: phenotypes and mechanisms of stem cell aging"},{"title3":"The role of the gut microbiome during host ageing"},{"title3":"Epigenetic Mechanisms of Longevity and Aging"},{"title3":"Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy"},{"title3":"Activation of AMPK by the Putative Dietary Restriction Mimetic Metformin Is Insufficient to Extend Lifespan in Drosophila"},{"title3":"Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels-An Ex Vivo Study"},{"title3":"Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels:An Ex Vivo Study"},{"title3":"Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis"},{"title3":"Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53"},{"title3":"Metformin as Anti-Aging Therapy: Is It for Everyone?"},{"title3":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin"},{"title3":"The Mitochondrial Basis of Aging"},{"title3":"Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo"},{"title3":"Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction"},{"title3":"Metformin Monotherapy Downregulates Diabetes-Associated Inflammatory Status and Impacts on Mortality"},{"title3":"Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway"},{"title3":"Metformin and Autoimmunity: A &quot;New Deal&quot; of an Old Drug"},{"title3":"Metformin and ageing: improving ageing outcomes beyond glycaemic control"},{"title3":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis"},{"title3":"Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response"},{"title3":"Role of Mitochondria in the Mechanism(s) of Action of Metformin"},{"title3":"Genome instability and aging"},{"title3":"Role of the Inflammation-Autophagy-Senescence Integrative Network in Osteoarthritis"},{"title3":"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin"},{"title3":"Autophagy was involved in the protective effect of metformin on hyperglycemia-induced cardiomyocyte apoptosis and Connexin43 downregulation in H9c2 cells"},{"title3":"Metformin exerts antidepressant effects by regulated DNA hydroxymethylation"},{"title3":"Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways"},{"title3":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis"},{"title3":"Telomere shortening rate predicts species life span"},{"title3":"Metformin induces a senescence-associated gene signature in breast cancer cells"},{"title3":"An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer"},{"title3":"Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes"},{"title3":"Regulation of insulin-like growth factor signaling by metformin in endometrial cancer cells"},{"title3":"Senolytics improve physical function and increase lifespan in old age"},{"title3":"Activation of AMPK/mTORC1-Mediated Autophagy by Metformin Reverses Clk1 Deficiency-Sensitized Dopaminergic Neuronal Death"},{"title3":"Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway"},{"title3":"Anti-tumor activity of metformin: from metabolic and epigenetic perspectives"},{"title3":"Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal"},{"title3":"Metformin Activates AMPK through the Lysosomal Pathway"},{"title3":"Metformin alters DNA methylation genome-wide via the H19/SAHH axis"},{"title3":"Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFkappaB Pathway Suppression"},{"title3":"Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction"}]},{"title2":"Metformin as a cellular protector; a synoptic view of modern evidences","References":[{"title3":"On the mechanism of action of hypoglycemia-producing biguanides A reevaluation and a molecular theory"},{"title3":"Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world"},{"title3":"Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation"},{"title3":"Bright renoprotective properties of metformin: beyond blood glucose regulatory effects"},{"title3":"Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin-associated lactic acidosis'"},{"title3":"Metformin and other antidiabetic agents in renal failure patients"},{"title3":"Accumulation of metformin by tissues of the normal and diabetic mouse"},{"title3":"Mild acute renal failure potentiates metformin accumulation in the diabetic rat kidney without further impairment of renal function"},{"title3":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus"},{"title3":"Metformin in patients with chronic kidney disease: strengths and weaknesses"},{"title3":"Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression"},{"title3":"Metformin reduces NAD(P)H oxidase activity in mouse cultured podocytes through purinergic dependent mechanism by increasing extracellular ATP concentration"},{"title3":"AMPK protects proximal tubular cells from stress-induced apoptosis by an ATP-independent mechanism: potential role of Akt activation"},{"title3":"Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin"},{"title3":"Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia"},{"title3":"Inhibition of the Unfolded Protein Response by metformin in renal proximal tubular epithelial cells"},{"title3":"Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1alpha expression and oxygen metabolism"},{"title3":"Metformin: intrinsic vasculoprotective properties"},{"title3":"Biguanides A review of history, pharmacodynamics and therapy"},{"title3":"Microcirculation in insulin resistance and diabetes: more than just a complication"},{"title3":"Turner RCThe UKProspective Diabetes StudyA review"},{"title3":"Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome"},{"title3":"Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease"},{"title3":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling"},{"title3":" Wiernsperger N, Rapin JR: unpublished results. "},{"title3":"Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention"},{"title3":"Metformin in diabetic patients with heart failure: safe and effective?"},{"title3":"Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon"},{"title3":"Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials"},{"title3":"Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process"},{"title3":"Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1"},{"title3":"Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells"},{"title3":"Metformin prevents methylglyoxal-induced apoptosis of mouse Schwann cells"},{"title3":"Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3"},{"title3":"Metformin protects rat hepatocytes against bile acid-induced apoptosis"},{"title3":"Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin"},{"title3":"Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons"},{"title3":"Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK"},{"title3":"Lipotoxicity in human Pancreatic islets and the protective effect of metformin"},{"title3":"Metformin Attenuates Palmitate-Induced Endoplasmic Reticulum Stress, Serine Phosphorylation of IRS-1 and Apoptosis in Rat Insulinoma Cells"},{"title3":"Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell line"},{"title3":"Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line"},{"title3":"Safety and otoprotection of metformin in radiation-induced sensorineural hearing loss in the guinea pig"},{"title3":"Identification of potential caloric restriction mimetics by microarray profiling"},{"title3":"Metformin induces a dietary restriction-like state and the oxidative stress response to extend C elegans Healthspan via AMPK, LKB1, and SKN-1"},{"title3":"Metformin slows down aging and extends life span of female SHR mice"},{"title3":"Metformin retards aging in C elegans by altering microbial folate and methionine metabolism"},{"title3":"Metformin improves healthspan and lifespan in mice"},{"title3":"Rapalogs and mTOR inhibitors as anti-aging therapeutics"},{"title3":"Metformin: its emerging role in oncology"},{"title3":"Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells"},{"title3":"Effect of metformin on apoptosis, cell cycle arrest migration and invasion of A498 cells"},{"title3":"Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling"},{"title3":"Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells"},{"title3":"In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma"},{"title3":"Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis"},{"title3":"Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway"},{"title3":"Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts"},{"title3":"The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin"},{"title3":"Prevention by metformin of alterations induced by chronic exposure to high glucose in human islet beta cells is associated with preserved ATP/ADP ratio"},{"title3":"Metformin Inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis"},{"title3":"Mitochondrial metabolism and type-2 diabetes: a specific target of metformin"},{"title3":"Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study"},{"title3":"Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration"},{"title3":"Metformin increases mitochondrial energy formation in L6 muscle cell cultures"},{"title3":"Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase Miller RA, Birnbaum MJ An energetic tale of AMPK-independent effects of metformin"},{"title3":"An energetic tale of AMPK-independent effects of metformin"},{"title3":"Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress"},{"title3":"Reaction of metformin with dicarbonyl compounds Possible implication in the inhibition of advanced glycation end product formation"},{"title3":"Metformin reduces systemic methylglyoxal levels in type 2 diabetes"},{"title3":"Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein"},{"title3":"Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes"},{"title3":" Adam WR, O'Brien RC. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure. Diabet Med 2014 Jun 9. "},{"title3":"The enigma of metformin-associated lactic acidosis"}]},{"title2":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","References":[]},{"title2":"Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies","References":[{"title3":"Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Patients with sepsis in infectious diseases department in years 1997-2010 - epidemiology and clinical features"},{"title3":"Early management of sepsis"},{"title3":"Cytokine storm and sepsis disease pathogenesis"},{"title3":"Conventional drug therapy for inflammatory bowel disease"},{"title3":"Inflammasomes on the crossroads of innate immune recognition and metabolic control"},{"title3":"Metformin; a review of its history and future: from lilac to longevity"},{"title3":"Gray SG, McGuire TM, Cohen N, Little PJ. The emerging role of metformin in gestational diabetes mellitus. Diabetes Obes Metab. 2017;19(6):765-72."},{"title3":"Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase"},{"title3":"Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury"},{"title3":"Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells"},{"title3":"Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice"},{"title3":"Metformin attenuated endotoxin-induced acute myocarditis via activating AMPK"},{"title3":"Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer"},{"title3":"Current understanding of metformin effect on the control of hyperglycemia in diabetes"},{"title3":"AMP-activated protein kinase and glycogen synthase kinase 3beta modulate the severity of Sepsis-induced lung injury"},{"title3":"Stimulation of brain AMP-activated protein kinase attenuates inflammation and acute lung injury in Sepsis"},{"title3":"Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation"},{"title3":"Lactic acidosis and severe septic shock in metformin users: a cohort study"},{"title3":"Jochmans S, Alphonsine JE, Chelly J, Vong LVP, Sy O, Rolin N, Ellrodt O, Monchi M, Vinsonneau C. Does metformin exposure before ICU stay have any impact on patients' outcome? A retrospective cohort study of diabetic patients. Ann Intensive Care. 2017;7(1):116."},{"title3":"Impact of metformin use on the prognostic value of lactate in sepsis"},{"title3":"Impact of metformin use on lactate kinetics in patients with severe sepsis and septic shock"},{"title3":"Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients"},{"title3":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group"},{"title3":"Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction"},{"title3":"Operating characteristics of a rank correlation test for publication bias"},{"title3":"Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity"},{"title3":"Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community"},{"title3":"Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes"},{"title3":"Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C"},{"title3":"Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study"},{"title3":"Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin"},{"title3":"Metformin inhibits Porphyromonas gingivalis lipopolysaccharide-influenced inflammatory response in human gingival fibroblasts via regulating activating transcription factor-3 expression"},{"title3":"Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction"},{"title3":"Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart"},{"title3":"Metformin protects against LPS-induced intestinal barrier dysfunction by activating AMPK pathway"},{"title3":"The alleviative effects of metformin for lipopolysaccharide-induced acute lung injury rat model and its underlying mechanism"},{"title3":"Metformin alleviated endotoxemia-induced acute lung injury via restoring AMPK-dependent suppression of mTOR"},{"title3":"Effect of metformin on survival rate in experimental sepsis"},{"title3":"Cheng SC, Scicluna BP, Arts RJ, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol. 2016;17(4):406-13."},{"title3":"Glucose feeds the TCA cycle via circulating lactate"},{"title3":"Outcome of severe lactic acidosis associated with metformin accumulation"},{"title3":"Metformin-induced lactic acidosis: no one left behind"},{"title3":"Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process"},{"title3":"Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin"},{"title3":"Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with type 2 diabetes mellitus"},{"title3":"Metformin attenuates production of nitric oxide in response to lipopolysaccharide by inhibiting MyD88-independent pathway"},{"title3":"AMPK: a nutrient and energy sensor that maintains energy homeostasis"},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase"},{"title3":"Metformin can inhibit helicobacter pylori growth"},{"title3":"Malik F, Mehdi SF. Is metformin poised for a second career as an antimicrobial? Diabetes Metab Res Rev. 2018;34(4):e2975."}]},{"title2":"Metformin: historical overview","References":[]},{"title2":"Is metformin poised for a second career as an antimicrobial?","References":[]},{"title2":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","References":[]},{"title2":"Context-dependent pharmacological effects of metformin on the immune system","References":[]},{"title2":"Anti-inflammatory effects of metformin irrespective of diabetes status","References":[{"title3":"Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin."},{"title3":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)."},{"title3":"Metformin and reduced risk of cancer in diabetic patients."},{"title3":"Molecular mechanism of action of metformin: old or new insights?"},{"title3":"Cellular and molecular mechanisms of metformin: an overview."},{"title3":"Cellular responses to the metal-binding properties of metformin."},{"title3":"Biomolecular mode of action of metformin in relation to its copper binding properties."},{"title3":"The copper binding properties of metformin-QCM-D, XPS and nanobead agglomeration."},{"title3":"Molecular action and pharmacogenetics of metformin: current understanding of an old drug."},{"title3":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain."},{"title3":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I."},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase."},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action."},{"title3":"Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats."},{"title3":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state."},{"title3":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP."},{"title3":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling."},{"title3":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure."},{"title3":"Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure."},{"title3":"Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase alpha2."},{"title3":"Metformin prevents the development of chronic heart failure in the SHHF rat model."},{"title3":"Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase."},{"title3":"Inflammation and metabolic disorders."},{"title3":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association."},{"title3":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells."},{"title3":"Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity."},{"title3":"The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver."},{"title3":"The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration."},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill."},{"title3":"An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials."},{"title3":"Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies."},{"title3":"Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis."},{"title3":"Novel cross-talk within the IKK family controls innate immunity."},{"title3":"Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells."},{"title3":"Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells."},{"title3":"Macrophage activation and polarization."},{"title3":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria."},{"title3":"An unexpected twist to the activation of IKKbeta: TAK1 primes IKKbeta for activation by autophosphorylation."},{"title3":"The effect of metformin on insulin resistance and exercise parameters in patients with heart failure."},{"title3":"C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet."},{"title3":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization."},{"title3":"Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes."},{"title3":"The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: controlled randomized clinical trial."},{"title3":"Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus."},{"title3":"10-year follow-up of intensive glucose control in type 2 diabetes."},{"title3":"Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction."},{"title3":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function."},{"title3":"Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls."},{"title3":"Metformin improves healthspan and lifespan in mice."},{"title3":"Central role for interleukin-2 in type 1 diabetes."},{"title3":"Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes."},{"title3":"IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function."},{"title3":"Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt."},{"title3":"An inflammatory T cell signature predicts obesity-associated type 2 diabetes (HUM3P.262)."},{"title3":"Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1beta gene in the Iranian population."},{"title3":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group."},{"title3":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis."}]},{"title2":"Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19","References":[{"title3":"Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis."},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice."},{"title3":"SARS-CoV and IFN: too little, too late."},{"title3":"Clinical and immunological features of severe and moderate coronavirus disease 2019."},{"title3":"SARS-CoV-2: a storm is raging."},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19."},{"title3":"Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia."},{"title3":"Understanding infection-induced thrombosis: lessons learned from animal models."},{"title3":"Exposure to air pollution and COVID-19 mortality in the United States."},{"title3":"Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in northern Italy?"},{"title3":"Air Pollution and the Novel Covid-19 Disease: a Putative Disease Risk Factor."},{"title3":"Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality."},{"title3":"Contribution of IL-1 beta and TNF-alpha to the initiation of the peripheral lung response to atmospheric particulates (PM10)."},{"title3":"Exposure to fine particulate air pollution is associated with endothelial injury and systemic inflammation."},{"title3":"Milan winter fine particulate matter (wPM2.5) induces IL-6 and IL-8 synthesis in human bronchial BEAS-2B cells, but specifically impairs IL-8 release."},{"title3":"Effects of short- and long-term exposures to particulate matter on inflammatory marker levels in the general population."},{"title3":"Particulate matter exposure and stress hormone levels: a randomized, double-blind, crossover trial of air purification."},{"title3":"The impact of immunosenescence on pulmonary disease."},{"title3":"Inflammaging and the lung."},{"title3":"Senescence in the lung: is this getting old?"},{"title3":"Cellular senescence in the lung across the age spectrum."},{"title3":"COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?"},{"title3":"Relationships between ion channels, mitochondrial functions and inflammation in human aging."},{"title3":"CRAC channels as targets for drug discovery and development."},{"title3":"Metformin relieves acute respiratory distress syndrome by reducing miR-138 expression."},{"title3":"Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy."},{"title3":"Targeting immunometabolism as an anti-inflammatory strategy."},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China."},{"title3":"COVID-19: combining antiviral and anti-inflammatory treatments."},{"title3":"Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections."},{"title3":"Metformin as a tool to target aging."},{"title3":"Strategies and challenges in clinical trials targeting human aging."},{"title3":"Benefits of Metformin in Attenuating the Hallmarks of Aging."},{"title3":"The orai ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: a retrospective cohort study."},{"title3":"COVID-19 does not lead to a &quot;typical&quot; acute respiratory distress syndrome."},{"title3":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases."}]},{"title2":"Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis","References":[{"title3":"Idiopathic pulmonary fibrosis: diagnosis, epidemiology and natural history"},{"title3":"Molecular and cellular mechanisms of pulmonary fibrosis"},{"title3":"Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis"},{"title3":"Mesenchymal stem cells in fibrotic disease"},{"title3":"Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition"},{"title3":"Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis"},{"title3":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis"},{"title3":"Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis"},{"title3":"Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury"},{"title3":"PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis"},{"title3":"Rosiglitazone dampens pulmonary inflammation in a porcine model of acute lung injury"},{"title3":"Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model"},{"title3":"The rosiglitazone decision process at FDA and EMA. What should we learn?"},{"title3":"Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study"},{"title3":"Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics"},{"title3":"Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study"},{"title3":"Progress in the application and mechanism of metformin in treating non-small cell lung cancer"},{"title3":"Metformin inhibits SUV39H1-mediated migration of prostate cancer cells"},{"title3":"Antidiabetic drugs and stroke risk"},{"title3":"Metformin attenuates lung fibrosis development via NOX4 suppression"},{"title3":"Metformin reverses established lung fibrosis in a bleomycin model"},{"title3":"Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis"},{"title3":"Upregulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis"},{"title3":"Matrix remodeling in pulmonary fibrosis and emphysema"},{"title3":"Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures"},{"title3":"An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension"},{"title3":"PPARgamma links BMP2 and TGFbeta1 pathways in vascular smooth muscle cells, regulating cell proliferation and glucose metabolism"},{"title3":"Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma"},{"title3":"Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations"},{"title3":"Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis"},{"title3":"MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation"},{"title3":"Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation"},{"title3":"Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: a retrospective cohort study"},{"title3":"PPARgamma in adipocyte differentiation and metabolism:Novel insights from genome-wide studies"},{"title3":"Deletion of PPARgamma in Alveolar macrophages is associated with a Th-1 pulmonary inflammatory response"},{"title3":"Osteoblast-Targeted suppression of PPARgamma increases osteogenesis through activation of mTOR signaling"},{"title3":"Peroxisomes: a nexus for lipid metabolism and cellular signaling"},{"title3":"Thy-1 signals through PPARgamma to promote lipofibroblast differentiation in the developing lung"},{"title3":"PPARgamma signaling mediates the evolution, development, homeostasis, and repair of the lung"},{"title3":"Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms"},{"title3":"Metformin inhibits intracellular lipid accumulation in the murine pre-adipocyte cell line, 3T3-L1"},{"title3":"Cellular and molecular mechanisms of metformin: an overview"},{"title3":"Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial beta-oxidation"},{"title3":"The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact"},{"title3":"Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis"},{"title3":"Tzouvelekis, A., Tzilas, V., Dassiou, M. &amp; Bouros, D. Metformin in idiopathic pulmonary fibrosis &quot;seeking the holy-grail through drug-repositioning&quot;. Respiration 96, 305-307 (2018)."},{"title3":"The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis"},{"title3":"Efficient temporally-controlled targeted mutagenesis in smooth muscle cells of the adult mouse"},{"title3":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain"},{"title3":"Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods"},{"title3":"Peptide arrays for kinome analysis: new opportunities and remaining challenges"},{"title3":"High throughput kinomic profiling of human clear cell renal cell carcinoma identifies kinase activity dependent molecular subtypes"},{"title3":"Correction: kinomic profiling of electromagnetic navigational bronchoscopy specimens: a new approach for personalized medicine"}]},{"title2":"Management of diabetes in patients with COVID-19","References":[]},{"title2":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","References":[]},{"title2":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies","References":[{"title3":"Odds ratio, relative risk, absolute risk reduction, and the number needed to treat:which of these should we use?"},{"title3":"The number needed to treat: a clinically useful measure of treatment effect"},{"title3":"Basis statistics for clinicians 3: assessing the effects of treatment: measures of association"},{"title3":"Clinically useful measures of effect in binary analyses of randomized trials"},{"title3":"Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study"},{"title3":"The performance of different propensity score methods for estimating marginal odds ratios"},{"title3":"The performance of different propensity score methods for estimating relative risks"},{"title3":"The central role of the propensity score in observational studies for causal effects"},{"title3":"Reducing bias in observational studies using subclassification on the propensity score"},{"title3":"Model-based direct adjustment"},{"title3":"A critical appraisal of propensity score matching in the medical literature from 1996 to 2003"},{"title3":"Propensity-score matching in the cardiovascular surgery literature from 2004-2006: a systematic review and suggestions for improvement"},{"title3":"A report card on propensity-score matching in the cardiology literature from 2004-2006: results of a systematic review"},{"title3":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations"},{"title3":"Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses"},{"title3":"Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data"},{"title3":"Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study"},{"title3":"Principles for modeling propensity scores in medical research: a systematic literature review"},{"title3":"Propensity score methods give similar results to traditional regression modeling in observational studies: a systematic review"},{"title3":"Interpretation and choice of effect measures in epidemiologic analyses"},{"title3":"A data-generation process for data with specified risk differences or numbers needed to treat"},{"title3":"The performance of two data-generation processes for data with specified marginal treatment odds ratios"},{"title3":"A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use"},{"title3":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study"},{"title3":"Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model"},{"title3":"Quality of cardiac care in Ontario:phase 1"},{"title3":"Standard distance in univariate and multivariate analysis"},{"title3":"A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals"},{"title3":"The relative ability of different propensity-score methods to balance measured covariates between treated and untreated subjects in observational studies"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"On principles for modeling propensity scores in medical research"},{"title3":"Nonparametric estimation of average treatment effects under exogeneity: a review"}]},{"title2":"The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies","References":[]},{"title2":"COVID-19 and renin angiotensin blockers: current evidence and recommendations","References":[{"title3":"Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis."},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury."},{"title3":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury."},{"title3":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse."},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia."}]},{"title2":"Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: results from the CORONADO study","References":[{"title3":"Covid-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports"},{"title3":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with Covid-19 diagnosis and mortality"},{"title3":"Covid-19 and renin angiotensin blockers: current evidence and recommendations"},{"title3":"In-Hospital use of statins is associated with a reduced risk of mortality among individuals with Covid-19"},{"title3":"Meta-analysis of effect of statins in patients with Covid-19"},{"title3":"Phenotypic characteristics and prognosis of inpatients with Covid-19 and diabetes: the CORONADO study"},{"title3":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies"},{"title3":"Risk factors for Covid-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"},{"title3":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts"},{"title3":"Hypolipidemia is associated with the severity of Covid-19"},{"title3":"Teaching old drugs new tricks: statins for Covid-19?"}]},{"title2":"Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects","References":[]},{"title2":"Metformin and COVID-19: from cellular mechanisms to reduced mortality","References":[{"title3":"Patients with diabetes are at higher risk for severe illness from COVID-19"},{"title3":"Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: a narrative review"},{"title3":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis"},{"title3":"Phenotypic characteristics and prognosis of in-patients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory"},{"title3":"Why is hyperglycemia worsening COVID-19 and its prognosis?"},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"Is the type of diabetes treatment relevant to outcome of COVID-19?"},{"title3":"2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)"},{"title3":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), UK Prospective Diabetes Study (UKPDS) Group"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and recent reports"},{"title3":"Diabetes, obesity and COVID-19: a complex interplay"},{"title3":"COVID-19 pandemic, coronaviruses, and diabetes mellitus"},{"title3":"Anti-inflammatory effects of metformin irrespective of diabetes status"},{"title3":"Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial"},{"title3":"COVID-19 and diabetes mellitus: may old anti-diabetic agents become the new philosopher's stone?"},{"title3":"Metformin in COVID-19: a possible role beyond diabetes"},{"title3":"Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?"},{"title3":"The mechanisms of action of metformin"},{"title3":"Metformin and COVID-19: a novel deal of an old drug"},{"title3":"Obesity and COVID-19: the mTOR pathway as a possible culprit"},{"title3":"Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)"},{"title3":"A proposed mechanism for the possible therapeutic potential of metformin in COVID-19"},{"title3":"Metformin, neutrophils and COVID-19 infection"},{"title3":"Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19"},{"title3":"Metformin use amid coronavirus disease 2019 pandemic"},{"title3":"COVID-19 and diabetes: is metformin a friend or foe?"},{"title3":"Comment on &quot;Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?.&quot;"},{"title3":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes"},{"title3":"Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies"},{"title3":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis"},{"title3":"Effect of metformin on survival rate in experimental sepsis"},{"title3":"Is metformin poised for a second career as an antimicrobial?"},{"title3":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin"},{"title3":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease"},{"title3":"Understanding and overcoming metformin gastrointestinal intolerance"},{"title3":"COVID-19 and the digestive system"},{"title3":"Metformin-associated lactic acidosis (MALA): moving towards a new paradigm"},{"title3":"SGLT2 inhibition during the COVID-19 epidemic: friend or foe?"},{"title3":"Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: potential contribution for diabetic complications and cardiovascular disease"}]},{"title2":"Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?","References":[{"title3":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic"},{"title3":"Bornstein SR, Rubino Francesco, Khunti K, Mingrone G, Hopkins D, Birkenfeld A, et al. Practical recommendation Lancet Diab Endocrinol. https://doi.org/10.1016/S2213-8587(20)30152-2."},{"title3":"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations"},{"title3":"Sinclair A, Dhatariya K, Burr O, Nagi D, Higgins K, Hopkins D, et al. Guidelines for the management of diabetes in care homes during the Covid-19 pandemic. Diabetic Med https://doi.org/10.1111/dme.14317."},{"title3":"COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology"},{"title3":"Our response to COVID-19 as endocrinologists and diabetologists"},{"title3":"Flumamine, a new synthetic analgesic and antifludrug"},{"title3":"The toxicity and general pharmacology of N1-p-chlorophenyl-N5-isopropyl biguanide"},{"title3":"Metformin: historical overview"},{"title3":"Pasik C. Diabetes and the biguanides: the mystery of each. In: Pasik C, editor. Glucophage: serving diabetology for 40 years. roupe Lipha, Lyon; 1997. p. 79."},{"title3":"Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)"},{"title3":"Metformin, a new era for an old drug in the treatment of immune mediated disease?"},{"title3":"Metformin inhibits pro-inflammatory responses via targeting nuclear factor-kappaB in HaCaT cells"},{"title3":"Metformin as a host-directed therapeutic in tuberculosis: is there a promise?"},{"title3":"The role of metformin in controlling oxidative stress in muscle of diabetic rats"},{"title3":"Metformin effect on gut microbiota: insights for HIV-related inflammation"},{"title3":"Metformin mediates protection against Legionella pneumonia through activation of AMPK and mitochondrial reactive oxygen species"},{"title3":"Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies"},{"title3":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis"},{"title3":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin"},{"title3":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes"},{"title3":"Characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis"}]},{"title2":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection","References":[{"title3":"Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes"},{"title3":"Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection"},{"title3":"Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection"},{"title3":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression"},{"title3":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis"},{"title3":"Metformin in COVID-19: a possible role beyond diabetes"},{"title3":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations"},{"title3":"COVID-19 and diabetes: is metformin a friend or foe?"},{"title3":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward"}]},{"title2":"Metformin treatment was associated with decreased mortality in Covid-19 patients with diabetes in a retrospective analysis","References":[{"title3":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 infection: the perspectives on immune responses"},{"title3":"Host-directed therapy as a novel treatment strategy to overcome tuberculosis: targeting immune modulation"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Commentary: COVID-19 in patients with diabetes"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"COVID-19: melatonin as a potential adjuvant treatment"},{"title3":"Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues"},{"title3":"Metformin, a new era for an old drug in the treatment of immune mediated disease?"},{"title3":"Metformin inhibits pro-inflammatory responses via targeting nuclear factor-kappaB in HaCaT cells"},{"title3":"Metformin effect on gut microbiota: insights for HIV-related inflammation"},{"title3":"Metformin as a host-directed therapeutic in tuberculosis: is there a promise?"},{"title3":"Metformin improves healthspan and lifespan in mice"},{"title3":"The role of metformin in controlling oxidative stress in muscle of diabetic rats"}]},{"title2":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19","References":[{"title3":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures"},{"title3":"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19"},{"title3":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy"},{"title3":"Sex difference and smoking predisposition in patients with COVID-19"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China"},{"title3":"Identification of sex-specific thresholds for accumulation of visceral adipose tissue in adults"},{"title3":"Medical consequences of obesity"},{"title3":"Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes"},{"title3":"Difficulties in diagnosing pulmonary embolism in the obese patient: a literature review"},{"title3":"Immunomodulation in COVID-19"},{"title3":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs"},{"title3":"Does Therapy With Anti-TNF-alpha Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?"},{"title3":"Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1beta (IL-1beta) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages"},{"title3":"Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock"},{"title3":"Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus"},{"title3":"Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients"},{"title3":"The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment"},{"title3":"Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review"},{"title3":"Regression Shrinkage and Selection Via the Lasso"},{"title3":"How to handle mortality when investigating length of hospital stay and time to clinical stability"},{"title3":"Remdesivir for the Treatment of Covid-19 - Preliminary Report"},{"title3":"Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching"},{"title3":"Variable selection for propensity score models"},{"title3":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease"},{"title3":"Tumor necrosis factor-alpha signaling in macrophages"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"The mechanisms of action of metformin"},{"title3":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States"},{"title3":"AMPK: a balancer of the renin-angiotensin system"},{"title3":"Metformin in COVID-19: A possible role beyond diabetes"},{"title3":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues"},{"title3":"Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study"},{"title3":"Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China"},{"title3":"Can we predict the severity of COVID-19 with a routine blood test?"},{"title3":"Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis"},{"title3":"Severe Covid-19"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Sex differences in immune responses"},{"title3":"Metformin inhibits IgE- and aryl hydrocarbon receptor-mediated mast cell activation in vitro and in vivo"},{"title3":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy"},{"title3":"Sexual dimorphism in the mast cell transcriptome and the pathophysiological responses to immunological and psychological stress"},{"title3":"Antihypertensive drugs and risk of COVID-19?"},{"title3":"Stereoselectivity at the beta2-adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists"},{"title3":"Metformin in 2019"},{"title3":"Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes"},{"title3":"National Survey of Primary Care Physicians' Knowledge, Practices, and Perceptions of Prediabetes"},{"title3":"Dropping Highly Collinear Variables from a Model: Why it Typically is Not a Good Idea*"},{"title3":"Collinearity and Causal Diagrams: A Lesson on the Importance of Model Specification"}]},{"title2":"Metformin use is associated with reduced mortality in a diverse population with covid-19 and diabetes","References":[{"title3":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area"},{"title3":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York"},{"title3":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China"},{"title3":"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports"},{"title3":"Hospitalization and Mortality among Black Patients and White Patients with Covid-19"},{"title3":"The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States"},{"title3":"Black-White Risk Differentials in COVID-19 (SARS-COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges"},{"title3":"Racial/ethnic differences in the burden of type 2 diabetes over the life course: a focus on the USA and India"},{"title3":"Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19"},{"title3":"Metformin: From Research to Clinical Practice"},{"title3":"Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis"},{"title3":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection"},{"title3":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status"},{"title3":"Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice"},{"title3":"The effects of metformin on the fibrinolytic system in diabetic and non-diabetic subjects"},{"title3":"Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release"},{"title3":"The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications"},{"title3":"COVID-19 and its implications for thrombosis and anticoagulation"},{"title3":"The need to manage the risk of thromboembolism in COVID-19 patients"},{"title3":"Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study"},{"title3":"Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes"},{"title3":"The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings"},{"title3":"Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study"},{"title3":"A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids"},{"title3":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"COVID-19 infection may cause ketosis and ketoacidosis"},{"title3":"Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19"},{"title3":"Sex differences in immune responses"},{"title3":"Metformin Use Is Associated with Reduced Mortality in a Diverse Population with Covid-19 and Diabetes"}]},{"title2":"Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with Covid-19 and pre-existing type 2 diabetes","References":[]},{"title2":"Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?","References":[{"title3":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available at: https://covid19.who.int/. [Accessed August 2020]."},{"title3":"Korea Centers for Disease Control and Prevention. The updates on COVID-19 in Korea as of 6 August. Available at: https://www.cdc.go.kr/board/board.es?mid=a30402000000&amp;bid=0030. [Accessed August 2020]."},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Patients with diabetes are at higher risk for severe illness from COVID-19"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports"},{"title3":"Metformin and COVID-19: from cellular mechanisms to reduced mortality"},{"title3":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19"},{"title3":"Metformin treatment was associated with decreased mortality in covid-19 patients with diabetes in a retrospective analysis"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and covid-19 in association with glucose-lowering medication"},{"title3":"#opendata4covid19. Available at: https://covid19data.hira.or.kr. [Accessed August 2020]."},{"title3":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial"},{"title3":"Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations"},{"title3":"Medication adherence: its importance in cardiovascular outcomes"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"Effect of metformin on survival rate in experimental sepsis"},{"title3":"Is metformin poised for a second career as an antimicrobial?"},{"title3":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin"},{"title3":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease"},{"title3":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis"},{"title3":"Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial"},{"title3":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019"},{"title3":"Korean Diabetes Association. Treatment Guideline for Diabetes. Available at: https://www.diabetes.or.kr/pro/publish/guide.php?code=guide&amp;number=735&amp;mode=view. [Accessed August 2020]."},{"title3":"Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study"},{"title3":"ClinCalc.com Metformin hydrochloride-drug usage statistics, United States, 2007-2010. Available from: https://clincalc.com/DrugStats/Drugs/MetforminHydrochloride. [Accessed September 2020]."}]},{"title2":"Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?"},{"title3":"Hyperglycaemia on admission to hospital and COVID-19"},{"title3":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States"},{"title3":"Marfella R, Paolisso P, Sardu C, Bergamaschi L, D'Angelo EC, Barbieri M, et al. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 2020; S1262-3636(20)30080.3."},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"COVID-19 and diabetes management: what should be considered?"},{"title3":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Bramante C, Ingraham N, Murray T, Marmor S, Hoversten S, Gronski J, et al. Observational study of metformin and risk of mortality in persons hospitalized with Covid-19. medRxiv. 2020; 06.19.20135095."},{"title3":"Rhee SY, Lee J, Nam H, Kyoung DS, Kim DJ. Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19. medRxiv. 2020; 05.20.20108555."},{"title3":"Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract 2020;162:108142."},{"title3":"COVID-19 and diabetes: can DPP4 inhibition play a role?"},{"title3":"Casas Rojo JM, Anton Santos JM, Millan Nunez-Cortes J, Lumbreras-Bermejo C, Ramos-Rincon JM, Roy-Vallejo E, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network. Rev Clin Esp. 2020; 05.24.20111971."},{"title3":"Functional evaluation: the Barthel Index"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2020"},{"title3":"Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples"},{"title3":"Anti-inflammatory effects of metformin irrespective of diabetes status"},{"title3":"Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodriguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020; S1359-6101(20)30109-X."},{"title3":"Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020."},{"title3":"The mechanisms of action of metformin"},{"title3":"Metformin in COVID-19: a possible role beyond diabetes"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020:e33213321."},{"title3":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications"},{"title3":"Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence"},{"title3":"Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy"},{"title3":"Association of hypertension with all-cause mortality among hospitalized patients with COVID-19"},{"title3":"Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis"}]},{"title2":"Risk of metformin in patients with type 2 diabetes with Covid-19: a preliminary retrospective report","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Coronavirus disease 2019 (COVID19): situation report:117"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome"},{"title3":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening"},{"title3":"Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"The novel coronavirus 2019 epidemic and kidneys"},{"title3":"O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"}]},{"title2":"Association of Blood Glucose control and outcomes in patients with Covid-19 and pre-existing type 2 diabetes","References":[{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)"},{"title3":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China"},{"title3":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study"},{"title3":"Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension"},{"title3":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies"},{"title3":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"Influence of diabetes mellitus on immunity to human tuberculosis"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind"},{"title3":"Web site and R package for computing E-values"},{"title3":"Factors determining the appearance of glucose in upper and lower respiratory tract secretions"},{"title3":"Benefits and harms of intensive glycemic control in patients with type 2 diabetes"},{"title3":"Multivariate and propensity score matching software with automated balance optimization: the matching package for R"},{"title3":"Penalized survival models and frailty"},{"title3":"Intensive insulin therapy in the medical ICU"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"Comparison of imputation methods for missing laboratory data in medicine"},{"title3":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Innate immune signaling and its role in metabolic and cardiovascular diseases"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"}]},{"title2":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports","References":[{"title3":"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations"},{"title3":"Diabetes and covid-19: a global health challenge"},{"title3":"COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next"},{"title3":"COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)"},{"title3":"COVID-19 pandemic, coronaviruses, and diabetes mellitus"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"},{"title3":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome"},{"title3":"Prevalence and impact of diabetes among people infected with SARS-CoV-2"},{"title3":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis"},{"title3":"Risk factors of critical &amp; mortal COVID-19 cases: A systematic literature review and meta-analysis"},{"title3":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis"},{"title3":"COVID-19 in patients with diabetes: risk factors that increase morbidity"},{"title3":"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Type 2 diabetes and its impact on the immune system"},{"title3":"Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)"},{"title3":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19"},{"title3":"COVID-19 and diabetes: Can DPP4 inhibition play a role?"},{"title3":"Phenotypic characteristics and prognosis of in-patients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA"},{"title3":"Renal involvement and early prognosis in patients with COVID-19 pneumonia"},{"title3":"Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Hyperglycemia and the worse prognosis of COVID-19"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Intensive versus conventional glucose control in critically ill patients"},{"title3":"Clinical practice, Glycemic control in the ICU"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"The need for diabetes care customization in the ICU at the time of SARS-CoV-2 outbreak"},{"title3":"Individualizing inpatient diabetes management during the coronavirus disease 2019 pandemic"},{"title3":"COVID-19 infection may cause ketosis and ketoacidosis"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Angiotensin receptor blockers and COVID-19"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"COVID-19 and diabetes management: What should be considered?"},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"Age, frailty and diabetes - triple jeopardy for vulnerability to COVID-19 infection"},{"title3":"Metformin in COVID-19: A possible role beyond diabetes"},{"title3":"Can dapagliflozin have a protective effect against COVID-19 infection?. A hypothesis"},{"title3":"COVID-19 and diabetes: Knowledge in progress"},{"title3":"Obesity a risk factor for increased COVID19 prevalence, severity and lethality (Review)"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity and SARS-CoV-2: a population to safeguard"},{"title3":"Targeting the adipose tissue in COVID-19"},{"title3":"Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue"},{"title3":"Is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in COVID-19"},{"title3":"Potential influences of obstructive sleep apnea and obesity on COVID-19 severity"},{"title3":"Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease"},{"title3":"Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis"},{"title3":"Comorbidities and multi-organ injuries in the treatment of COVID-19"},{"title3":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China"},{"title3":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission"},{"title3":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study"},{"title3":"Does COVID-19 disprove the obesity paradox in ARDS?"},{"title3":"COVID-19 and obesity-lack of clarity, guidance, and implications for care"},{"title3":"Obesity and impaired metabolic health in patients with COVID-19"},{"title3":"Obesity could shift severe COVID-19 disease to younger ages"},{"title3":"Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients"},{"title3":"Supportive treatment with tocilizumab for COVID-19: a systematic review"},{"title3":"Negative impact of hyperglycemia on tocilizumab therapy on COVID-19 patients"}]},{"title2":"Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review","References":[]},{"title2":"Metformin use and mortality among patients with diabetes and atherothrombosis","References":[]}]},{"title1":"Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study","References":[{"title2":"WHO. Coronavirus disease (COVID-9) outbreak situation, https://www.who.int/emergencies/diseases/novel-coronavirus-2019; 2020 [accessed 4 May 2020].","References":[]},{"title2":"WHO. WHOTimeline-COVID-19, https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19; 2020 [accessed May 4, 00].","References":[]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Tuberculosis and diabetes mellitus: convergence of two epidemics"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score"},{"title3":"Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp; Mortality (HIMM) surveillance"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis"},{"title3":"Connecting type 1 and type 2 diabetes through innate immunity"},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"}]},{"title2":"Practical recommendations for the management of diabetes in patients with COVID-19","References":[{"title3":"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis"},{"title3":"Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single center"},{"title3":"Pneumonia mortality, comorbidities matter?"},{"title3":"Influenza A-associated severe pneumonia in hospitalized patients: risk factors and NAI treatments"},{"title3":"Middle East respiratory syndrome"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"The sweeter side of ACE2: physiological evidence for a role in diabetes"},{"title3":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"COVID-19 and diabetes: can DPP4 inhibition play a role?"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers"},{"title3":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts"},{"title3":"Impact of obesity and metabolic syndrome on immunity"},{"title3":"Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic"},{"title3":"Altered lipid metabolism in recovered SARS patients twelve years after infection"},{"title3":"Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial"},{"title3":"A review of micronutrients and the immune system-working in harmony to reduce the risk of infection"},{"title3":"Managing diabetes during the COVID- 19 epidemic"},{"title3":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Potential effect of hydroxychloroquine in diabetes mellitus: a systematic review on preclinical and clinical trial studies"}]},{"title2":"Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature","References":[{"title3":"Woldometer (2020) COVID-19 coronavirus pandemic. Available from https://www.worldometers.info/coronavirus/. Accessed 13 Apr 2020"},{"title3":"World Health Organization HO (2020) Coronavirus disease 2019 (COVID-19) situation report-62. Available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 22 Mar 2020"},{"title3":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection:a review of immune changes in patients with viral pneumonia"},{"title3":"World Health Organization (2020) Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19). Available from https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19). Accessed 20 Apr 2020"},{"title3":"COVID-19: a fast evolving pandemic"},{"title3":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study"},{"title3":"Immune dysfunction in patients with diabetes mellitus (DM)"},{"title3":"Common infections in diabetes: pathogenesis, management and relationship to glycaemic control"},{"title3":"Type 2 diabetes and pneumonia outcomes: a population-based cohort study"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Impact of comorbidity on fatality rate of patients with Middle East respiratory syndrome"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Diabetes and the severity of pandemic influenza A (H1N1) infection"},{"title3":"Fadini GP, Morieri ML, Longato E, Avogaro A (2020) Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Investig. 10.1007/s40618-020-01236-2"},{"title3":"Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19"},{"title3":"Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 10.1056/NEJMoa2002032"},{"title3":"Dietz W, Santos-Burgoa C (2020) Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring). 10.1002/oby.22818"},{"title3":"COVID-19 and smoking: a systematic review of the evidence"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 10.1001/jama.2020.4683"},{"title3":"Guan WJ, Liang WH, Zhao Y et al (2020) Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J:2000547. 10.1183/13993003.00547-2020"},{"title3":"International Society for Paediatric and Adolescent Diabetes (2020) Summary of recommendations regarding COVID-19 in children with diabetes: keep calm and mind your diabetes care and public health advice. Available from: https://www.ispad.org/page/CoronavirusinfectionCOVID-19-IIISPADSummary. Updated 25 Mar 2020; accessed 8 Apr 2020"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Chen G, Wu, D, Guo, W et al (2020) Clinical and immunological features in severe and moderate forms of Coronavirus disease 2019. J Clin Invest 137244. doi: 10.1172/JCI137244"},{"title3":"Zhang JJ, Dong X, Cao YY et al (2020) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 10.1111/all.14238"},{"title3":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 10.1111/jth.14817"},{"title3":"Guo W, Li M, Dong Y et al (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev e3319. doi: 10.1002/dmrr.3319"},{"title3":"The role of inflammation in diabetes: current concepts and future perspectives"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis"},{"title3":"Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Center for Disease Control and Prevention (2020) How to protect yourself?: Coronavirus disease 2019 (COVID-19). Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. Accessed 29 Mar 2020"},{"title3":"American Diabetes Association (2020) How COVID-19 affects people with diabetes. Available from: https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes. Accessed 8 Apr 2020"},{"title3":"MacIntosh K (2020) Coronavirus disease 2019 (COVID-19): epidemiology, virology, clinical features, diagnosis, and prevention. UpToDate. Available from: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19#H2325386707. Updated 1 Apr 2020; accessed 08 Apr 2020"},{"title3":"Laboratory diagnosis of emerging human coronavirus infections - the state of the art"},{"title3":"World Health Organization (2020) Mental health and psychosocial considerations during COVID-19 outbreak: document number: WHO/2019-nCoV/MentalHealth/2020.1. Available from https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf. Accessed 23 Mar 2020"},{"title3":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic"},{"title3":"Effect of acetaminophen on CGM glucose in an outpatient setting"},{"title3":"Matthews R (2020) Glucose control key with COVID-19 in diabetes, say experts. Medscape. Available from https://www.medscape.com/viewarticle/927044. Accessed 18 Mar 2020"},{"title3":"Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists"},{"title3":"Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed"},{"title3":"Diabetes UK (2020) Updates: Coronvirus and diabetes. Available from: https://www.diabetes.org.uk/about_us/news/coronavirus. Accessed 8 Apr 2020"},{"title3":"Metformin-associated lactic acidosis: current perspectives on causes and risk"},{"title3":"SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis: a South Australian clinical case series and Australian spontaneous adverse event notifications"},{"title3":"SGLT2 inhibitors in type 2 diabetes management: key evidence and implications for clinical practice"},{"title3":"Comment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?"},{"title3":"Safety and efficacy of DPP4 inhibitor and basal insulin in type 2 diabetes: an updated review and challenging clinical scenarios"},{"title3":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)"},{"title3":"Pharmacotherapy for hyperglycemia in noncritically ill hospitalized patients"},{"title3":"15. Diabetes Care in the Hospital: standards of medical care in diabetes-2019"},{"title3":"Intensive versus conventional glucose control in critically ill patients"},{"title3":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control"},{"title3":"Patel AB, Verma A (2020) COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. 10.1001/jama.2020.4812"},{"title3":"Driggin E, Madhavan MV, Bikdeli B et al (2020) Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 10.1016/j.jacc.2020.03.031"},{"title3":"Li Y, Wang M, Zhou Y et al (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. SSRN. 10.2139/ssrn.3550025"},{"title3":"Bangash MN, Patel J, Parekh D (2020) COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 10.1016/S2468-1253(20)30084-4"},{"title3":"Of chloroquine and COVID-19"},{"title3":"Yao X, Ye F, Zhang M et al (2020) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis ciaa237. doi: 10.1093/cid/ciaa237"},{"title3":"Zhou D, Dai SM, Tong Q (2020) COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother dkaa114. doi: 10.1093/jac/dkaa114"},{"title3":"Gautret P, Lagier JC, Parola P et al (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 105949. doi: 10.1016/j.ijantimicag.2020.105949"},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19"},{"title3":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA"},{"title3":"Anesi GL (2020) Coronavirus disease 2019 (COVID-19): critical care issues. UpToDate. Available from: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-critical-care-issues. Updated 8 Apr 2020; accessed 10 Apr 2020"},{"title3":"FDA (2020) Remdesivir: EUA letter of authorisation. Published 1 May 2020. Available from https://www.fda.gov/media/137564/download. Accessed 2 May 2020"},{"title3":"Metformin relieves acute respiratory distress syndrome by reducing miR-138 expression"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"COVID-19 and diabetes: can DPP4 inhibition play a role?"},{"title3":"Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/beta-catenin signaling pathway"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Chang R, Zun W (2020) Repositioning chloroquine as an ideal antiviral prophylaxis against COVID-19 - time is now. Preprints. 10.20944/preprints202003.0279.v1"}]},{"title2":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis","References":[{"title3":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis"},{"title3":"Understanding the odds ratio and the relative risk"},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, february 12-march 28, 2020"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"The relative merits of risk ratios and odds ratios"}]},{"title2":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","References":[{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)"},{"title3":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China"},{"title3":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study"},{"title3":"Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension"},{"title3":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies"},{"title3":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"Influence of diabetes mellitus on immunity to human tuberculosis"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind"},{"title3":"Web site and R package for computing E-values"},{"title3":"Factors determining the appearance of glucose in upper and lower respiratory tract secretions"},{"title3":"Benefits and harms of intensive glycemic control in patients with type 2 diabetes"},{"title3":"Multivariate and propensity score matching software with automated balance optimization: the matching package for R"},{"title3":"Penalized survival models and frailty"},{"title3":"Intensive insulin therapy in the medical ICU"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"Comparison of imputation methods for missing laboratory data in medicine"},{"title3":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Innate immune signaling and its role in metabolic and cardiovascular diseases"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"}]},{"title2":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","References":[]},{"title2":"Metformin and inflammation: its potential beyond glucose-lowering effect","References":[]},{"title2":"The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19","References":[{"title3":"The proximal origin of SARS-CoV-2"},{"title3":"Combination therapy of IFNbeta1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients"},{"title3":"Importance of nucleic acid recognition in inflammation and autoimmunity"},{"title3":"Autoantibodies against type I IFNs in patients with life-threatening"},{"title3":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up"},{"title3":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)"},{"title3":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry"},{"title3":"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study"},{"title3":"Beneficial impact of baricitinib in COVID-19 moderate pneumonia; multicentre study"},{"title3":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019"},{"title3":"Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial"},{"title3":"Preliminary predictive criteria for COVID-19 cytokine storm"},{"title3":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment"},{"title3":"Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE)"},{"title3":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases"},{"title3":"Type I interferons in host defence and inflammatory diseases"},{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-"},{"title3":"Treating inflammation by blocking interleukin-1 in humans"},{"title3":"Baricitinib for COVID-19: a suitable treatment?"},{"title3":"SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes"},{"title3":"Why tocilizumab could be an effective treatment for severe"},{"title3":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry"},{"title3":"Germline genetic variants of viral entry and innate immunity may influence susceptibility to SARS-CoV-2 infection: toward a polygenic risk score for risk stratification"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Use of intravenous immunoglobulin (Prevagen or Octagam) for the treatment of"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Dexamethasone in hospitalized patients with"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Anakinra for severe forms of COVID-19: a cohort study"},{"title3":"Mild cytokine elevation, moderate CD4+ T cell response and abundant antibody production in children with COVID-19"},{"title3":"Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience"},{"title3":"Neutrophil extracellular traps: double-edged swords of innate immunity"},{"title3":"(A Little) Clarity on convalescent plasma for"},{"title3":"Role of Toll-like receptors in the pathogenesis of COVID-19"},{"title3":"Immunopathogenesis and treatment of cytokine storm in"},{"title3":"Anakinra in COVID-19: important considerations for clinical trials"},{"title3":"Interferon-based therapies in COVID-19"},{"title3":"Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets"},{"title3":"A novel TNF-alpha-targeting aptamer for TNF-alpha-mediated acute lung injury and acute liver failure"},{"title3":"Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab"},{"title3":"Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review"},{"title3":"Multiple parameters required for diagnosis of COVID-19 in clinical practice"},{"title3":"Early high-titer plasma therapy to prevent severe Covid-19 in older adults"},{"title3":"COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms"},{"title3":"Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases"},{"title3":"Vaccine efficacy probable against COVID-19 variants"},{"title3":"Factors associated with adverse COVID-19 outcomes in patients with psoriasis:insights from a global registry-based study"},{"title3":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial"},{"title3":"Administration of intravenous immunoglobulin in the treatment of COVID-19: a review of available evidence"},{"title3":"Four-month clinical status of a cohort of patients after hospitalization for COVID-19"},{"title3":"Genotype and phenotype of COVID-19: their roles in pathogenesis"},{"title3":"Comparative survival analysis of immunomodulatory therapy for coronavirus disease 2019 cytokine storm"},{"title3":"COVID-19 cytokine storm: what is in a name?"},{"title3":"Coronavirus infections:more than just the common cold"},{"title3":"Repurposed antiviral drugs for Covid-19 : interim WHO Solidarity Trial results"},{"title3":"Why we need to keep using the patient made term &quot;Long Covid.&quot; BMJ Opinion"},{"title3":"Systemic and organ-specific immune-related manifestations of COVID-19"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"The potential for repurposing anti-TNF as a therapy for the treatment of"},{"title3":"Meta-analysis of the effect of colchicine on mortality and mechanical ventilation"},{"title3":"Tocilizumab in patients hospitalized with Covid-19 pneumonia"},{"title3":"Virology, pathogenesis, diagnosis and in-line treatment of COVID-19"},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia"},{"title3":"The pyrin inflammasome in health and disease"},{"title3":"MIS-C: post-infectious syndrome or persistent infection? The Lancet Infectious Diseases 21 (5): e116"},{"title3":"JAK inhibition as a new treatment strategy for patients with COVID-19"},{"title3":"A randomized trial of convalescent plasma in Covid-19 severe pneumonia"},{"title3":"Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19"},{"title3":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment"},{"title3":"Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic"},{"title3":"COVID-19: combining antiviral and anti-inflammatory treatments"},{"title3":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19"},{"title3":"Efficacy of tocilizumab in patients hospitalized with"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"cross-disciplinary perspectives"},{"title3":"IL-6 in inflammation, immunity, and disease"},{"title3":"PAMPs and DAMPs: signal 0s that spur autophagy and immunity"},{"title3":"Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial"},{"title3":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome"},{"title3":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy"},{"title3":"Intravenous immunoglobulin for the treatment of COVID-19: a promising tool"},{"title3":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology"},{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"MDA5 is critical to host defense during infection with murine coronavirus"},{"title3":"Inborn errors of type I IFN immunity in patients with life-threatening"},{"title3":"Rational use of tocilizumab in the treatment of novel coronavirus pneumonia"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"}]},{"title2":"ACE2 and COVID-19 and the resulting ARDS","References":[{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected-Interim guidance"},{"title3":"WHO Director-General'sremarks at the media briefing on 2019-nCoV on 11 February 2020"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"The role of angiotensin-converting enzyme 2 in the pathologic pathway of SARS"},{"title3":"Structure of dimeric full-length human ACE2 in complex with B0AT1"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The function and application of angiotensin- converting enzyme 2"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Cryo-Em structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Homeostasis of the local renin-angiotensin system and acute lung injury"},{"title3":"The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV"},{"title3":"Single-Cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"Acute respiratory distress syndrome"},{"title3":"Clinical features and progression of acute respiratory distress syndrome in coronavirus disease"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"An experimental study of therapeutic effect of ACEI on chemical-induced ARDS in rats"},{"title3":"The role of angiotensin-converting enzyme inhibition in endotoxin-induced lung injury in rats"},{"title3":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia"},{"title3":"Experts recommendation on COVID-19 combined with cardiac insufficiency"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19"},{"title3":"HFSA/ACC/AHA statement addresses concerns re:using RAAS antagonists in COVID-19. [EB/OL]. ACC News Story"},{"title3":"Renin-Angiotensin-Aldosterone system blockers and the risk of Covid-19"},{"title3":"Cardiovascular disease, drug therapy, and mortality in Covid-19"}]},{"title2":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","References":[{"title3":"Novel coronavirus (2019-nCoV) situation report - 14"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East respiratory syndrome (MERS)"},{"title3":"Clinical features of patients infected with 2019 coronavirus in Wuhan, China"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)"},{"title3":"The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Advances in respiratory virus therapeutics:a meeting report from the 6th ISIRV antiviral group conference"},{"title3":"Host-directed therapies for improving poor treatment outcomes associated with the Middle East respiratory syndrome coronavirus infections"},{"title3":"Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice"},{"title3":"Cell therapy in acute respiratory distress syndrome"},{"title3":"Immune therapy in sepsis: are we ready to try again?"},{"title3":"Clinically relevant immune responses against cytomegalovirus: implications for precision medicine"}]},{"title2":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis","References":[{"title3":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 infection: the perspectives on immune responses"},{"title3":"Host-directed therapy as a novel treatment strategy to overcome tuberculosis: targeting immune modulation"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Commentary: COVID-19 in patients with diabetes"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"COVID-19: melatonin as a potential adjuvant treatment"},{"title3":"Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues"},{"title3":"Metformin, a new era for an old drug in the treatment of immune mediated disease?"},{"title3":"Metformin inhibits pro-inflammatory responses via targeting nuclear factor-kappaB in HaCaT cells"},{"title3":"Metformin effect on gut microbiota: insights for HIV-related inflammation"},{"title3":"Metformin as a host-directed therapeutic in tuberculosis: is there a promise?"},{"title3":"Metformin improves healthspan and lifespan in mice"},{"title3":"The role of metformin in controlling oxidative stress in muscle of diabetic rats"}]},{"title2":"WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases Interim guidance, https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117; 2020 [accessed 1 May 2020].","References":[]},{"title2":"National Health Commission of the People's Republic of China. New Coronavirus Pneumonia Prevention and Control Program (version 7.0), http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf; 2020 [accessed 29 April 2020].","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy","References":[]},{"title2":"Acute respiratory failure in COVID-19: is it &quot;typical&quot; ARDS?","References":[]},{"title2":"Metformin, a new era for an old drug in the treatment of immune mediated disease?","References":[]},{"title2":"Metformin induces suppression of NAD(P)H oxidase activity in podocytes","References":[]},{"title2":"Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice","References":[]},{"title2":"Metformin in COVID-19: a possible role beyond diabetes","References":[{"title3":"The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth"},{"title3":"Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System [published online ahead of print, 2020 Apr 8]"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Angiotensin-converting enzyme 2 regulates autophagy in acute lung injury through AMPK/mTOR signaling"},{"title3":"AMPK: a balancer of the renin-angiotensin system"},{"title3":"Angiotensin Converting Enzyme 2: A Double-Edged Sword [published online ahead of print, 2020 Mar 26]"},{"title3":"Metformin in prostate cancer: Two for the price of one"},{"title3":"Effect of Silubin-retard (1-butyl-biguanide hydrochloride) on the course of influenza-virus infection in mice"},{"title3":"Inhaled biguanides and mTOR inhibition for influenza and coronavirus"},{"title3":"Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis"},{"title3":"A SARS-CoV-2-Human ProteinProtein Interaction Map Reveals Drug Targets and Potential Drug- Repurposing"},{"title3":"AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting Glycolysis"},{"title3":"COVID-19 and Diabetes: Knowledge in Progress"},{"title3":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"COVID-19 and diabetes management: what should be considered?"},{"title3":"Metformin Might Inhibit Virus through Increasing Insulin Sensitivity"}]},{"title2":"Metformin and COVID-19: from cellular mechanisms to reduced mortality","References":[{"title3":"Patients with diabetes are at higher risk for severe illness from COVID-19"},{"title3":"Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: a narrative review"},{"title3":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis"},{"title3":"Phenotypic characteristics and prognosis of in-patients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory"},{"title3":"Why is hyperglycemia worsening COVID-19 and its prognosis?"},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"Is the type of diabetes treatment relevant to outcome of COVID-19?"},{"title3":"2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)"},{"title3":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), UK Prospective Diabetes Study (UKPDS) Group"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and recent reports"},{"title3":"Diabetes, obesity and COVID-19: a complex interplay"},{"title3":"COVID-19 pandemic, coronaviruses, and diabetes mellitus"},{"title3":"Anti-inflammatory effects of metformin irrespective of diabetes status"},{"title3":"Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial"},{"title3":"COVID-19 and diabetes mellitus: may old anti-diabetic agents become the new philosopher's stone?"},{"title3":"Metformin in COVID-19: a possible role beyond diabetes"},{"title3":"Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?"},{"title3":"The mechanisms of action of metformin"},{"title3":"Metformin and COVID-19: a novel deal of an old drug"},{"title3":"Obesity and COVID-19: the mTOR pathway as a possible culprit"},{"title3":"Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)"},{"title3":"A proposed mechanism for the possible therapeutic potential of metformin in COVID-19"},{"title3":"Metformin, neutrophils and COVID-19 infection"},{"title3":"Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19"},{"title3":"Metformin use amid coronavirus disease 2019 pandemic"},{"title3":"COVID-19 and diabetes: is metformin a friend or foe?"},{"title3":"Comment on &quot;Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?.&quot;"},{"title3":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes"},{"title3":"Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies"},{"title3":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis"},{"title3":"Effect of metformin on survival rate in experimental sepsis"},{"title3":"Is metformin poised for a second career as an antimicrobial?"},{"title3":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin"},{"title3":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease"},{"title3":"Understanding and overcoming metformin gastrointestinal intolerance"},{"title3":"COVID-19 and the digestive system"},{"title3":"Metformin-associated lactic acidosis (MALA): moving towards a new paradigm"},{"title3":"SGLT2 inhibition during the COVID-19 epidemic: friend or foe?"},{"title3":"Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: potential contribution for diabetic complications and cardiovascular disease"}]},{"title2":"Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing Type 2 diabetes","References":[]},{"title2":"Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study","References":[]},{"title2":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection","References":[{"title3":"Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes"},{"title3":"Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection"},{"title3":"Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection"},{"title3":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression"},{"title3":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis"},{"title3":"Metformin in COVID-19: a possible role beyond diabetes"},{"title3":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations"},{"title3":"COVID-19 and diabetes: is metformin a friend or foe?"},{"title3":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward"}]},{"title2":"Bramante C, Ingraham N, Murray T, Marmor S, Hoversten S, Gronski J, et al. Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19. medRxiv [Preprint]. 2020 Jun 28:2020.06.19.20135095. http://doi.org/10.1101/2020.06.19.20135095.","References":[]},{"title2":"Metformin down-regulates TNF-alpha secretion via suppression of scavenger receptors in macrophages","References":[{"title3":"Prevalence and trends in obesity among US adults, 1999-2008"},{"title3":"Ten year change of body mass index in Korean: 1997-2007"},{"title3":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001"},{"title3":"Obesity, metabolic syndrome, and cardiovascular disease"},{"title3":"Global estimates of the prevalence of diabetes for 2010 and 2030"},{"title3":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation"},{"title3":"Obesity, inflammation, and insulin resistance"},{"title3":"Mechanisms of obesity-associated insulin resistance: many choices on the menu"},{"title3":"Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies"},{"title3":"Macrophages, inflammation, and insulin resistance"},{"title3":"Patho-/physiological roles of adipose tissue macrophages"},{"title3":"Macrophage-mediated inflammation in metabolic disease"},{"title3":"The cellular and signaling networks linking the immune system and metabolism in disease"},{"title3":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization"},{"title3":"The role of the immune system in obesity and insulin resistance"},{"title3":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition"},{"title3":"Monocyte and macrophage dynamics during atherogenesis"},{"title3":"Role of macrophage scavenger receptors in atherosclerosis"},{"title3":"Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling"},{"title3":"A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses"},{"title3":"Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-kappaB activation in macrophages"},{"title3":"Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity"},{"title3":"Metformin"},{"title3":"Mechanism by which metformin reduces glucose production in type 2 diabetes"},{"title3":"Metformin: new understandings, new uses"},{"title3":"Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes"},{"title3":"Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells"},{"title3":"Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis"},{"title3":"Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice"},{"title3":"Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats"},{"title3":"Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice"},{"title3":"Endoplasmic reticulum (ER) stress and vascular complication"},{"title3":"Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics"},{"title3":"Inducible nitric oxide synthase: what difference does it make?"},{"title3":"Anti-inflammatory function of Withangulatin A by targeted inhibiting COX-2 expression via MAPK and NF-kappaB pathways"},{"title3":"Involvement of TNF and NF-kappa B in the transcriptional control of cyclooxygenase-2 expression by IFN-gamma in macrophages"},{"title3":"Proinflammatory cytokines"},{"title3":"Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses"},{"title3":"Anti-inflammatory cytokines"},{"title3":"TNF-alpha and IL-12: a balancing act in macrophage functioning"},{"title3":"The TNF and TNF receptor superfamilies: integrating mammalian biology"},{"title3":"Anti-cytokine therapy for rheumatoid arthritis"},{"title3":"Signalling pathways of the TNF superfamily: a double-edged sword"},{"title3":"The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans"},{"title3":"A new tumor necrosis factor (TNF)-alpha regulator, lipopolysaccharides-induced TNF-alpha factor, is associated with obesity and insulin resistance"},{"title3":"Tumor necrosis factor alpha inhibits signaling from the insulin receptor"},{"title3":"Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year"},{"title3":"Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization"},{"title3":"The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk"},{"title3":"Cytokines and atherosclerosis: a comprehensive review of studies in mice"},{"title3":"Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men"},{"title3":"Interleukin-10 inhibits the down-regulation of ATP binding cassette transporter A1 by tumour necrosis factor-alpha in THP-1 macrophage-derived foam cells"},{"title3":"Atherogenic effects of TNF-alpha and IL-6 via up-regulation of scavenger receptors"},{"title3":"Role of inflammation in atherosclerosis"},{"title3":"NF-kappaB: a key role in inflammatory diseases"}]},{"title2":"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Early transmission dynamics in Wuhan, China, of novel Coronavirus-Infected pneumonia"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Adipokines in inflammation and metabolic disease"},{"title3":"Immunological goings-on in visceral adipose tissue"},{"title3":"Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation"},{"title3":"Hispanics/Latinos with type 2 diabetes have functional and symptomatic pulmonary impairment Mirroring kidney microangiopathy: findings from the Hispanic community health Study/Study of Latinos (HCHS/SOL)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Prevalence and control of diabetes in Chinese adults"},{"title3":"Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage"},{"title3":"Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters"},{"title3":"Diabetes mellitus induces a thickening of the pulmonary basal lamina"},{"title3":"Obesity accelerates T cell senescence in murine visceral adipose tissue"},{"title3":"Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation"},{"title3":"The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy"},{"title3":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes"},{"title3":"Diabetes and the severity of pandemic influenza A (H1N1) infection"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation"},{"title3":"The impact of glycosylation on the biological function and structure of human immunoglobulins"},{"title3":"Igg Fc glycosylation in human immunity"}]},{"title2":"Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?","References":[{"title3":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available at: https://covid19.who.int/. [Accessed August 2020]."},{"title3":"Korea Centers for Disease Control and Prevention. The updates on COVID-19 in Korea as of 6 August. Available at: https://www.cdc.go.kr/board/board.es?mid=a30402000000&amp;bid=0030. [Accessed August 2020]."},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Patients with diabetes are at higher risk for severe illness from COVID-19"},{"title3":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports"},{"title3":"Metformin and COVID-19: from cellular mechanisms to reduced mortality"},{"title3":"Observational study of metformin and risk of mortality in patients hospitalized with Covid-19"},{"title3":"Metformin treatment was associated with decreased mortality in covid-19 patients with diabetes in a retrospective analysis"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and covid-19 in association with glucose-lowering medication"},{"title3":"#opendata4covid19. Available at: https://covid19data.hira.or.kr. [Accessed August 2020]."},{"title3":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial"},{"title3":"Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations"},{"title3":"Medication adherence: its importance in cardiovascular outcomes"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"Effect of metformin on survival rate in experimental sepsis"},{"title3":"Is metformin poised for a second career as an antimicrobial?"},{"title3":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin"},{"title3":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease"},{"title3":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis"},{"title3":"Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial"},{"title3":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019"},{"title3":"Korean Diabetes Association. Treatment Guideline for Diabetes. Available at: https://www.diabetes.or.kr/pro/publish/guide.php?code=guide&amp;number=735&amp;mode=view. [Accessed August 2020]."},{"title3":"Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study"},{"title3":"ClinCalc.com Metformin hydrochloride-drug usage statistics, United States, 2007-2010. Available from: https://clincalc.com/DrugStats/Drugs/MetforminHydrochloride. [Accessed September 2020]."}]},{"title2":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","References":[]},{"title2":"Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?"},{"title3":"Hyperglycaemia on admission to hospital and COVID-19"},{"title3":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States"},{"title3":"Marfella R, Paolisso P, Sardu C, Bergamaschi L, D'Angelo EC, Barbieri M, et al. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 2020; S1262-3636(20)30080.3."},{"title3":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"COVID-19 and diabetes management: what should be considered?"},{"title3":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Bramante C, Ingraham N, Murray T, Marmor S, Hoversten S, Gronski J, et al. Observational study of metformin and risk of mortality in persons hospitalized with Covid-19. medRxiv. 2020; 06.19.20135095."},{"title3":"Rhee SY, Lee J, Nam H, Kyoung DS, Kim DJ. Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19. medRxiv. 2020; 05.20.20108555."},{"title3":"Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract 2020;162:108142."},{"title3":"COVID-19 and diabetes: can DPP4 inhibition play a role?"},{"title3":"Casas Rojo JM, Anton Santos JM, Millan Nunez-Cortes J, Lumbreras-Bermejo C, Ramos-Rincon JM, Roy-Vallejo E, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network. Rev Clin Esp. 2020; 05.24.20111971."},{"title3":"Functional evaluation: the Barthel Index"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2020"},{"title3":"Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples"},{"title3":"Anti-inflammatory effects of metformin irrespective of diabetes status"},{"title3":"Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodriguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020; S1359-6101(20)30109-X."},{"title3":"Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020."},{"title3":"The mechanisms of action of metformin"},{"title3":"Metformin in COVID-19: a possible role beyond diabetes"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020:e33213321."},{"title3":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications"},{"title3":"Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence"},{"title3":"Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy"},{"title3":"Association of hypertension with all-cause mortality among hospitalized patients with COVID-19"},{"title3":"Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis"}]},{"title2":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome","References":[{"title3":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Characteristics of coronavirus disease 2019 in China"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Diabetes and infection: assessing the association with glycaemic control in population-based studies"},{"title3":"Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome"},{"title3":"Hospitalization for pneumonia is associated with decreased 1-Year survival in patients with type 2 diabetes: results from a prospective cohort study"},{"title3":"The effect of diabetes on the risk and mortality of acute lung injury/acute respiratory distress syndrome: a meta-analysis"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"}]}]},{"title1":"Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes","References":[{"title2":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019","References":[]},{"title2":"The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth","References":[]},{"title2":"Metformin: historical overview","References":[]},{"title2":"Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock","References":[]},{"title2":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis","References":[{"title3":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)"},{"title3":"Standards of Medical Care in Diabetes-2017: summary of revisions"},{"title3":"10-year follow-up of intensive glucose control in type 2 diabetes"},{"title3":"Glycemic and weight changes after persistent use of incident oral diabetes therapy: a Veterans Administration retrospective cohort study"},{"title3":"Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control"},{"title3":"Insights from advanced analytics at the Veterans Health Administration"},{"title3":"A new equation to estimate glomerular filtration rate"},{"title3":"Generalized canonical correlation analysis with missing values"},{"title3":"GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials"},{"title3":"KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease"},{"title3":"Conceptual model of CKD: applications and implications"},{"title3":"Multiple imputation using chained equations: issues and guidance for practice"},{"title3":"Estimating and using propensity scores with partially missing data"},{"title3":"Comparing the performance of propensity score methods in healthcare database studies with rare outcomes"},{"title3":"Proportional hazards tests and diagnostics based on weighted residuals"},{"title3":"A proportional hazards model for the subdistribution of a competing risk"},{"title3":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations"},{"title3":"Tutorial in biostatistics: competing risks and multi-state models"},{"title3":"Competing risks in epidemiology: possibilities and pitfalls"},{"title3":"Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies"},{"title3":"Comparative effectiveness of incident oral antidiabetic drugs on kidney function"},{"title3":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway"},{"title3":"Metformin inhibits chemokine expression through the AMPK/NF-kappaB signaling pathway"},{"title3":"Metformin attenuates cyclosporine A-induced renal fibrosis in rats"},{"title3":"Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease"},{"title3":"Metformin improves vascular function in CKD patients with metabolic syndrome [abstract]"},{"title3":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease"},{"title3":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study"},{"title3":"Comparative effectiveness of second-line agents for the treatment of diabetes type 2 in preventing kidney function decline"},{"title3":"Association of treatment with metformin vs sulfonylurea with major adverse cardiovascular events among patients with diabetes and reduced kidney function"},{"title3":"Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study"},{"title3":"Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease"}]},{"title2":"Practical recommendations for the management of diabetes in patients with COVID-19","References":[{"title3":"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis"},{"title3":"Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single center"},{"title3":"Pneumonia mortality, comorbidities matter?"},{"title3":"Influenza A-associated severe pneumonia in hospitalized patients: risk factors and NAI treatments"},{"title3":"Middle East respiratory syndrome"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"The sweeter side of ACE2: physiological evidence for a role in diabetes"},{"title3":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"COVID-19 and diabetes: can DPP4 inhibition play a role?"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers"},{"title3":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts"},{"title3":"Impact of obesity and metabolic syndrome on immunity"},{"title3":"Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic"},{"title3":"Altered lipid metabolism in recovered SARS patients twelve years after infection"},{"title3":"Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial"},{"title3":"A review of micronutrients and the immune system-working in harmony to reduce the risk of infection"},{"title3":"Managing diabetes during the COVID- 19 epidemic"},{"title3":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Potential effect of hydroxychloroquine in diabetes mellitus: a systematic review on preclinical and clinical trial studies"}]},{"title2":"Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure","References":[]},{"title2":"Anti-inflammatory effects of metformin irrespective of diabetes status","References":[{"title3":"Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin."},{"title3":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)."},{"title3":"Metformin and reduced risk of cancer in diabetic patients."},{"title3":"Molecular mechanism of action of metformin: old or new insights?"},{"title3":"Cellular and molecular mechanisms of metformin: an overview."},{"title3":"Cellular responses to the metal-binding properties of metformin."},{"title3":"Biomolecular mode of action of metformin in relation to its copper binding properties."},{"title3":"The copper binding properties of metformin-QCM-D, XPS and nanobead agglomeration."},{"title3":"Molecular action and pharmacogenetics of metformin: current understanding of an old drug."},{"title3":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain."},{"title3":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I."},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase."},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action."},{"title3":"Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats."},{"title3":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state."},{"title3":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP."},{"title3":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling."},{"title3":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure."},{"title3":"Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure."},{"title3":"Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase alpha2."},{"title3":"Metformin prevents the development of chronic heart failure in the SHHF rat model."},{"title3":"Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase."},{"title3":"Inflammation and metabolic disorders."},{"title3":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association."},{"title3":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells."},{"title3":"Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity."},{"title3":"The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver."},{"title3":"The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration."},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill."},{"title3":"An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials."},{"title3":"Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies."},{"title3":"Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis."},{"title3":"Novel cross-talk within the IKK family controls innate immunity."},{"title3":"Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells."},{"title3":"Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells."},{"title3":"Macrophage activation and polarization."},{"title3":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria."},{"title3":"An unexpected twist to the activation of IKKbeta: TAK1 primes IKKbeta for activation by autophosphorylation."},{"title3":"The effect of metformin on insulin resistance and exercise parameters in patients with heart failure."},{"title3":"C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet."},{"title3":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization."},{"title3":"Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes."},{"title3":"The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: controlled randomized clinical trial."},{"title3":"Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus."},{"title3":"10-year follow-up of intensive glucose control in type 2 diabetes."},{"title3":"Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction."},{"title3":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function."},{"title3":"Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls."},{"title3":"Metformin improves healthspan and lifespan in mice."},{"title3":"Central role for interleukin-2 in type 1 diabetes."},{"title3":"Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes."},{"title3":"IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function."},{"title3":"Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt."},{"title3":"An inflammatory T cell signature predicts obesity-associated type 2 diabetes (HUM3P.262)."},{"title3":"Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1beta gene in the Iranian population."},{"title3":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group."},{"title3":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis."}]},{"title2":"Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)","References":[]},{"title2":"Lactic acidosis and severe septic shock in metformin users: a cohort study","References":[{"title3":"Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock)"},{"title3":"The role of serum lactate in the acute care setting"},{"title3":"Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock"},{"title3":"Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock"},{"title3":"Occult hypoperfusion and mortality in patients with suspected infection"},{"title3":"Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes"},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase"},{"title3":"Metformin overdose causes platelet mitochondrial dysfunction in humans"},{"title3":"Metformin overdose causes platelet mitochondrial dysfunction in humans"},{"title3":"Incidence of lactic acidosis in metformin users"},{"title3":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study"},{"title3":"Lactic acidosis in patients with diabetes treated with metformin"},{"title3":"Lactic acidosis induced by metformin: incidence, management and prevention"},{"title3":"Biguanide-associated lactic acidosis. Case report and review of the literature"},{"title3":"Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature"},{"title3":"Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Etiology and therapeutic approach to elevated lactate levels"},{"title3":"Excess lactate: an index of reversibility of shock in human patients"},{"title3":"Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock?"},{"title3":"Metformin and other antidiabetic agents in renal failure patients"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"Cardiovascular shock"},{"title3":"The AMP-activated protein kinase--fuel gauge of the mammalian cell?"},{"title3":"AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart"},{"title3":"Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study"},{"title3":"Adiponectin-mediated modulation of hypertrophic signals in the heart"}]},{"title2":"Metabolic effects of metformin in the failing heart","References":[{"title3":"Metformin in heart failure patients"},{"title3":"The impact of oral anti-diabetic medications on heart failure: Lessons learned from preclinical studies"},{"title3":"Glycemic control and heart failure among adult patients with diabetes"},{"title3":"Clinical impact of oral antidiabetic medications in heart failure patients"},{"title3":"Diabetes and cardiovascular events in high-risk patients: Insights from a multicenter registry in a middle-income country"},{"title3":"Update on cardiovascular effects of older and newer anti-diabetic medications"},{"title3":"Cardiovascular safety outcomes of new antidiabetic therapies"},{"title3":"EMPA-REG OUTCOME  trial investigators. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: Results of the EMPA-REG OUTCOME  trial"},{"title3":"RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus"},{"title3":"Metformin: An old but still the best treatment for type 2 diabetes"},{"title3":"Metformin and metabolic diseases: A focus on hepatic aspects"},{"title3":"Understanding the benefit of metformin use in cancer treatment"},{"title3":"Do metformin a real anticarcinogen? A critical reappraisal of experimental data"},{"title3":"Repurposing metformin: An old drug with new tricks in its binding pockets"},{"title3":"A brief history of the development of diabetes medications"},{"title3":"The blooming of the French lilac"},{"title3":"The Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus"},{"title3":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)"},{"title3":"Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials"},{"title3":"Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes"},{"title3":"Cellular and molecular mechanisms of metformin: An overview"},{"title3":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain"},{"title3":"AMP-activated protein kinase in metabolic control and insulin signaling"},{"title3":"AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function"},{"title3":"AMP-activated protein kinase: Maintaining energy homeostasis at the cellular and whole body levels"},{"title3":"Is AMPK the savior of the failing heart?"},{"title3":"AMP-activated protein kinase in the regulation of hepatic energy metabolism: From physiology to therapeutic perspectives"},{"title3":"Mitochondrial respiratory defect causes dysfunctional lactate turnover via AMP-activated protein kinase activation in human-induced pluripotent stem cell-derived hepatocytes"},{"title3":"AMPK in health and disease"},{"title3":"Measurements of gluconeogenesis and glycogenolysis: A methodological review"},{"title3":"Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"Regulation of acetyl CoA carboxylase and carnitine palmitoyl transferase-1 in rat adipocytes"},{"title3":"Activation of AMP-activated protein kinase in the liver: A new strategy for the management of metabolic hepatic disorders"},{"title3":"Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle"},{"title3":"Skeletal muscle lactate overproduction during metformin intoxication: An animal study with reverse microdialysis"},{"title3":"Metformin and the gastrointestinal tract"},{"title3":"OCT1 expression in adipocytes could contribute to increased metformin action in obese subjects"},{"title3":"Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin"},{"title3":"Comparison of glucose lowering effect of metformin and acarbose in type 2 diabetes mellitus: A. meta-analysis"},{"title3":"Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects"},{"title3":"Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling"},{"title3":"The role of beta-cell dysfunction in the cardiometabolic syndrome"},{"title3":"Lipotoxicity in human pancreatic islets and the protective effect of metformin"},{"title3":"Metformin: An old drug for the treatment of diabetes but a new drug for the protection of the endothelium"},{"title3":"Metformin pathways: Pharmacokinetics and pharmacodynamics"},{"title3":"Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects"},{"title3":"Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin"},{"title3":"Diabetic cardiomyopathy: Understanding the molecular and cellular basis to progress in diagnosis and treatment"},{"title3":"Cardiac steatosis in diabetes mellitus: A 1H-magnetic resonance spectroscopy study"},{"title3":"Insulin signaling and heart failure"},{"title3":"The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus"},{"title3":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction"},{"title3":"Forkhead box transcription factor 1: Role in the pathogenesis of diabetic cardiomyopathy"},{"title3":"Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus"},{"title3":"Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: Noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway"},{"title3":"Understanding asymptomatic diastolic dysfunction in clinical practice"},{"title3":"Diabetic cardiomyopathy revisited"},{"title3":"Diabetes and chronic heart failure: From diabetic cardiomyopathy to therapeutic approach"},{"title3":"Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes"},{"title3":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission"},{"title3":"Redox-dependent regulation of the Na+-K+; pump: New twists to an old target for treatment of heart failure"},{"title3":"New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction"},{"title3":"The opposing roles of NO and oxidative stress in cardiovascular disease"},{"title3":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation"},{"title3":"Heart failure with preserved ejection fraction: Defining the function of ROS and NO"},{"title3":"Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts"},{"title3":"Metabolic dysfunction in heart failure: Diagnostic, prognostic, and pathophysiologic insights from metabolomic profiling"},{"title3":"Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model"},{"title3":"Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction"},{"title3":"Akt1 in the cardiovascular system: Friend or foe?"},{"title3":"Diabetic cardiomyopathy in Zucker diabetic fatty rats: The forgotten right ventricle"},{"title3":"Right ventricular involvement in diabetic cardiomyopathy"},{"title3":"Systematic review of the association between lung function and Type 2 diabetes mellitus"},{"title3":"Taking diabetes to heart:deregulation of myocardial lipid metabolism in diabetic cardiomyopathy"},{"title3":"Modulating fatty acid oxidation in heart failure"},{"title3":"Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure"},{"title3":"Energy metabolism in heart failure and remodeling"},{"title3":"Cardiac metabolism and its interactions with contraction, growth, and survival of the cardiomyocte"},{"title3":"Metabolic coordination of physiological and pathological cardiac remodeling"},{"title3":"Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study"},{"title3":"Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome"},{"title3":"Etiology of insulin resistance"},{"title3":"Insulin-like growth factor-1 deficiency and metabolic syndrome"},{"title3":"JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes"},{"title3":"Insulin resistance, metabolic stress, and atherosclerosis"},{"title3":"Insulin signalling mechanisms for triacylglycerol storage"},{"title3":"Metabolic alterations following visceral fat removal and expansion. Beyond anatomic location"},{"title3":"Lipotoxic heart disease in obese rats: Implications for human obesity"},{"title3":"Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms"},{"title3":"Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation"},{"title3":"Protein kinase C as regulator of vascular smooth muscle function and potential target in vascular disorders"},{"title3":"Metabolic remodelling in diabetic cardiomyopathy"},{"title3":"Induction of vascular insulin resistance, endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C beta isoform in the endothelium"},{"title3":"Metabolic alterations induce oxidative stress in diabetic and failing hearts: Different pathways, same outcome"},{"title3":"Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes"},{"title3":"Metabolic cardiomyopathies"},{"title3":"Free fatty acid effects on the atrial myocardium: Membrane ionic currents are remodeled by the disruption of T-tubular architecture"},{"title3":"Malonyl-CoA regulation in skeletal muscle: Its link to cell citrate and the glucose-fatty acid cycle"},{"title3":"Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats"},{"title3":"Aging-Induced Biological Changes and Cardiovascular Diseases"},{"title3":"Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment"},{"title3":"Mechanisms for increased glycolysis in the hypertrophied rat heart"},{"title3":"Metformin prevents progression of heart failure in dogs: Role of AMP-activated protein kinase"},{"title3":"AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B"},{"title3":"Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3"},{"title3":"Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats"},{"title3":"Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte"},{"title3":"Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt"},{"title3":"Consolidation and translation regulation"},{"title3":"Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase"},{"title3":"p70 S6 kinase: An enigma with variations"},{"title3":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure"},{"title3":"Regulatory role of mitochondria in oxidative stress and atherosclerosis"},{"title3":"Nitric oxide in skeletal muscle: Role on mitochondrial biogenesis and function"},{"title3":"Exercise training boosts eNOS-dependent mitochondrial bio-genesis in mouse heart: Role in adaptation of glucose metabolism"},{"title3":"Cardiac NO signalling in the metabolic syndrome"},{"title3":"Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure"},{"title3":"Modulation of iNOS activity in age-related cardiac dysfunction"},{"title3":"Nitric oxide synthase: Expression and expressional control of the three isoforms"},{"title3":"Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages"},{"title3":"Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes"},{"title3":"Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase"},{"title3":"Metformin improves cardiac function in rats via activation of AMP-activated protein kinase"},{"title3":"Effects of metformin on collagen glycation and diastolic dysfunction in diabetic myocardium"},{"title3":"Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway"},{"title3":"Qiliqiangxin attenuates cardiac remodeling via inhibition of TGF-beta1/Smad3 and NF-kappaB signaling pathways in a rat model of myocardial infarction"},{"title3":"3-Deoxyglucosone: A potential glycating agent accountable for structural alteration in H3 histone protein through generation of different AGEs"},{"title3":"Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention"},{"title3":"Advanced glycation end products and diabetic complications"},{"title3":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus"},{"title3":"Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products"},{"title3":"Diabetes and the risk of heart failure"},{"title3":"Diabetic cardiomyopathy: Pathophysiology and clinical features"},{"title3":"Metformin reduces systemic methylglyoxal levels in type 2 diabetes"},{"title3":"Metformin therapy and clinical uses"},{"title3":"Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A.-I"},{"title3":"Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins"},{"title3":"Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products"},{"title3":"Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats"},{"title3":"Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus"},{"title3":"Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats"},{"title3":"Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction"},{"title3":"Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation, oxidative stress and P38MAPK pathway in rat"},{"title3":"Improved clinical outcomes associated with metformin in patients with diabetes and heart failure"},{"title3":"Treatment of type 2 diabetes and outcomes in patients with heart failure: A nested case-control study from the U.K. General Practice Research Database"},{"title3":"Metformin use and mortality in ambulatory patients with diabetes and heart failure"},{"title3":"The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy"},{"title3":"Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes"},{"title3":"Contraindications can damage your health:Is metformin a case in point?"},{"title3":"Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure. Systematic review of observational studies involving 34 000 patients"},{"title3":"Heart failure in diabetes: Effects of antihyperglycaemic drug therapy"},{"title3":"Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology"}]},{"title2":"Metformin: from mechanisms of action to therapies","References":[]},{"title2":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS)","References":[]},{"title2":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","References":[]},{"title2":"Evaluating the yield of medical tests","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Clinical risks for development of the acute respiratory distress syndrome"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Epidemiology and outcome of acute respiratory failure in intensive care unit patients"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2:a new cardiac regulator"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2"},{"title3":"Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome"},{"title3":"Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis"},{"title3":"Male-female differences in fertility and blood pressure in ACE-deficient mice"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study"},{"title3":"Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia"},{"title3":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice"},{"title3":"Consequences of alteration in capillary permeability"},{"title3":"Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure"},{"title3":"PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide"},{"title3":"Hypoxia and angiotensin II infusion redistribute lung blood flow in lambs"},{"title3":"Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome"}]},{"title2":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","References":[{"title3":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)"},{"title3":"Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994)"},{"title3":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus"},{"title3":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis"},{"title3":"New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser"},{"title3":"Clinical pharmacokinetics of metformin"},{"title3":"Kidney function and age are both predictors of pharmacokinetics of metformin"},{"title3":"Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations"},{"title3":"Relationship of plasma creatinine and lactic acid in type 2 diabetic patients without renal dysfunction"},{"title3":"Fasting plasma lactate concentrations in ambulatory elderly patients with type 2 diabetes receiving metformin therapy: a retrospective cross-sectional study"},{"title3":"Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function"},{"title3":"Metformin therapy in patients with chronic kidney disease"},{"title3":"Metformin treatment in NIDDM patients with mild renal impairment"},{"title3":"Diabetes medication use and blood lactate level among participants with type 2 diabetes: the atherosclerosis risk in communities carotid MRI study"},{"title3":"The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: the Fremantle Diabetes Study"},{"title3":"Metformin-induced lacticacidemia in patients with type 2 diabetes mellitus"},{"title3":"Disposition of metformin (N,N-dimethylbiguanide) in man"},{"title3":"Metformin:mode of action and clinical implications for diabetes and cancer"},{"title3":"Plasma biguanide levels are correlated with metabolic effects in diabetic patients"},{"title3":"The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment"},{"title3":"Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas"},{"title3":"Metformin-associated lactic acidosis in Sweden 1977-1991"},{"title3":"Epidemiology of adverse drug reactions to phenformin and metformin"},{"title3":"Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit"},{"title3":"Outcome of severe lactic acidosis associated with metformin accumulation"},{"title3":"Metformin-associated lactic acidosis in diabetic patients with acute renal failure: a critical analysis of its pathogenesis and prognosis"},{"title3":"Metformin intoxication requiring dialysis"},{"title3":"Severe acidosis in patients taking metformin:rapid reversal and survival despite high APACHE score"},{"title3":"Assessing the appropriate use of metformin in an inpatient setting and the effectiveness of two pharmacy-based measures to improve guideline adherence"},{"title3":"Metformin-associated lactic acidosis: a prognostic and therapeutic study"},{"title3":"Metformin induced lactic acidosis:particularities and course"},{"title3":"Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy"},{"title3":"Role of metformin accumulation in metformin-associated lactic acidosis"},{"title3":"Lactic acidosis in medical ICU:the role of diabetes mellitus and metformin"},{"title3":"Metformin-associated lactic acidosis in an intensive care unit"},{"title3":"Diabetes, metformin and lactic acidosis"},{"title3":"Lactic acidosis in patients with diabetes"},{"title3":"Acidosis in the hospital setting: is metformin a common precipitant?"},{"title3":"Impact of acute kidney injury on metformin-associated lactic acidosis"},{"title3":"Metformin-associated lactic acidosis in Chinese patients with type II diabetes"},{"title3":"Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?"},{"title3":"Metformin-associated lactic acidosis requiring hospitalization: a national 10 year survey and a systematic literature review"},{"title3":"Metformin and lactic acidosis: cause or coincidence? a review of case reports"},{"title3":"Lactic acidosis in metformin-treated patients: prognostic value of arterial lactate levels and plasma metformin concentrations"},{"title3":"Incidence of lactic acidosis in metformin users"},{"title3":"Lactic acidosis in metformin therapy: searching for a link with metformin in reports of &quot;metformin-associated lactic acidosis.&quot;"},{"title3":"The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database"},{"title3":"Lactic acidosis rates in type 2 diabetes"},{"title3":"Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements"},{"title3":"Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Metformin use and mortality among patients with diabetes and atherothrombosis"},{"title3":"Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register"},{"title3":"Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study"},{"title3":"Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome"},{"title3":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study"},{"title3":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study"},{"title3":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)"},{"title3":"Cardiovascular outcomes in trials of oral diabetes medications: a systematic review"},{"title3":"Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study"},{"title3":"Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study"},{"title3":"Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients"},{"title3":"Limitations of metformin use in patients with kidney disease: are they warranted?"},{"title3":"Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study"},{"title3":"Prevalence of risk determinants for metformin-associated lactic acidosis and metformin utilization in the study of health in Pomerania"},{"title3":"Contraindications to metformin therapy among patients with type 2 diabetes mellitus"},{"title3":"Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin"},{"title3":"Renal status among patients using metformin in a primary care setting"},{"title3":"Do risk factors for lactic acidosis influence dosing of metformin?"},{"title3":"Frequency of inappropriate metformin prescriptions"},{"title3":"Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy"},{"title3":"Contraindications to metformin therapy in patients with type 2 diabetes:a population-based study of adherence to prescribing guidelines"},{"title3":"Contra-indications to metformin therapy are largely disregarded"},{"title3":"First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization"},{"title3":"Contraindications to metformin therapy in patients with NIDDM"},{"title3":"Diabetes therapies in renal impairment"},{"title3":"A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study"},{"title3":"SGLT-2 inhibitors and their potential in the treatment of diabetes"},{"title3":"Metformin: effects on micro and macrovascular complications in type 2 diabetes"},{"title3":"NICE Guidelines: The Management of Type 2 Diabetes"},{"title3":"KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update"},{"title3":"Unleash metformin: reconsideration of the contraindication in patients with renal impairment"},{"title3":"Use of metformin in the setting of mild-to-moderate renal insufficiency"},{"title3":"Metformin: the safest hypoglycaemic agent in chronic kidney disease?"},{"title3":"Review: metformin: potential benefits and use in chronic kidney disease"},{"title3":"Request to Revise the Prescribing Label for Metformin"}]},{"title2":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"Metabolic acidosis: pathophysiology, diagnosis and management","References":[]},{"title2":"Lactic acidosis induced by metformin: incidence, management and prevention","References":[]},{"title2":"Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial","References":[]},{"title2":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage","References":[{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure"},{"title3":"Evaluating the yield of medical tests"},{"title3":"HIF-1-miR-219-SMC4 regulatory pathway promoting proliferation and migration of HCC under hypoxic condition"},{"title3":"Decision curve analysis: a novel method for evaluating prediction models"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Performance of the PSI and CURB-65 scoring systems in predicting 30-day mortality in healthcare-associated pneumonia"},{"title3":"CURB-65 score is equal to NEWS for identifying mortality risk of pneumonia patients: an observational study"},{"title3":"Performance of the CURB-65 score in predicting critical care interventions in patients admitted with community-acquired pneumonia"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19"},{"title3":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis"},{"title3":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"COVID-19 infection: the perspectives on immune responses"},{"title3":"The role of neutrophil to lymphocyte count ratio in the differential diagnosis of pulmonary tuberculosis and bacterial community-acquired pneumonia: a cross-sectional study at Ayder and Mekelle Hospitals"},{"title3":"Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer"},{"title3":"Risk factors for mortality due to ventilator-associated pneumonia in a Chinese hospital: a retrospective study"},{"title3":"Neutrophil-to-lymphocyte ratio in adult community-acquired pneumonia patients correlates with unfavorable clinical outcomes"},{"title3":"Neutrophil-to-lymphocyte ratio improves the accuracy and sensitivity of pneumonia severity index in predicting 30-day mortality of CAP patients"},{"title3":"Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"}]},{"title2":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis","References":[{"title3":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 infection: the perspectives on immune responses"},{"title3":"Host-directed therapy as a novel treatment strategy to overcome tuberculosis: targeting immune modulation"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Commentary: COVID-19 in patients with diabetes"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"COVID-19: melatonin as a potential adjuvant treatment"},{"title3":"Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues"},{"title3":"Metformin, a new era for an old drug in the treatment of immune mediated disease?"},{"title3":"Metformin inhibits pro-inflammatory responses via targeting nuclear factor-kappaB in HaCaT cells"},{"title3":"Metformin effect on gut microbiota: insights for HIV-related inflammation"},{"title3":"Metformin as a host-directed therapeutic in tuberculosis: is there a promise?"},{"title3":"Metformin improves healthspan and lifespan in mice"},{"title3":"The role of metformin in controlling oxidative stress in muscle of diabetic rats"}]},{"title2":"Web site and R package for computing E-values","References":[{"title3":"Sensitivity analysis in observational research: Introducing the E-value"},{"title3":"Sensitivity analysis without assumptions"},{"title3":"Sensitivity analysis for unmeasured confounding: E-values for observational studies"}]},{"title2":"COVID-19: consider cytokine storm syndromes and immunosuppression","References":[{"title3":"Coronavirus disease 2019 (COVID-19)situation report - 52"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Adult haemophagocytic syndrome"},{"title3":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis"},{"title3":"Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial"},{"title3":"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome"}]},{"title2":"Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock","References":[]},{"title2":"Lactic acidosis in patients with diabetes treated with metformin","References":[]},{"title2":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","References":[{"title3":"The proximal origin of SARS-CoV-2"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Angiotensin-converting enzyme 2: the first decade"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-converting enzyme II in the heart and the kidney"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Pulmonary surfactant"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Data, disease and diplomacy: GISAID's innovative contribution to global health"},{"title3":"Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells"},{"title3":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Nextstrain: real-time tracking of pathogen evolution"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches"},{"title3":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate"},{"title3":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses"},{"title3":"NIH Image to ImageJ: 25 years of image analysis"},{"title3":"Comprehensive Integration of Single-Cell Data"},{"title3":"Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets"},{"title3":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"Detection of SARS-CoV-2 in Different Types of Clinical Specimens"},{"title3":"Human blood vessel organoids as a model of diabetic vasculopathy"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Single-Cell Transcriptomics of a Human Kidney Allograft Biopsy Specimen Defines a Diverse Inflammatory Response"},{"title3":"Comparative Analysis and Refinement of Human PSC-Derived Kidney Organoid Differentiation with Single-Cell Transcriptomics"},{"title3":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore"},{"title3":"Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"}]},{"title2":"New Coronavirus Pneumonia Prevention and Control Program (National Health Commission of China)","References":[]},{"title2":"Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study","References":[]},{"title2":"Type 2 diabetes mellitus treatment patterns across Europe: a population-based multi-database study","References":[]},{"title2":"The effects of metformin on gut microbiota and the immune system as research frontiers","References":[]},{"title2":"The mechanisms of action of metformin","References":[{"title3":"The right place for metformin today"},{"title3":"Where does metformin stand in modern day management of type 2 diabetes?"},{"title3":"Metformin: Is it a drug for all reasons and diseases?"},{"title3":"Metformin: historical overview"},{"title3":"Flumamine, a new synthetic analgesic and anti-flu drug"},{"title3":"Patients with obesity and a history of metformin treatment have lower influenza mortality: a retrospective cohort study"},{"title3":"Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England"},{"title3":"Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis"},{"title3":"Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19"},{"title3":"Metformin in 2019"},{"title3":"Metformin: from mechanisms of action to therapies"},{"title3":"Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial"},{"title3":"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss"},{"title3":"GDF15 mediates the effects of metformin on body weight and energy balance"},{"title3":"Metformin for pregnancy and beyond: the pros and cons"},{"title3":"A review on the use of metformin in pregnancy and its associated fetal outcomes"},{"title3":"Metformin from mother to unborn child - are there unwarranted effects?"},{"title3":"Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial"},{"title3":"Accumulation of metformin by tissues of the normal and diabetic mouse"},{"title3":"Pharmacokinetics of metformin after intravenous and oral administration to man"},{"title3":"[11C]-Labeled metformin distribution in the liver and small intestine using dynamic positron emission tomography in mice demonstrates tissue-specific transporter dependency"},{"title3":"Metformin transporter pharmacogenomics: insights into drug disposition - where are we now?"},{"title3":"Clinical pharmacokinetics of metformin"},{"title3":"Are metformin doses used in murine cancer models clinically relevant?"},{"title3":"Metformin action: concentrations matter"},{"title3":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus"},{"title3":"Metformin pharmacokinetics in mouse tumors: implications for human therapy"},{"title3":"Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling"},{"title3":"Metformin biodistribution: a key to mechanisms of action?"},{"title3":"Metformin as adjunct antituberculosis therapy"},{"title3":"Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies"},{"title3":"Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes"},{"title3":"Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals"},{"title3":"Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats"},{"title3":"Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis"},{"title3":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2"},{"title3":"Metformin acts in the gut and induces gut-liver crosstalk"},{"title3":"In vivo imaging of human 11C-metformin in peripheral organs: dosimetry, biodistribution, and kinetic analyses"},{"title3":"Metformin and the intestine"},{"title3":"Why does the intestine lack basolateral efflux transporters for cationic compounds? A provocative hypothesis"},{"title3":"Multiple transport mechanisms involved in the intestinal absorption of metformin: impact on the nonlinear absorption kinetics"},{"title3":"Reconsideration of inhibitory effect of metformin on intestinal glucose absorption"},{"title3":"Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine"},{"title3":"Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes"},{"title3":"Metformin and intestinal glucose handling"},{"title3":"Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes"},{"title3":"Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes"},{"title3":"Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: results from a randomized clinical trial"},{"title3":"Association between colonic 18F-FDG uptake and glycemic control in patients with diabetes mellitus"},{"title3":"Dose-dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18F-labelled fluorodeoxyglucose positron emission tomography-MRI"},{"title3":"Enhanced release of glucose into the intraluminal space of the intestine associated with metformin treatment as revealed by [18F]fluorodeoxyglucose PET-MRI"},{"title3":"Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport"},{"title3":"GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice"},{"title3":"A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes"},{"title3":"Metformin and the gastrointestinal tract"},{"title3":"Kjobsted, R. et al. Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance. Preprint at bioRxivhttps://www.biorxiv.org/content/10.1101/2022.05.22.492936v1 (2022)."},{"title3":"Metformin stimulates intestinal glycolysis and lactate release: a single-dose study of metformin in patients with intrahepatic portosystemic stent"},{"title3":"Metformin causes a futile intestinal-hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state"},{"title3":"Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans"},{"title3":"The regulation of glucose and lipid homeostasis via PLTP as a mediator of BAT-liver communication"},{"title3":"Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro"},{"title3":"Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides"},{"title3":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria"},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase"},{"title3":"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis"},{"title3":"Metformin's therapeutic efficacy in the treatment of diabetes does not involve inhibition of mitochondrial glycerol phosphate dehydrogenase"},{"title3":"Metformin-induced mitochondrial complex I inhibition: facts, uncertainties, and consequences"},{"title3":"Mitochondrial targets of metformin - are they physiologically relevant?"},{"title3":"Role of mitochondria in the mechanism(s) of action of metformin"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin"},{"title3":"Metformin activates AMPK through the lysosomal pathway"},{"title3":"Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex"},{"title3":"Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase"},{"title3":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP"},{"title3":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state"},{"title3":"Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis"},{"title3":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin"},{"title3":"Quantitative in vivo proteomics of metformin response in liver reveals AMPK-dependent and -independent signaling networks"},{"title3":"Cellular and molecular mechanisms of metformin action"},{"title3":"Effect of metformin on intact mitochondria from liver and brain: concept revisited"},{"title3":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain"},{"title3":"Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism"},{"title3":"Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK)"},{"title3":"The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism"},{"title3":"Diabetes drugs for nonalcoholic fatty liver disease: a systematic review"},{"title3":"Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis"},{"title3":"Pen-2 is essential for gamma-secretase complex stability and trafficking but partially dispensable for endoproteolysis"},{"title3":"5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo"},{"title3":"Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non-human primates and mice"},{"title3":"Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo"},{"title3":"Control of gluconeogenesis by metformin: does redox trump energy charge?"},{"title3":"Citrin/mitochondrial glycerol-3-phosphate dehydrogenase double knock-out mice recapitulate features of human citrin deficiency"},{"title3":"Lactate-induced glucose output is unchanged by metformin at a therapeutic concentration - a mass spectrometry imaging study of the perfused rat liver"},{"title3":"Commentary: lactate-induced glucose output is unchanged by metformin at a therapeutic concentration - a mass spectrometry imaging study of the perfused rat liver"},{"title3":"Cellular responses to the metal-binding properties of metformin"},{"title3":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I"},{"title3":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation"},{"title3":"Let-7 underlies metformin-induced inhibition of hepatic glucose production"},{"title3":"Gut metagenome in European women with normal, impaired and diabetic glucose control"},{"title3":"Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus"},{"title3":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota"},{"title3":"Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut"},{"title3":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug"},{"title3":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota"},{"title3":"Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial"},{"title3":"Effects of metformin on the gut microbiota in obesity and type 2 diabetes mellitus"},{"title3":"Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India"},{"title3":"Association of metformin administration with gut microbiome dysbiosis in healthy volunteers"},{"title3":"Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study"},{"title3":"Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis"},{"title3":"Effect of metformin on metabolic improvement and gut microbiota"},{"title3":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice"},{"title3":"Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway"},{"title3":"Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats"},{"title3":"Metformin strongly affects gut microbiome composition in high-fat diet-induced type 2 diabetes mouse model of both sexes"},{"title3":"Metformin-induced reductions in tumor growth involves modulation of the gut microbiome"},{"title3":"Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota"},{"title3":"Considering gut microbiota in treatment of type 2 diabetes mellitus"},{"title3":"Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice"},{"title3":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin"},{"title3":"Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials"},{"title3":"Metformin exerts anti-inflammatory and mucus barrier protective effects by enriching Akkermansia muciniphila in mice with ulcerative colitis"},{"title3":"Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling"},{"title3":"Metformin reduces aging-related leaky gut and improves cognitive function by beneficially modulating gut microbiome/goblet cell/mucin axis"},{"title3":"Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine"},{"title3":"An in vitro model maintaining taxon-specific functional activities of the gut microbiome"},{"title3":"Metaproteomics reveals growth phase-dependent responses of an in vitro gut microbiota to metformin"},{"title3":"Understanding the representative gut microbiota dysbiosis in metformin-treated type 2 diabetes patients using genome-scale metabolic modeling"},{"title3":"Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism"},{"title3":"Host-microbe-drug-nutrient screen identifies bacterial effectors of metformin therapy"},{"title3":"Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids"},{"title3":"Gut microbiota compositions and metabolic functions in type 2 diabetes differ with glycemic durability to metformin monotherapy"},{"title3":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits"},{"title3":"The role of incretins on insulin function and glucose homeostasis"},{"title3":"Mechanism of glucose-lowering by metformin in type 2 diabetes: role of bile acids"},{"title3":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity"},{"title3":"Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality"},{"title3":"Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db/db mice"},{"title3":"Effect of metformin on short-term high-fat diet-induced weight gain and anxiety-like behavior and the gut microbiota"},{"title3":"Metformin alleviates autistic-like behaviors elicited by high-fat diet consumption and modulates the crosstalk between serotonin and gut microbiota in mice"},{"title3":"Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis"},{"title3":"Repurposing metformin as a potential treatment for inflammatory bowel disease: evidence from cell to the clinic"},{"title3":"Metformin affects gut microbiota composition and diversity associated with amelioration of dextran sulfate sodium-induced colitis in mice"},{"title3":"Enhancing metformin effects by adding gut microbiota modulators to ameliorate the metabolic status of obese, insulin-resistant hosts"},{"title3":"Microbial imidazole propionate affects responses to metformin through p38gamma-dependent inhibitory AMPK phosphorylation"},{"title3":"Understanding and overcoming metformin gastrointestinal intolerance"},{"title3":"Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients"},{"title3":"The effects of metformin on the gut microbiota of patients with type 2 diabetes: a two-center, quasi-experimental study"},{"title3":"Inflammation, metaflammation and immunometabolic disorders"},{"title3":"An integrated view of immunometabolism"},{"title3":"Inflammation in obesity, diabetes, and related disorders"},{"title3":"Immune-metabolic interactions in homeostasis and the progression to NASH"},{"title3":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity"},{"title3":"Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis"},{"title3":"Metabolic adaptations of tissue-resident immune cells"},{"title3":"Metformin as an anti-inflammatory agent: a short review"},{"title3":"Metformin promotes mitophagy in mononuclear cells: a potential in vitro model for unraveling metformin's mechanism of action"},{"title3":"Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients"},{"title3":"The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo"},{"title3":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin"},{"title3":"Metabolism of tissue macrophages in homeostasis and pathology"},{"title3":"Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt"},{"title3":"Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation"},{"title3":"Metformin targets mitochondrial electron transport to reduce air-pollution-induced thrombosis"},{"title3":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases"},{"title3":"Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention"},{"title3":"Benefits of metformin in attenuating the hallmarks of aging"},{"title3":"Metformin enhances B cell function and antibody responses of elderly individuals with type-2 diabetes mellitus"},{"title3":"Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies"},{"title3":"Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice"},{"title3":"Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation"},{"title3":"Metformin and autoimmunity: a &quot;new deal&quot; of an old drug"},{"title3":"Metformin inhibits the type 1 IFN response in human CD4+ T cells"},{"title3":"Metformin mitigates autoimmune insulitis by inhibiting Th1 and Th17 responses while promoting Treg production"},{"title3":"Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial"},{"title3":"Is metformin poised for a second career as an antimicrobial?"},{"title3":"A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity"},{"title3":"Latent tuberculosis in patients with diabetes mellitus: prevalence, progression and public health implications"},{"title3":"Metformin alters human host responses to Mycobacterium tuberculosis in healthy subjects"},{"title3":"Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits"},{"title3":"Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: results of a phase II clinical trial"},{"title3":"Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition"},{"title3":"Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD"},{"title3":"Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles"},{"title3":"Metformin and reduced risk of cancer in diabetic patients"},{"title3":"Repurposing metformin for the prevention of cancer and cancer recurrence"},{"title3":"Dual anticancer role of metformin: an old drug regulating AMPK dependent/independent pathways in metabolic, oncogenic/tumorsuppresing and immunity context"},{"title3":"Diabetes and cancer: 5 years into the recent controversy"},{"title3":"Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: the MA.32 randomized clinical trial"},{"title3":"Metformin and cancer, an ambiguanidous relationship"},{"title3":"The Immunological Genome Project: networks of gene expression in immune cells"},{"title3":"The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans"},{"title3":"Phenformin, but not metformin, delays development of T cell acute lymphoblastic leukemia/lymphoma via cell-autonomous AMPK activation"},{"title3":"Therapeutic repurposing of biguanides in cancer"},{"title3":"Metformin and ageing: improving ageing outcomes beyond glycaemic control"},{"title3":"If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice"},{"title3":"Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans"},{"title3":"A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study"},{"title3":"Obesity and COVID-19 severity in a designated hospital in Shenzhen, China"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"Global pandemics interconnected - obesity, impaired metabolic health and COVID-19"},{"title3":"Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes"},{"title3":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing"},{"title3":"Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses"},{"title3":"Metformin suppresses monocyte immunometabolic activation by SARS-CoV-2 spike protein subunit 1"},{"title3":"Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial"},{"title3":"Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19"},{"title3":"Bramante, C. T. et al. Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up. Preprint at medRxivhttps://www.medrxiv.org/content/10.1101/2022.12.21.22283753v1 (2022)."},{"title3":"Growth differentiation factor 15 as a novel biomarker for metformin"},{"title3":"Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: a nested, case-control study"},{"title3":"The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance"},{"title3":"A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects"},{"title3":"GDF15 in appetite and exercise: essential player or coincidental bystander?"},{"title3":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand"},{"title3":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates"},{"title3":"Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study"},{"title3":"The effects of metformin on simple obesity: a meta-analysis"},{"title3":"Growth differentiation factor 15 is not associated with glycemic control in patients with type 2 diabetes mellitus treated with metformin: a post-hoc analysis of AIM study"},{"title3":"Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: a hidden treasure"},{"title3":"Metformin and GDF15: where are we now?"},{"title3":"Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice"},{"title3":"AMPK/alpha-ketoglutarate axis dynamically mediates DNA demethylation in the Prdm16 promoter and brown adipogenesis"},{"title3":"Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice"},{"title3":"Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats"},{"title3":"Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes"},{"title3":"Metformin and brown adipose tissue thermogenetic activity in genetically obese Zucker rats"},{"title3":"Metformin reduces macrophage HIF1alpha-dependent proinflammatory signaling to restore brown adipocyte function in vitro"},{"title3":"A nationwide wastewater-based assessment of metformin consumption across Australia"},{"title3":"Metformin contamination in global waters: biotic and abiotic transformation, byproduct generation and toxicity, and evaluation as a pharmaceutical indicator"},{"title3":"Occurrence, toxic effects and removal of metformin in the aquatic environments in the world: recent trends and perspectives"},{"title3":"Metformin as an emerging concern in wastewater: occurrence, analysis and treatment methods"},{"title3":"Metformin environmental exposure: a systematic review"},{"title3":"Pharmaceutical pollution of the world's rivers"},{"title3":"Low-dose metformin exposure causes changes in expression of endocrine disruption-associated genes"},{"title3":"Metformin disrupts Danio rerio metabolism at environmentally relevant concentrations: a full life-cycle study"},{"title3":"Developmental phenotypic and transcriptomic effects of exposure to nanomolar levels of metformin in zebrafish"},{"title3":"Are fish populations at risk? Metformin disrupts zebrafish development and reproductive processes at chronic environmentally relevant concentrations"},{"title3":"Aerobic degradation of the antidiabetic drug metformin by Aminobacter sp. strain NyZ550"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis","References":[]},{"title2":"Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies","References":[{"title3":"IEA-EEF European Congress of Epidemiology 2009 Warsaw, Poland 26-29 August. Eur J Epidemiol 2009;24 Suppl 1."},{"title3":"Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women"},{"title3":"Public health service study of Reye's syndrome and medications. Report of the main study"},{"title3":"Reserpine use in relation to breast cancer"},{"title3":"A survey of childhood malignancies"},{"title3":"Prenatal X-ray exposure and childhood cancer"},{"title3":"Alternative data sources in a case-control study of conjugated estrogens and cancer"},{"title3":"Risk of kiney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs"},{"title3":"Epidemiology of hepatocellular adenoma. The role of oral contraceptive use"},{"title3":"Use of recommended medications after myocardial infarction in Austria"},{"title3":"Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK"},{"title3":"Thinking big: large-scale collaborative research in observational epidemiology"},{"title3":"Confounding in publications of observational intervention studies"},{"title3":"Appropriate epidemiologic methods as a prerequisite for valid study results"},{"title3":"Regression models and life tables"},{"title3":"The Rotterdam study: 2010 objectives and design update"},{"title3":"Thiazide diuretics and the risk for hip fracture"},{"title3":"Estimation of the time-dependent accelerated failure time model in the presence of confounding factors"},{"title3":"Young JG, Hernan MA, Picciotto S, Robins JM. Relation between three classes of structural models for the effect of a time-varying exposure on survival. Lifetime Data Anal. 2009 Nov 6 (Epub ahead of print)."}]},{"title2":"Lactic acidosis in sepsis: it's not all anaerobic: implications for diagnosis and management","References":[]},{"title2":"Metformin - the drug for the treatment of autoimmune diseases; a new use of a known anti-diabetic drug","References":[]},{"title2":"Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase","References":[{"title3":"Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia"},{"title3":"Acute hepatitis C: current status and remaining challenges"},{"title3":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors"},{"title3":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance"},{"title3":"Hepatitis C virus infection: molecular pathways to metabolic syndrome"},{"title3":"Hepatitis C virus, ER stress, and oxidative stress"},{"title3":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]"},{"title3":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis"},{"title3":"Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin"},{"title3":"Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients"},{"title3":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"An energetic tale of AMPK-independent effects of metformin"},{"title3":"AMP-activated protein kinase in metabolic control and insulin signaling"},{"title3":"Treatment of insulin resistance with metformin in naive genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin"},{"title3":"The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes"},{"title3":"Thiazolidinediones"},{"title3":"Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin"},{"title3":"A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus"},{"title3":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Inteferons pen the JAK-STAT pathway"},{"title3":"Systematic identification of type I and type II interferon-induced antiviral factors"},{"title3":"Regulation of hepatic innate immunity by hepatitis C virus"},{"title3":"Interferon-stimulated genes and their role in controlling hepatitis C virus"},{"title3":"Hepatitis C treatment: an incipient therapeutic revolution"},{"title3":"New hepatitis C therapies: the toolbox, strategies, and challenges"},{"title3":"The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-beta signaling"},{"title3":"Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy"},{"title3":"The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance"},{"title3":"Inhibition of hepatitis C virus replication through adenosine monophosphate-activated protein kinase-dependent and -independent pathways"},{"title3":"Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase"},{"title3":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism"},{"title3":"AMPK in health and disease"},{"title3":"AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis"},{"title3":"AMP-activated kinase (AMPK) promotes innate immunity and antiviral defense through modulation of stimulator of interferon genes (STING) signaling"},{"title3":"Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling"},{"title3":"Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner"},{"title3":"Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system"}]},{"title2":"Metformin protects against infection-induced myocardial dysfunction","References":[{"title3":"A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction?"},{"title3":"Comparable increase B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure"},{"title3":"Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor gamma coactivator-1 signaling"},{"title3":"Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle"},{"title3":"Adaptations and maladaptations of the heart in diabetes, part I: general concepts"},{"title3":"PPARs: diverse regulators in energy metabolism and metabolic diseases"},{"title3":"The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression"},{"title3":"Impairment of glucose metabolism in hearts from rats treated with endotoxin"},{"title3":"AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart"},{"title3":"Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus"},{"title3":"Improved clinical outcomes associated with metformin in patients with diabetes and heart failure"},{"title3":"Role of AMP-activated protein kinase in mechanism of metformin action"},{"title3":"Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease"},{"title3":"AMP-activated protein kinase in metabolic control and insulin signaling"},{"title3":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling"},{"title3":"A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection"},{"title3":"The role of PPARalpha in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats"},{"title3":"Metformin inhibits HMGB1 release in LPS-treated RAW 264. 7 cells and increases survival rate of endotoxaemic mice"},{"title3":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research"},{"title3":"Regulation of adverse remodeling by osteopontin in a genetic heart failure model"},{"title3":"Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy"},{"title3":"Tumor necrosis factor-alpha confers cardioprotection through ectopic expression of keratins K8 and K18"},{"title3":"Optimizing dosage of ketamine and xylazine in murine echocardiography"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method"},{"title3":"Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock"},{"title3":"Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat cardiomyocyte protects against programmed cell death"},{"title3":"Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction"},{"title3":"Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response"},{"title3":"Myocardial fatty acid metabolism in health and disease"},{"title3":"Peroxisome proliferator-activated receptor-gamma activation prevents sepsis-related cardiac dysfunction and mortality in mice"},{"title3":"Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake"},{"title3":"Effect of calpain inhibitor I, an inhibitor of the proteolysis of kappa B, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat"},{"title3":"Stress-hyperglycemia, insulin and immunomodulation in sepsis"},{"title3":"Metformin improves healthspan and lifespan in mice"},{"title3":"Distinct perturbation on the translatome by the antidiabetic drug metformin"},{"title3":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure"},{"title3":"Effect of metformin on survival rate in experimental sepsis"},{"title3":"Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart"},{"title3":"Transcriptional regulation of metabolism"},{"title3":"Metformin-associated lactic acidosis in Sweden 1977-1991"},{"title3":"Autophagy during cardiac remodeling"},{"title3":"Endotoxemia engages the RhoA kinase pathway to impair cardiac function by altering cytoskeleton mitochondrial fission, and autophagy"},{"title3":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases"},{"title3":"Myocarditis: current trends in diagnosis and treatment"},{"title3":"Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart"},{"title3":"Metformin and its clinical use: new insights for an old drug in clinical practice"}]},{"title2":"Metformin and autoimmunity: a &quot;New Deal&quot; of an old drug","References":[]},{"title2":"Sensitivity analysis in observational research: introducing the E-value","References":[]},{"title2":"Comparison of imputation methods for missing laboratory data in medicine","References":[{"title3":"Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines"},{"title3":"Machine learning algorithms outperform conventional regression models in identifying risk factors for hepatocellular carcinoma in patients with cirrhosis"},{"title3":"Multiple imputation of missing blood pressure covariates in survival analysis"},{"title3":"Missing value estimation methods for DNA microarrays"},{"title3":"MissForest:non-parametric missing value imputation for mixed-type data"},{"title3":"Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis"},{"title3":"A general coefficient of similarity and some of its properties"}]},{"title2":"2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","References":[]},{"title2":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension","References":[]},{"title2":"Time-varying covariates and coefficients in Cox regression models","References":[]},{"title2":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","References":[{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Practical recommendations for the management of diabetes in patients with COVID-19"},{"title3":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)"},{"title3":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China"},{"title3":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study"},{"title3":"Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension"},{"title3":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies"},{"title3":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection"},{"title3":"Influence of diabetes mellitus on immunity to human tuberculosis"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind"},{"title3":"Web site and R package for computing E-values"},{"title3":"Factors determining the appearance of glucose in upper and lower respiratory tract secretions"},{"title3":"Benefits and harms of intensive glycemic control in patients with type 2 diabetes"},{"title3":"Multivariate and propensity score matching software with automated balance optimization: the matching package for R"},{"title3":"Penalized survival models and frailty"},{"title3":"Intensive insulin therapy in the medical ICU"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"Comparison of imputation methods for missing laboratory data in medicine"},{"title3":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Innate immune signaling and its role in metabolic and cardiovascular diseases"},{"title3":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"}]}]}]}